<!DOCTYPE html> <!--[if lt IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8 lt-ie7"> <![endif]--> <!--[if IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8"> <![endif]--> <!--[if IE 8]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9"> <![endif]--> <!--[if gt IE 8]><!--> <html class="aui ltr" dir="ltr" lang="en-US" prefix="og: http://ogp.me/ns#"> <!--<![endif]--> <head> <title>Insulin detemir versus insulin glargine for type 2 diabetes mellitus - Swinnen, SG - 2011 | Cochrane Library</title> <meta property="og:title" content="Insulin detemir versus insulin glargine for type 2 diabetes mellitus - Swinnen, SG - 2011 | Cochrane Library" /> <meta property="og:url" content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD006383.pub2/references" /> <meta property="og:type" content="article" /> <meta property=”og:image” content=”https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png” /> <meta content="initial-scale=1.0, width=device-width" name="viewport" /> <meta name="dc.identifier" scheme="DOI" content="10.1002/14651858.CD006383.pub2" /> <meta name="citation_title" content="Insulin detemir versus insulin glargine for type 2 diabetes mellitus" /> <meta name="citation_author" content="Sanne G Swinnen" /> <meta name="citation_author_institution" content="Academic Medical Centre" /> <meta name="citation_author" content="Airin CR Simon" /> <meta name="citation_author_institution" content="Academic Medical Centre" /> <meta name="citation_author_email" content="a.c.simon@amc.uva.nl" /> <meta name="citation_author" content="Frits Holleman" /> <meta name="citation_author_institution" content="Academic Medical Centre" /> <meta name="citation_author" content="Joost B Hoekstra" /> <meta name="citation_author_institution" content="Academic Medical Centre" /> <meta name="citation_author" content="J Hans DeVries" /> <meta name="citation_author_institution" content="Academic Medical Centre" /> <meta name="citation_journal_title" content="Cochrane Database of Systematic Reviews" /> <meta name="citation_publisher" content="John Wiley &amp; Sons, Ltd" /> <meta name="citation_issue" content="7" /> <meta name="citation_doi" content="10.1002/14651858.CD006383.pub2" /> <meta name="citation_date" content="2011" /> <meta name="citation_online_date" content="2011/07/06" /> <meta name="citation_abstract_html_url" content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD006383.pub2/abstract" /> <meta name="citation_fulltext_html_url" content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD006383.pub2/full" /> <meta name="citation_pdf_url" content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD006383.pub2/pdf/CDSR/CD006383/CD006383.pdf" /> <meta name="citation_issn" content="1465-1858" /> <meta name="citation_language" content="en" /> <meta name="citation_keywords" content="Diabetes Mellitus, Type 2 [blood, *drug therapy]; Glycated Hemoglobin A [metabolism]; Hypoglycemic Agents [*therapeutic use]; Insulin [*analogs &amp; derivatives, therapeutic use]; Insulin Detemir; Insulin Glargine; Insulin, Long‐Acting; Randomized Controlled Trials as Topic" /> <script type="text/javascript" src="//script.crazyegg.com/pages/scripts/0056/6375.js" async="async"></script> <script type="text/javascript">window.dataLayer={};var xtend=function(){var a={};var b=false;var c=0;var d=arguments.length;if(Object.prototype.toString.call(arguments[0])==="[object Boolean]"){b=arguments[0];c++}var f=function(g){for(var h in g){if(Object.prototype.hasOwnProperty.call(g,h)){if(b&&Object.prototype.toString.call(g[h])==="[object Object]"){a[h]=xtend(true,a[h],g[h])}else{a[h]=g[h]}}}};for(;c<d;c++){var e=arguments[c];f(e)}return a};</script> <script type="text/javascript">var o={auth:{customerIds:["P#DRAAEAC","EAL00000056729","DRAA3TITLES","TSINGH009S","EAL0001468","EAL00000045347"],individualId:null,brandedCustomer:"EAL0001468",roles:["Guest"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <script type="text/javascript">var o={page:{siteSection:"Content",languageCode:"en",cms:{pageTitle:"Content"}}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <meta content="text/html; charset=UTF-8" http-equiv="content-type" /> <link href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/cochrane-theme/images/favicon.ico" rel="Shortcut Icon" /> <link href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;content&#x3f;templateType&#x3d;references&#x26;urlTitle&#x3d;&#x2f;cdsr&#x2f;doi&#x2f;10&#x2e;1002&#x2f;14651858&#x2e;CD006383&#x2e;pub2&#x26;doi&#x3d;10&#x2e;1002&#x2f;14651858&#x2e;CD006383&#x2e;pub2&#x26;type&#x3d;cdsr&#x26;contentLanguage&#x3d;" rel="canonical" /> <link href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;zh&#x2f;content&#x3f;templateType&#x3d;references&#x26;urlTitle&#x3d;&#x2f;cdsr&#x2f;doi&#x2f;10&#x2e;1002&#x2f;14651858&#x2e;CD006383&#x2e;pub2&#x26;doi&#x3d;10&#x2e;1002&#x2f;14651858&#x2e;CD006383&#x2e;pub2&#x26;type&#x3d;cdsr&#x26;contentLanguage&#x3d;" hreflang="zh-CN" rel="alternate" /> <link href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;zh_TW&#x2f;content&#x3f;templateType&#x3d;references&#x26;urlTitle&#x3d;&#x2f;cdsr&#x2f;doi&#x2f;10&#x2e;1002&#x2f;14651858&#x2e;CD006383&#x2e;pub2&#x26;doi&#x3d;10&#x2e;1002&#x2f;14651858&#x2e;CD006383&#x2e;pub2&#x26;type&#x3d;cdsr&#x26;contentLanguage&#x3d;" hreflang="zh-TW" rel="alternate" /> <link href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;hr&#x2f;content&#x3f;templateType&#x3d;references&#x26;urlTitle&#x3d;&#x2f;cdsr&#x2f;doi&#x2f;10&#x2e;1002&#x2f;14651858&#x2e;CD006383&#x2e;pub2&#x26;doi&#x3d;10&#x2e;1002&#x2f;14651858&#x2e;CD006383&#x2e;pub2&#x26;type&#x3d;cdsr&#x26;contentLanguage&#x3d;" hreflang="hr-HR" rel="alternate" /> <link href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;content&#x3f;templateType&#x3d;references&#x26;urlTitle&#x3d;&#x2f;cdsr&#x2f;doi&#x2f;10&#x2e;1002&#x2f;14651858&#x2e;CD006383&#x2e;pub2&#x26;doi&#x3d;10&#x2e;1002&#x2f;14651858&#x2e;CD006383&#x2e;pub2&#x26;type&#x3d;cdsr&#x26;contentLanguage&#x3d;" hreflang="x-default" rel="alternate" /> <link href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;content&#x3f;templateType&#x3d;references&#x26;urlTitle&#x3d;&#x2f;cdsr&#x2f;doi&#x2f;10&#x2e;1002&#x2f;14651858&#x2e;CD006383&#x2e;pub2&#x26;doi&#x3d;10&#x2e;1002&#x2f;14651858&#x2e;CD006383&#x2e;pub2&#x26;type&#x3d;cdsr&#x26;contentLanguage&#x3d;" hreflang="en-US" rel="alternate" /> <link href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;fr&#x2f;content&#x3f;templateType&#x3d;references&#x26;urlTitle&#x3d;&#x2f;cdsr&#x2f;doi&#x2f;10&#x2e;1002&#x2f;14651858&#x2e;CD006383&#x2e;pub2&#x26;doi&#x3d;10&#x2e;1002&#x2f;14651858&#x2e;CD006383&#x2e;pub2&#x26;type&#x3d;cdsr&#x26;contentLanguage&#x3d;" hreflang="fr-FR" rel="alternate" /> <link href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;de&#x2f;content&#x3f;templateType&#x3d;references&#x26;urlTitle&#x3d;&#x2f;cdsr&#x2f;doi&#x2f;10&#x2e;1002&#x2f;14651858&#x2e;CD006383&#x2e;pub2&#x26;doi&#x3d;10&#x2e;1002&#x2f;14651858&#x2e;CD006383&#x2e;pub2&#x26;type&#x3d;cdsr&#x26;contentLanguage&#x3d;" hreflang="de-DE" rel="alternate" /> <link href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;ja&#x2f;content&#x3f;templateType&#x3d;references&#x26;urlTitle&#x3d;&#x2f;cdsr&#x2f;doi&#x2f;10&#x2e;1002&#x2f;14651858&#x2e;CD006383&#x2e;pub2&#x26;doi&#x3d;10&#x2e;1002&#x2f;14651858&#x2e;CD006383&#x2e;pub2&#x26;type&#x3d;cdsr&#x26;contentLanguage&#x3d;" hreflang="ja-JP" rel="alternate" /> <link href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;ko&#x2f;content&#x3f;templateType&#x3d;references&#x26;urlTitle&#x3d;&#x2f;cdsr&#x2f;doi&#x2f;10&#x2e;1002&#x2f;14651858&#x2e;CD006383&#x2e;pub2&#x26;doi&#x3d;10&#x2e;1002&#x2f;14651858&#x2e;CD006383&#x2e;pub2&#x26;type&#x3d;cdsr&#x26;contentLanguage&#x3d;" hreflang="ko-KR" rel="alternate" /> <link href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;ms&#x2f;content&#x3f;templateType&#x3d;references&#x26;urlTitle&#x3d;&#x2f;cdsr&#x2f;doi&#x2f;10&#x2e;1002&#x2f;14651858&#x2e;CD006383&#x2e;pub2&#x26;doi&#x3d;10&#x2e;1002&#x2f;14651858&#x2e;CD006383&#x2e;pub2&#x26;type&#x3d;cdsr&#x26;contentLanguage&#x3d;" hreflang="ms-MY" rel="alternate" /> <link href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;fa&#x2f;content&#x3f;templateType&#x3d;references&#x26;urlTitle&#x3d;&#x2f;cdsr&#x2f;doi&#x2f;10&#x2e;1002&#x2f;14651858&#x2e;CD006383&#x2e;pub2&#x26;doi&#x3d;10&#x2e;1002&#x2f;14651858&#x2e;CD006383&#x2e;pub2&#x26;type&#x3d;cdsr&#x26;contentLanguage&#x3d;" hreflang="fa-IR" rel="alternate" /> <link href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;pl&#x2f;content&#x3f;templateType&#x3d;references&#x26;urlTitle&#x3d;&#x2f;cdsr&#x2f;doi&#x2f;10&#x2e;1002&#x2f;14651858&#x2e;CD006383&#x2e;pub2&#x26;doi&#x3d;10&#x2e;1002&#x2f;14651858&#x2e;CD006383&#x2e;pub2&#x26;type&#x3d;cdsr&#x26;contentLanguage&#x3d;" hreflang="pl-PL" rel="alternate" /> <link href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;pt&#x2f;content&#x3f;templateType&#x3d;references&#x26;urlTitle&#x3d;&#x2f;cdsr&#x2f;doi&#x2f;10&#x2e;1002&#x2f;14651858&#x2e;CD006383&#x2e;pub2&#x26;doi&#x3d;10&#x2e;1002&#x2f;14651858&#x2e;CD006383&#x2e;pub2&#x26;type&#x3d;cdsr&#x26;contentLanguage&#x3d;" hreflang="pt-PT" rel="alternate" /> <link href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;ru&#x2f;content&#x3f;templateType&#x3d;references&#x26;urlTitle&#x3d;&#x2f;cdsr&#x2f;doi&#x2f;10&#x2e;1002&#x2f;14651858&#x2e;CD006383&#x2e;pub2&#x26;doi&#x3d;10&#x2e;1002&#x2f;14651858&#x2e;CD006383&#x2e;pub2&#x26;type&#x3d;cdsr&#x26;contentLanguage&#x3d;" hreflang="ru-RU" rel="alternate" /> <link href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;es&#x2f;content&#x3f;templateType&#x3d;references&#x26;urlTitle&#x3d;&#x2f;cdsr&#x2f;doi&#x2f;10&#x2e;1002&#x2f;14651858&#x2e;CD006383&#x2e;pub2&#x26;doi&#x3d;10&#x2e;1002&#x2f;14651858&#x2e;CD006383&#x2e;pub2&#x26;type&#x3d;cdsr&#x26;contentLanguage&#x3d;" hreflang="es-ES" rel="alternate" /> <link href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;ta&#x2f;content&#x3f;templateType&#x3d;references&#x26;urlTitle&#x3d;&#x2f;cdsr&#x2f;doi&#x2f;10&#x2e;1002&#x2f;14651858&#x2e;CD006383&#x2e;pub2&#x26;doi&#x3d;10&#x2e;1002&#x2f;14651858&#x2e;CD006383&#x2e;pub2&#x26;type&#x3d;cdsr&#x26;contentLanguage&#x3d;" hreflang="ta-IN" rel="alternate" /> <link href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;th&#x2f;content&#x3f;templateType&#x3d;references&#x26;urlTitle&#x3d;&#x2f;cdsr&#x2f;doi&#x2f;10&#x2e;1002&#x2f;14651858&#x2e;CD006383&#x2e;pub2&#x26;doi&#x3d;10&#x2e;1002&#x2f;14651858&#x2e;CD006383&#x2e;pub2&#x26;type&#x3d;cdsr&#x26;contentLanguage&#x3d;" hreflang="th-TH" rel="alternate" /> <link class="lfr-css-file" href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;cochrane-theme&#x2f;css&#x2f;main&#x2e;css&#x3f;browserId&#x3d;other&#x26;themeId&#x3d;cochrane_WAR_cochranetheme&#x26;minifierType&#x3d;css&#x26;languageId&#x3d;en_US&#x26;b&#x3d;6210&#x26;t&#x3d;1581423095000" rel="stylesheet" type="text/css" /> <link class="lfr-css-file" href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;cochrane-theme&#x2f;css&#x2f;aui&#x2e;css&#x3f;browserId&#x3d;other&#x26;themeId&#x3d;cochrane_WAR_cochranetheme&#x26;minifierType&#x3d;css&#x26;languageId&#x3d;en_US&#x26;b&#x3d;6210&#x26;t&#x3d;1581423095000" rel="stylesheet" type="text/css" /> <link href="&#x2f;html&#x2f;css&#x2f;main&#x2e;css&#x3f;browserId&#x3d;other&#x26;themeId&#x3d;cochrane_WAR_cochranetheme&#x26;minifierType&#x3d;css&#x26;languageId&#x3d;en_US&#x26;b&#x3d;6210&#x26;t&#x3d;1559916431000" rel="stylesheet" type="text/css" /> <link href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/scolaris-content-display/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1581717691000" rel="stylesheet" type="text/css" /> <link href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/notifications-portlet/notifications/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1581717708000" rel="stylesheet" type="text/css" /> <link href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/html/portlet/login/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1581717784000" rel="stylesheet" type="text/css" /> <script type="text/javascript">var Liferay={Browser:{acceptsGzip:function(){return false},getMajorVersion:function(){return 13},getRevision:function(){return"605.1"},getVersion:function(){return"13.0"},isAir:function(){return false},isChrome:function(){return false},isFirefox:function(){return false},isGecko:function(){return true},isIe:function(){return false},isIphone:function(){return false},isLinux:function(){return false},isMac:function(){return true},isMobile:function(){return false},isMozilla:function(){return false},isOpera:function(){return false},isRtf:function(){return true},isSafari:function(){return true},isSun:function(){return false},isWap:function(){return false},isWapXhtml:function(){return false},isWebKit:function(){return true},isWindows:function(){return false},isWml:function(){return false}},Data:{NAV_SELECTOR:"#navigation",isCustomizationView:function(){return false},notices:[null]},ThemeDisplay:{getLayoutId:function(){return"7"},getLayoutURL:function(){return"https://www.cochranelibrary.com/en/content"},getParentLayoutId:function(){return"0"},isPrivateLayout:function(){return"false"},isVirtualLayout:function(){return false},getBCP47LanguageId:function(){return"en-US"},getCDNBaseURL:function(){return"https://www.cochranelibrary.com"},getCDNDynamicResourcesHost:function(){return""},getCDNHost:function(){return""},getCompanyId:function(){return"20155"},getCompanyGroupId:function(){return"20195"},getDefaultLanguageId:function(){return"en_US"},getDoAsUserIdEncoded:function(){return""},getLanguageId:function(){return"en_US"},getParentGroupId:function(){return"20182"},getPathContext:function(){return""},getPathImage:function(){return"/image"},getPathJavaScript:function(){return"/html/js"},getPathMain:function(){return"/en/c"},getPathThemeImages:function(){return"https://www.cochranelibrary.com/cochrane-theme/images"},getPathThemeRoot:function(){return"/cochrane-theme"},getPlid:function(){return"20757"},getPortalURL:function(){return"https://www.cochranelibrary.com"},getPortletSetupShowBordersDefault:function(){return true},getScopeGroupId:function(){return"20182"},getScopeGroupIdOrLiveGroupId:function(){return"20182"},getSessionId:function(){return""},getSiteGroupId:function(){return"20182"},getURLControlPanel:function(){return"/group/control_panel?refererPlid=20757"},getURLHome:function(){return"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane"},getUserId:function(){return"20159"},getUserName:function(){return""},isAddSessionIdToURL:function(){return false},isFreeformLayout:function(){return false},isImpersonated:function(){return false},isSignedIn:function(){return false},isStateExclusive:function(){return false},isStateMaximized:function(){return false},isStatePopUp:function(){return false}},PropsValues:{NTLM_AUTH_ENABLED:false}};var themeDisplay=Liferay.ThemeDisplay;Liferay.AUI={getAvailableLangPath:function(){return"available_languages.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1559916434000"},getCombine:function(){return true},getComboPath:function(){return"/combo/?browserId=other&minifierType=&languageId=en_US&b=6210&t=1559916434000&"},getFilter:function(){return"min"},getJavaScriptRootPath:function(){return"/html/js"},getLangPath:function(){return"aui_lang.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1559916434000"},getStaticResourceURLParams:function(){return"?browserId=other&minifierType=&languageId=en_US&b=6210&t=1559916434000"}};Liferay.authToken="y8F68iId";Liferay.currentURL="\x2fweb\x2fcochrane\x2fcontent\x3ftemplateType\x3dreferences\x26urlTitle\x3d\x2fcdsr\x2fdoi\x2f10\x2e1002\x2f14651858\x2eCD006383\x2epub2\x26doi\x3d10\x2e1002\x2f14651858\x2eCD006383\x2epub2\x26type\x3dcdsr\x26contentLanguage\x3d";Liferay.currentURLEncoded="\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dreferences\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD006383\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD006383\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D";</script> <script src="/html/js/barebone.jsp?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;colorSchemeId=01&amp;minifierType=js&amp;minifierBundleId=javascript.barebone.files&amp;languageId=en_US&amp;b=6210&amp;t=1559916434000" type="text/javascript"></script> <script type="text/javascript"></script> <script type="text/javascript">var o={database:"CDSR",page:{pageType:"Article References"},article:{availableLanguage:["en","es","ms","ja","fr"],languageCode:"en",accessStatus:"licensed",doi:"10.1002/14651858.CD006383.pub2",title:"Insulin detemir versus insulin glargine for type 2 diabetes mellitus",firstPublishedDate:"Jul 6, 2011 12:00:00 AM",isCurrentVersion:true,editorialGroup:"Cochrane Metabolic and Endocrine Disorders Group",availableParts:["PDF Full","PDF Standard","PDF Abstract","HTML","Comments","Information","References","Stats","Related Content"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <link class="lfr-css-file" href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;cochrane-theme&#x2f;css&#x2f;custom&#x2e;css&#x3f;browserId&#x3d;other&#x26;themeId&#x3d;cochrane_WAR_cochranetheme&#x26;minifierType&#x3d;css&#x26;languageId&#x3d;en_US&#x26;b&#x3d;6210&#x26;t&#x3d;1581423095000" rel="stylesheet" type="text/css" /> <style type="text/css"></style> <script src="//assets.adobedtm.com/6e626c9ec247e474f6b98eb15a79a185cf7e26a5/satelliteLib-b0f13d7a13ebe8b0b1b00a9f0730a084926e292f.js"></script> <!--[if lt IE 9]> <script src="/cochrane-theme/vendor/respond/dest/respond.min.js?t=1581423095000" type="text/javascript"></script> <![endif]--> </head> <body class=" yui3-skin-sam controls-visible guest-site signed-out public-page site"> <div class="site-container"> <a href="#main-content" id="skip-to-content">Skip to Content</a> <div id="js-cookie-message" class="cookie-message cookie-message--hidden system-message-container"> <div class="container"> <a href="#" class="fa fa-times js-cookie-close pull-right" aria-label="Close cookies message"></a> <div class="system-message-wrapper container"> <i class="fa fa-exclamation-triangle" aria-hidden="true"></i> <div class="system-message-title">Cookies</div> <div class="system-message-description"> <p> Our site uses cookies to improve your experience. You can find out more about our use of cookies in About Cookies, including instructions on how to turn off cookies if you wish to do so. By continuing to browse this site you agree to us using cookies as described in <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/N7XGCZUQPW4C675JNSTYTLUDN7XB/WileyCDA/Section/id-813473.html">About Cookies</a>. </p> <a href="#" class="btn secondary js-cookie-close js-cookie-accept">I accept</a> </div> </div> </div> </div> <script>document.body.className=document.body.className+" js_enabled";</script><header> <div class="container"> <div class="branding"> <h1 class="brand-container"> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/"> <span class="brand-name">The Cochrane Library</span> <img class="brand-logo" src="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/cochrane-theme/images/en-US_logo.png" alt="Cochrane Library logo" title="Cochrane Library" /> </a> </h1> <span class="additional-branding"> <p class="brand-message"> <em>Trusted evidence.</em> <em>Informed decisions.</em> <em>Better health.</em> </p> </span> </div> <div class="desktop-search basic-search-container"> <div class="desktop-search-form"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end " id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img id="owel__null__null" src="/scolaris-search/icon.png" alt="" /> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class=" portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_auth=y8F68iId&p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=1&p_p_state=normal&p_p_mode=view&_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input type="hidden" name="searchType" value="basic" /> <input type="hidden" name="facetDisplayName" value="" /> <input type="hidden" name="facetQueryTerm" value="" /> <input type="hidden" name="facetQueryField" value="" /> <input type="hidden" name="facetCategory" value="" /> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select title="Search by options" aria-label="Search by options" name="searchBy" class="custom-select-enabled search-type"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" style="display: none;" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=topics-list&p_p_cacheability=cacheLevelPage"> <select class="search-select-topic-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input type="text" size="30" class="field browser-search search-text ui-autocomplete-input" value="" aria-label="Enter search term" id="searchText" name="searchText" placeholder="Search">
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button type="submit" class="searchByBtn" aria-label="Search">
<i class="fa fa-search" aria-hidden="true"></i>
</button>
</div>
</div>
</fieldset>
</form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=references&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD006383.pub2&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD006383.pub2';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input type="hidden" name="freelabel" id="freelabel" value='Free access'>
<input type="hidden" name="openlabel" id="openlabel" value='Open access'>
</div>
</section>
</div>
</div>
<div class="search-tools-nav">
<a href="/en/browse-by-topic" class="btn secondary">Browse</a>
<a href="/en/advanced-search" class="btn primary advanced-search-button">Advanced search</a>
</div>
</div>
<a href="#" class="toggle-menu-switch"><i class="fa fa-bars" aria-hidden="true"></i> <div class="toggle-menu-text">Open menu</div></a>
</div>
<div class="auxiliary-container">
<div class="container">
<div class="header-auxiliary-menu">
<p class="auxiliary-menu-item access">Access provided by: <strong>Tsinghua University</strong></p>
<div class="auxiliary-menu-item language-selector">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_  portlet-static portlet-static-end  " id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img id="bvrs__null__null" src="/scolaris-language-portlet/icon.png" alt="" /> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class=" portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hr, ja, ko, ms, pl, pt, ru, ta, th, zh, za]"> <a title="Select your preferred language" class="open-language-modal" href="#"> <i class="fa fa-file-text"></i> English </a> <a title="Select your preferred language" class="open-language-modal" href="#"> <i class="fa fa-globe"></i> English </a> </div> <div class="language-selector-modal-content" style="display: none;" data-modal-title="Language selection" data-size="large"> <div class="form-content language-selector-modal"> <div class="row-fluid"> <h3><i class="fa fa-file-text"></i> Cochrane Review language</h3> <p>Select your preferred language for Cochrane Reviews. You will see translated Review sections in your preferred language. Sections without translation will be in English.</p> <div> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=de" class="content-language-selector " data-languagecode="de">Deutsch</a> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=en" class="content-language-selector is-active" data-languagecode="en">English</a> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=es" class="content-language-selector " data-languagecode="es">Español</a> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fa" class="content-language-selector " data-languagecode="fa">فارسی</a> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fr" class="content-language-selector " data-languagecode="fr">Français</a> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hr" class="content-language-selector " data-languagecode="hr">Hrvatski</a> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ja" class="content-language-selector " data-languagecode="ja">日本語</a> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ko" class="content-language-selector " data-languagecode="ko">한국어</a> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ms" class="content-language-selector " data-languagecode="ms">Bahasa Malaysia</a> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pl" class="content-language-selector " data-languagecode="pl">Polski</a> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pt" class="content-language-selector " data-languagecode="pt">Português</a> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ru" class="content-language-selector " data-languagecode="ru">Русский</a> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ta" class="content-language-selector " data-languagecode="ta">தமிழ்</a> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=th" class="content-language-selector " data-languagecode="th">ภาษาไทย</a> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh" class="content-language-selector " data-languagecode="zh">简体中文</a> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=za" class="content-language-selector " data-languagecode="za">繁體中文</a> </div> <h3 class="portal-language-header"><i class="fa fa-globe"></i> Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> <div> <a href="/en/cdsr/doi/10.1002/14651858.CD006383.pub2/references/en" class="portal-language-selector is-active" data-portallanguage="en">English</a> <a href="/es/cdsr/doi/10.1002/14651858.CD006383.pub2/references/es" class="portal-language-selector " data-portallanguage="es">Español</a> </div> </div> <button class="btn primary btn-cancel" type="button">Cancel</button> <a class="btn secondary ok-btn pull-right" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> </div> <div style="display:none"> <input type="hidden" name="freelabel" id="freelabel" value='Free access'>
<input type="hidden" name="openlabel" id="openlabel" value='Open access'>
</div>
</section>
</div>
</div>
<a class="auxiliary-menu-item signin last" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/c/portal/login?p_l_id=20757&redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD006383.pub2%2Freferences" rel="nofollow">
<i class="icon fa fa-user"></i> Sign In
</a>
<span class="auxiliary-container-extended"></span>
</div>
</div>
</div>
<div class="access-provider-mobile">
<p class="access">Access provided by: <strong>Tsinghua University</strong></p>
</div>
</header>
<div class="main-nav-wrapper">
<span class="main-nav-left-extended"></span>
<nav class="main container">
<ul>
<li class=" nav-root-item parent">
<a href="#">Cochrane Reviews<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class=" child-nav-item" id="layout_14" role="presentation">
<a aria-labelledby="layout_14" href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;en&#x2f;cdsr&#x2f;reviews" role="menuitem">
Search Reviews (CDSR)
</a>
</li>
<li class=" child-nav-item" id="layout_15" role="presentation">
<a aria-labelledby="layout_15" href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;en&#x2f;cdsr&#x2f;reviews&#x2f;topics" role="menuitem">
Browse Reviews
</a>
</li>
<li class=" child-nav-item" id="layout_18" role="presentation">
<a aria-labelledby="layout_18" href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;en&#x2f;cdsr&#x2f;table-of-contents" role="menuitem">
Issues
</a>
</li>
<li class=" child-nav-item" id="layout_17" role="presentation">
<a aria-labelledby="layout_17" href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;en&#x2f;cdsr&#x2f;editorials" role="menuitem">
Editorials
</a>
</li>
<li class=" child-nav-item" id="layout_19" role="presentation">
<a aria-labelledby="layout_19" href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;en&#x2f;special-collections" role="menuitem">
Special Collections
</a>
</li>
<li class=" child-nav-item" id="layout_20" role="presentation">
<a aria-labelledby="layout_20" href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;en&#x2f;cdsr&#x2f;supplements" role="menuitem">
Supplements
</a>
</li>
<li class=" child-nav-item" id="layout_13" role="presentation">
<a aria-labelledby="layout_13" href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;en&#x2f;cdsr&#x2f;about-cdsr" role="menuitem">
About the CDSR
</a>
</li>
</ul>
</li>
<li class=" nav-root-item parent">
<a href="#">Trials<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class=" child-nav-item" id="layout_22" role="presentation">
<a aria-labelledby="layout_22" href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;en&#x2f;central" role="menuitem">
Search Trials (CENTRAL)
</a>
</li>
<li class=" child-nav-item" id="layout_114" role="presentation">
<a aria-labelledby="layout_114" href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;en&#x2f;central&#x2f;about-central" role="menuitem">
About CENTRAL
</a>
</li>
</ul>
</li>
<li class=" nav-root-item parent">
<a href="#">Clinical Answers<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class=" child-nav-item" id="layout_29" role="presentation">
<a aria-labelledby="layout_29" href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;en&#x2f;cca" role="menuitem">
Browse Clinical Answers
</a>
</li>
<li class=" child-nav-item" id="layout_91" role="presentation">
<a aria-labelledby="layout_91" href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;en&#x2f;cca&#x2f;about" role="menuitem">
About Clinical Answers
</a>
</li>
</ul>
</li>
<li class=" nav-root-item parent">
<a href="#">About<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class=" child-nav-item" id="layout_116" role="presentation">
<a aria-labelledby="layout_116" href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;en&#x2f;about&#x2f;about-cochrane-library" role="menuitem">
About the Cochrane Library
</a>
</li>
<li class=" child-nav-item" id="layout_34" role="presentation">
<a aria-labelledby="layout_34" href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochrane&#x2e;org&#x2f;about-us" role="menuitem">
About Cochrane
</a>
</li>
<li class=" child-nav-item" id="layout_121" role="presentation">
<a aria-labelledby="layout_121" href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;en&#x2f;about&#x2f;about-cochrane-reviews" role="menuitem">
About Cochrane Reviews
</a>
</li>
<li class=" child-nav-item" id="layout_92" role="presentation">
<a aria-labelledby="layout_92" href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;en&#x2f;about&#x2f;author-information" role="menuitem">
Information for authors
</a>
</li>
<li class=" child-nav-item" id="layout_188" role="presentation">
<a aria-labelledby="layout_188" href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;en&#x2f;about&#x2f;releases" role="menuitem">
What&#039;s new
</a>
</li>
</ul>
</li>
<li class=" nav-root-item parent">
<a href="#">Help<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class=" child-nav-item" id="layout_177" role="presentation">
<a aria-labelledby="layout_177" href="https&#x3a;&#x2f;&#x2f;www&#x2e;wiley&#x2e;com&#x2f;network&#x2f;cochranelibrarytraining" role="menuitem">
Cochrane Library Training
</a>
</li>
<li class=" child-nav-item" id="layout_44" role="presentation">
<a aria-labelledby="layout_44" href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;en&#x2f;help&#x2f;access" role="menuitem">
Access options
</a>
</li>
<li class=" child-nav-item" id="layout_150" role="presentation">
<a aria-labelledby="layout_150" href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;en&#x2f;help&#x2f;permissions" role="menuitem">
Permissions and reprints
</a>
</li>
<li class=" child-nav-item" id="layout_93" role="presentation">
<a aria-labelledby="layout_93" href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;en&#x2f;help&#x2f;media" role="menuitem">
Media information
</a>
</li>
<li class=" child-nav-item" id="layout_97" role="presentation">
<a aria-labelledby="layout_97" href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;en&#x2f;help&#x2f;contact-us" role="menuitem">
Contact us
</a>
</li>
<li class=" child-nav-item" id="layout_125" role="presentation">
<a aria-labelledby="layout_125" href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;en&#x2f;about&#x2f;terms-and-conditions" role="menuitem">
Terms and conditions
</a>
</li>
<li class=" child-nav-item" id="layout_176" role="presentation">
<a aria-labelledby="layout_176" href="https&#x3a;&#x2f;&#x2f;hub&#x2e;wiley&#x2e;com&#x2f;docs&#x2f;cochrane-library&#x2f;cochrane-library-known-issues-DOC-16221&#x3f;referrer&#x3d;cochrane" role="menuitem">
Known issues
</a>
</li>
</ul>
</li>
<li class="about-link"><a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TT655TMH/about-us" target="_blank"><span>About Cochrane</span><i class="fa fa-caret-right"></i></a></li>
</ul>
</nav>
</div>
<div class="portlet-boundary portlet-boundary_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_  portlet-static portlet-static-end  " id="p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_">
<span id="p_scolariscontentlanguagebanner_WAR_scolarislanguageportlet"></span>
<section class="portlet" id="portlet_scolariscontentlanguagebanner_WAR_scolarislanguageportlet">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Language\x20Banner\x20Portlet')">
<img id="etlj__null__null" src="/scolaris-language-portlet/icon.png" alt="" /> <span class="taglib-text hide-accessible">Scolaris Content Language Banner Portlet</span> </span> <span class="portlet-title-text">Scolaris Content Language Banner Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentlanguagebanner_WAR_scolarislanguageportlet" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class=" portlet-content-container"> <div class="portlet-body"> <section class="content-language-banner system-message-container" data-content-language="en" data-portal-language="en" style="display: none"> <div class="container"> <a href="#0" class="fa fa-times content-language-banner-close pull-right" aria-label="Close"></a> <i class="fa fa-globe" aria-hidden="true"></i> <div class="system-message-title">Content Language Selection</div> <div class="system-message-description">Your language preference is set to <strong class="language">English</strong>. Where translations are available, article sections will display in this language. Return to <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=reset-content-language&p_p_cacheability=cacheLevelPage" class="language secondary">English</a>.</div> </div> </section> </div> </div> </div> <div style="display:none"> <input type="hidden" name="freelabel" id="freelabel" value='Free access'>
<input type="hidden" name="openlabel" id="openlabel" value='Open access'>
</div>
</section>
</div>
<div id="content" class="">
<div class="columns-1" id="main-content" role="main">
<div class="portlet-layout row-fluid">
<div class="portlet-column portlet-column-only span12" id="column-1">
<div class="portlet-dropzone portlet-column-content portlet-column-content-only" id="layout-column_column-1">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_  portlet-static portlet-static-end scolaris-content-display-portlet " id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img id="rjus__column1__0" src="/scolaris-content-display/icon.png" alt="" /> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class=" portlet-content-container"> <div class="portlet-body"> <div class="publication cdsr container"> <div class="article-navigation-container" id="cdsr-nav"> <nav class="article-navigation"> <ul class="tools"> <li class="cdsr-nav-link pulldown-menu readcube-menu closed"> <a href="#0" class="pulldown-menu-trigger"> <i class="icon fa fa-file-pdf-o"></i>View PDF <i aria-hidden="true" class="fa fa-caret-up"></i> <i aria-hidden="true" class="fa fa-caret-down"></i> </a> <ul class="pulldown-menu-items"> <li class=""> <a href="/cdsr/doi/10.1002/14651858.CD006383.pub2/pdf/full/en" class="download media pdf-link-full pdf-link" title="Article in PDF format"> <span class="readcube-label "> Full </span> <span class="readcube-description "> All content </span> </a> <a href="/cdsr/doi/10.1002/14651858.CD006383.pub2/epdf/full/en" class="download media pdf-link-full readcube-epdf-link" title="Article in PDF format"> <span class="readcube-label "> Full </span> <span class="readcube-description "> All content </span> </a> </li> <li class=""> <a href="/cdsr/doi/10.1002/14651858.CD006383.pub2/pdf/standard/en" class="download media pdf-link-standard pdf-link" title="Article in PDF format"> <span class="readcube-label "> Standard </span> <span class="readcube-description "> Excludes data and analyses, and appendices </span> </a> <a href="/cdsr/doi/10.1002/14651858.CD006383.pub2/epdf/standard/en" class="download media pdf-link-standard readcube-epdf-link" title="Article in PDF format"> <span class="readcube-label "> Standard </span> <span class="readcube-description "> Excludes data and analyses, and appendices </span> </a> </li> <li class=""> <a href="/cdsr/doi/10.1002/14651858.CD006383.pub2/pdf/abstract/en" class="download media pdf-link-abstract pdf-link" title="Article in PDF format"> <span class="readcube-label "> Summary </span> <span class="readcube-description "> Abstract and plain language summary only </span> </a> <a href="/cdsr/doi/10.1002/14651858.CD006383.pub2/epdf/abstract/en" class="download media pdf-link-abstract readcube-epdf-link" title="Article in PDF format"> <span class="readcube-label "> Summary </span> <span class="readcube-description "> Abstract and plain language summary only </span> </a> </li> </ul> </li> <li class="cdsr-nav-link cite-article-link" data-article-id="CD006383.PUB2" data-modal-title="Cite this Review"> <a href="/cdsr/doi/10.1002/14651858.CD006383.pub2/#"> <i class="icon fa fa-share"></i>Cite this Review </a> </li> <li class="cdsr-nav-link"> <a class="request-permissions" data-english-only-message="Please note, that requesting permissions is available in English only. Apologies for any inconvenience." href="/cdsr/doi/10.1002/14651858.CD006383.pub2/#" data-copyright="Copyright © 2011 The Cochrane Collaboration. Published by John Wiley &amp; Sons, Ltd." data-creative-commons="false"> <span class="request-permissions-icon"></span> Request Permissions </a> </li> <li class="cdsr-nav-link comment-on-review"> <a id="comment-on-review" class="js-old-version-modal-trigger" href="/cdsr/doi/10.1002/14651858.CD006383.pub2/comment" data-new-version="" data-english-only-message="Please note, that commenting is available in English only. Apologies for any inconvenience."> <i class="icon fa fa-comment"></i>Comment on Review </a> </li> <li class="cdsr-nav-link comment-on"> <span>Read comments on this Review(0)</span> </li> </ul> <ul class="share clearfix"> <li class="cdsr-nav-link print-cdsr-link" data-print-urlbase="/cdsr/doi/10.1002/14651858.CD006383.pub2/print" data-content-language="en" data-indicator-tooltip="scolaris.print.modal.language.tooltip.en" data-print-options="[{&quot;param&quot;: &quot;abstract&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Abstract&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé scientifique&quot;},{&quot;language&quot;:&quot;ja&quot;,&quot;title&quot;:&quot;アブストラクト&quot;}]},{&quot;param&quot;: &quot;pls&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Plain language summary&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen en términos sencillos&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé simplifié&quot;},{&quot;language&quot;:&quot;ms&quot;,&quot;title&quot;:&quot;Ringkasan bahasa mudah&quot;}]},{&quot;param&quot;: &quot;conclusions&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors' conclusions&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Conclusiones de los autores&quot;}]},{&quot;param&quot;: &quot;summaryOfFindings&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Summary of findings&quot;}]},{&quot;param&quot;: &quot;background&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Background&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Antecedentes&quot;}]},{&quot;param&quot;: &quot;objectives&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Objectives&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Objetivos&quot;}]},{&quot;param&quot;: &quot;methods&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Methods&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Métodos&quot;}]},{&quot;param&quot;: &quot;results&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Results&quot;}]},{&quot;param&quot;: &quot;discussion&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Discussion&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Discusión&quot;}]},{&quot;param&quot;: &quot;references&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;References&quot;}]},{&quot;param&quot;: &quot;characteristics&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Characteristics of studies&quot;}]},{&quot;param&quot;: &quot;data&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Data and analysis&quot;}]},{&quot;param&quot;: &quot;information&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Information&quot;}]},{&quot;param&quot;: &quot;authors&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors&quot;}]},{&quot;param&quot;: &quot;appendices&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Appendices&quot;}]}]"> <a href="/cdsr/doi/10.1002/14651858.CD006383.pub2/#"> <i class="icon fa fa-print"></i>Print </a> </li> <li class="cdsr-nav-link share-cdsr-link" data-share-url="/cdsr/doi/10.1002/14651858.CD006383.pub2/full"> <a href="/cdsr/doi/10.1002/14651858.CD006383.pub2/#"> <i class="icon fa fa-share-alt"></i>Share </a> </li> <li class="cdsr-nav-link"> <a href="/c/portal/login" class="article-not-followed cochrane-link signin"> <span class="article-follow-display"><i class="icon fa fa-plus"></i>Follow</span> </a> </li> </ul> <ul id="linked-articles" data-type="cdsr" class="linked-content tools clearfix linked-content-trigger"> <li> <a href="#0"> <span class="linked-to-this"> Linked to this Review <span class="linked-content-count"></span> </span> <i aria-hidden="true" class="fa fa-caret-down"></i> </a> </li> </ul> <ul class="linked-content-dropdown"> <li data-type="cca" class="linked-cca"> <p>Cochrane Clinical Answers</p> </li> <li data-type="editorial" class="linked-editorials"> <p>Editorials</p> </li> <li data-type="podcast" class="linked-podcasts"> <p>Podcasts</p> </li> <li data-type="sc" class="linked-sc"> <p>Special Collections</p> </li> </ul> <ul class="nav-long-form"> <li class="cdsr-nav-link bold-nav-link "> <a href="/cdsr/doi/10.1002/14651858.CD006383.pub2/full"> Abstract </a> </li> <li class="cdsr-nav-link bold-nav-link "> <a href="/cdsr/doi/10.1002/14651858.CD006383.pub2/full#CD006383-abs-0005"> Plain language summary </a> </li> <li class="cdsr-nav-link bold-nav-link "> <a href="/cdsr/doi/10.1002/14651858.CD006383.pub2/full#CD006383-sec1-0007"> Authors' conclusions </a> </li> <li class="cdsr-nav-link bold-nav-link "> <a href="/cdsr/doi/10.1002/14651858.CD006383.pub2/full#CD006383-sec1-0001"> Summary of findings </a> </li> <li class="cdsr-nav-link "> <a href="/cdsr/doi/10.1002/14651858.CD006383.pub2/full#CD006383-sec1-0002"> Background </a> </li> <li class="cdsr-nav-link "> <a href="/cdsr/doi/10.1002/14651858.CD006383.pub2/full#CD006383-sec1-0003"> Objectives </a> </li> <li class="cdsr-nav-link "> <a href="/cdsr/doi/10.1002/14651858.CD006383.pub2/full#CD006383-sec1-0004"> Methods </a> </li> <li class="cdsr-nav-link "> <a href="/cdsr/doi/10.1002/14651858.CD006383.pub2/full#CD006383-sec1-0005"> Results </a> </li> <li class="cdsr-nav-link "> <a href="/cdsr/doi/10.1002/14651858.CD006383.pub2/full#CD006383-sec1-0006"> Discussion </a> </li> </ul> <ul class="tools"> <li class="cdsr-nav-link "> <a href="/cdsr/doi/10.1002/14651858.CD006383.pub2/appendices#CD006383-sec1-0012"> Appendices </a> </li> </ul> <ul> <li class="cdsr-nav-link article-section-link"> <a href="/cdsr/doi/10.1002/14651858.CD006383.pub2/information"> Information </a> </li> <li class="cdsr-nav-link article-section-link"> <a href="/cdsr/doi/10.1002/14651858.CD006383.pub2/information#authors"> Authors </a> </li> <li class="cdsr-nav-link article-section-link"> <a href="/cdsr/doi/10.1002/14651858.CD006383.pub2/information#history"> History </a> </li> <li class="cdsr-nav-link article-section-link"> <a href="/cdsr/doi/10.1002/14651858.CD006383.pub2/information#keywords"> Keywords </a> </li> </ul> <ul> <li class="cdsr-nav-link bold-nav-link translation-notes-link"> <a href="/cdsr/doi/10.1002/14651858.CD006383.pub2/#"> <i class="icon fa fa-globe"></i>Translation notes </a> </li> </ul> <ul> <li class="cdsr-nav-link references-link"> <a href="/cdsr/doi/10.1002/14651858.CD006383.pub2/references"> References </a> </li> <li class="cdsr-nav-link references-link"> <a href="/cdsr/doi/10.1002/14651858.CD006383.pub2/references#characteristicStudies"> Characteristics of studies </a> </li> <li class="cdsr-nav-link references-link"> <a href="/cdsr/doi/10.1002/14651858.CD006383.pub2/references#dataAndAnalyses"> Data and analyses </a> </li> </ul> <ul class="tools"> <li class="cdsr-nav-link "> <a class="figures-and-tables-link" href="/cdsr/doi/10.1002/14651858.CD006383.pub2/#"> <i class="icon fa fa-line-chart"></i>Figures and tables </a> </li> <li class="cdsr-nav-link download-stats-data-link " data-download-href="/cdsr/doi/10.1002/14651858.CD006383.pub2/media/CDSR/CD006383/table_n/CD006383StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> <a href="/cdsr/doi/10.1002/14651858.CD006383.pub2/media/CDSR/CD006383/table_n/CD006383StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> <i class="icon fa fa-download"></i>Download statistical data </a> </li> <li class="cdsr-nav-link "> <a href="/cdsr/doi/10.1002/14651858.CD006383.pub2/related-content"> <i class="icon fa fa-sitemap fa-rotate-270"></i>Related content <span class="note podcast-indicator">Podcast available</span> </a> </li> </ul> </nav> </div> <article class="information" data-article-id="CD006383.PUB2"> <header> <h1 class="publication-title"><h1 lang="en" class="publication-title">Insulin detemir versus insulin glargine for type 2 diabetes mellitus</h1></h1> </header> <div class="publication-control-bar"> <span class="publication-control-button publication-control-collapse"> Collapse all </span> <span class="publication-control-button publication-control-expand"> Expand all </span> </div><h2 class="title section-collapse-title"> References <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <section class="references bibliographies" id="references"> <section> <div class="section-header" id="CD006383-bbs1-0001"> <h3 class="title">References to studies included in this review</h3> <div class="jump-to"> <p>Jump to: </p> <ul class="jump-to-links"> <li><a class="jump-to" href="#CD006383-bbs1-0002">excluded studies</a></li> <li><a class="jump-to" href="#CD006383-bbs1-0003">ongoing studies</a></li> <li><a class="jump-to" href="#CD006383-bbs1-0004">additional references</a></li> </ul> </div> </div> <div class="bibliographies references_includedStudies" id="CD006383-bbs2-0001"> <div class="reference-title-banner"> <h4 class="title">Hollander 2008 {published and unpublished data} </h4> </div> <div class="bibliography-section" id="CD006383-bib-0001"> <div class="citation-journal">Hollander P, Cooper J, Bregnhøi J, Pedersen CB. <span class="citation-title">A 52‐week, multinational, open‐label, parallel‐group, noninferiority, treat‐to‐target trial comparing insulin detemir with insulin glargine in a basal‐bolus regimen with mealtime insulin aspart in patients with type 2 diabetes</span>. <span class="citation"> Clinical Therapeutics </span><span class="pubYear">2008</span>;<span class="volume">30</span>:1976‐87. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/19108786" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=A+52%E2%80%90week,+multinational,+open%E2%80%90label,+parallel%E2%80%90group,+noninferiority,+treat%E2%80%90to%E2%80%90target+trial+comparing+insulin+detemir+with+insulin+glargine+in+a+basal%E2%80%90bolus+regimen+with+mealtime+insulin+aspart+in+patients+with+type+2+diabetes+&author=P+Hollander&author=J+Cooper&author=J+Bregnh%C3%B8i&author=CB+Pedersen&publication_year=2008&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD006383-bbs2-0002"> <div class="reference-title-banner"> <h4 class="title">Raskin 2009 {published and unpublished data} </h4> </div> <div class="bibliography-section" id="CD006383-bib-0002"> <div class="citation-journal">Raskin P, Gylvin T, Weng W, Chaykin L. <span class="citation-title">Comparison of insulin detemir and insulin glargine using a basal‐bolus regimen in a randomized, controlled clinical study in patients with type 2 diabetes</span>. <span class="citation"> Diabetes Metabolism Research and Reviews </span><span class="pubYear">2009</span>;<span class="volume">25</span>:542‐8. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/19565569" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Comparison+of+insulin+detemir+and+insulin+glargine+using+a+basal%E2%80%90bolus+regimen+in+a+randomized,+controlled+clinical+study+in+patients+with+type+2+diabetes+&author=P+Raskin&author=T+Gylvin&author=W+Weng&author=L+Chaykin&publication_year=2009&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD006383-bbs2-0003"> <div class="reference-title-banner"> <h4 class="title">Rosenstock 2008 {published and unpublished data} </h4> </div> <div class="bibliography-section" id="CD006383-bib-0003"> <div class="citation-journal">Rosenstock J, Davies M, Home PD, Larsen J, Koenen C, Schernthaner G. <span class="citation-title">A randomised, 52‐week, treat‐to‐target trial comparing insulin detemir with insulin glargine when administered as add‐on to glucose‐lowering drugs in insulin‐naive people with type 2 diabetes</span>. <span class="citation"> Diabetologia </span><span class="pubYear">2008</span>;<span class="volume">51</span>:408‐16. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/18204830" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=A+randomised,+52%E2%80%90week,+treat%E2%80%90to%E2%80%90target+trial+comparing+insulin+detemir+with+insulin+glargine+when+administered+as+add%E2%80%90on+to+glucose%E2%80%90lowering+drugs+in+insulin%E2%80%90naive+people+with+type+2+diabetes+&author=J+Rosenstock&author=M+Davies&author=PD+Home&author=J+Larsen&author=C+Koenen&author=G+Schernthaner&publication_year=2008&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD006383-bbs2-0004"> <div class="reference-title-banner"> <h4 class="title">Swinnen 2010a {published and unpublished data} </h4> </div> <div class="bibliography-section" id="CD006383-bib-0004"> <div class="citation-journal">Swinnen SG, Dain MP, Aronson R, Davies M, Gerstein HC, Pfeiffer AF, et al. <span class="citation-title">A 24‐week, randomized, treat‐to‐target trial comparing initiation of insulin glargine once‐daily with insulin detemir twice‐daily in patients with type 2 diabetes inadequately controlled on oral glucose‐lowering drugs</span>. <span class="citation"> Diabetes Care </span><span class="pubYear">2010</span>;<span class="volume">33</span>(6):1176‐8. [MEDLINE: 20200301] <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/20200301" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=A+24%E2%80%90week,+randomized,+treat%E2%80%90to%E2%80%90target+trial+comparing+initiation+of+insulin+glargine+once%E2%80%90daily+with+insulin+detemir+twice%E2%80%90daily+in+patients+with+type+2+diabetes+inadequately+controlled+on+oral+glucose%E2%80%90lowering+drugs+&author=SG+Swinnen&author=MP+Dain&author=R+Aronson&author=M+Davies&author=HC+Gerstein&author=AF+Pfeiffer&publication_year=2010&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> </section> <section> <div class="section-header" id="CD006383-bbs1-0002"> <h3 class="title">References to studies excluded from this review</h3> <div class="jump-to"> <p>Jump to: </p> <ul class="jump-to-links"> <li><a class="jump-to" href="#CD006383-bbs1-0001">included studies</a></li> <li><a class="jump-to" href="#CD006383-bbs1-0003">ongoing studies</a></li> <li><a class="jump-to" href="#CD006383-bbs1-0004">additional references</a></li> </ul> </div> </div> <div class="bibliographies references_excludedStudies" id="CD006383-bbs2-0005"> <div class="reference-title-banner"> <h4 class="title">King 2009 {published data only} </h4> </div> <div class="bibliography-section" id="CD006383-bib-0005"> <div class="citation-journal">King AB. <span class="citation-title">Once‐daily insulin detemir is comparable to once‐daily insulin glargine in providing glycaemic control over 24 h in patients with type 2 diabetes: A double‐blind, randomized, crossover study</span>. <span class="citation"> Diabetes, Obesity and Metabolism </span><span class="pubYear">2009</span>;<span class="volume">11</span>:69‐71. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Once%E2%80%90daily+insulin+detemir+is+comparable+to+once%E2%80%90daily+insulin+glargine+in+providing+glycaemic+control+over+24+h+in+patients+with+type+2+diabetes:+A+double%E2%80%90blind,+randomized,+crossover+study+&author=AB+King&publication_year=2009&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD006383-bbs2-0006"> <div class="reference-title-banner"> <h4 class="title">Klein 2007 {published data only} </h4> </div> <div class="bibliography-section" id="CD006383-bib-0006"> <div class="citation-journal">Klein O, Lynge J, Endahl L, Damholt B, Nosek L, Heise T. <span class="citation-title">Albumin‐bound basal insulin analogues (insulin detemir and NN344): comparable time‐action profiles but less variability than insulin glargine in type 2 diabetes</span>. <span class="citation"> Diabetes, Obesity and Metabolism </span><span class="pubYear">2007</span>;<span class="volume">9</span>:290‐9. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Albumin%E2%80%90bound+basal+insulin+analogues+(insulin+detemir+and+NN344):+comparable+time%E2%80%90action+profiles+but+less+variability+than+insulin+glargine+in+type+2+diabetes+&author=O+Klein&author=J+Lynge&author=L+Endahl&author=B+Damholt&author=L+Nosek&author=T+Heise&publication_year=2007&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD006383-bbs2-0007"> <div class="reference-title-banner"> <h4 class="title">Lucidi 2010 {published data only} </h4> </div> <div class="bibliography-section" id="CD006383-bib-0007"> <div class="citation-other">P. Lucidi, P. Rosetti, F. Porcellati, P. Candeloro, P. Cioli, S. Marzotti, et al. <span class="citation-title">Basal insulin NPH, glargine and detemir in type 2 diabetes: hepatospecificity, effects on glucose and lipid metabolism, and pancreatic islet alpha and beta cell rest: a PK‐PD study</span>. Diabetologia. <span class="pubYear">2010</span>; Vol. 53:S391. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Basal+insulin+NPH,+glargine+and+detemir+in+type+2+diabetes:+hepatospecificity,+effects+on+glucose+and+lipid+metabolism,+and+pancreatic+islet+alpha+and+beta+cell+rest:+a+PK%E2%80%90PD+study+&author=Lucidi+P.&author=Rosetti+P.&author=Porcellati+F.&author=Candeloro+P.&author=Cioli+P.&author=Marzotti+S.&publication_year=2010&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD006383-bbs2-0008"> <div class="reference-title-banner"> <h4 class="title">Matsuura K 2009 {published data only} </h4> </div> <div class="bibliography-section" id="CD006383-bib-0008"> <div class="citation-other">Matsuura K, Mori Y, Itoh Y, Yokoyama J, Tajima N. <span class="citation-title">Effect of miglitol on 24‐hour glucose fluctuation in type 2 diabetic patients treated with long‐acting insulin glargine or detemir as single agents as assessed by using continuous glucose monitoring</span>. Diabetes. <span class="pubYear">2009</span>; Vol. 58:A131. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Effect+of+miglitol+on+24%E2%80%90hour+glucose+fluctuation+in+type+2+diabetic+patients+treated+with+long%E2%80%90acting+insulin+glargine+or+detemir+as+single+agents+as+assessed+by+using+continuous+glucose+monitoring+&author=K+Matsuura&author=Y+Mori&author=Y+Itoh&author=J+Yokoyama&author=N+Tajima&publication_year=2009&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD006383-bbs2-0009"> <div class="reference-title-banner"> <h4 class="title">NCT00566124 {published data only} </h4> </div> <div class="bibliography-section" id="CD006383-bib-0009"> <div class="citation-other"><span class="citation-title">Basal Insulins ‐ Pharmacodynamics</span>. ClinicalTrials.gov<span class="pubYear">2007</span>. <ul class="citation-link-group"> </ul> </div> </div> </div> </section> <section> <div class="section-header" id="CD006383-bbs1-0003"> <h3 class="title">References to ongoing studies</h3> <div class="jump-to"> <p>Jump to: </p> <ul class="jump-to-links"> <li><a class="jump-to" href="#CD006383-bbs1-0001">included studies</a></li> <li><a class="jump-to" href="#CD006383-bbs1-0002">excluded studies</a></li> <li><a class="jump-to" href="#CD006383-bbs1-0004">additional references</a></li> </ul> </div> </div> <div class="bibliographies references_ongoingStudies" id="CD006383-bbs2-0010"> <div class="reference-title-banner"> <h4 class="title">NCT00656422 {published data only} </h4> </div> <div class="bibliography-section" id="CD006383-bib-0010"> <div class="citation-other"><span class="citation-title">Weight gain, eating patterns and development of body composition during initiation of basal insulin therapy in patients with type 2 diabetes: a comparison of insulin detemir and insulin glargine</span>. ClinicalTrials.gov<span class="pubYear">2008</span>. <ul class="citation-link-group"> </ul> </div> </div> </div> <div class="bibliographies references_ongoingStudies" id="CD006383-bbs2-0011"> <div class="reference-title-banner"> <h4 class="title">NCT00699686 {published data only} </h4> </div> <div class="bibliography-section" id="CD006383-bib-0011"> <div class="citation-other"><span class="citation-title">Effects of adding basal insulin on endothelial progenitor cell levels in poorly‐controlled type 2 diabetic patients with cardiovascular disease. A randomised cross‐over study comparing insulin detemir and glargine</span>. ClinicalTrials.gov<span class="pubYear">2008</span>. <ul class="citation-link-group"> </ul> </div> </div> </div> <div class="bibliographies references_ongoingStudies" id="CD006383-bbs2-0012"> <div class="reference-title-banner"> <h4 class="title">NCT00862875 {published data only} </h4> </div> <div class="bibliography-section" id="CD006383-bib-0012"> <div class="citation-other"><span class="citation-title">Effects of basal insulin analogue detemir on body composition, epicardial fat and energy metabolism</span>. ClinicalTrials.gov<span class="pubYear">2009</span>. <ul class="citation-link-group"> </ul> </div> </div> </div> <div class="bibliographies references_ongoingStudies" id="CD006383-bbs2-0013"> <div class="reference-title-banner"> <h4 class="title">NCT00909480 {published data only} </h4> </div> <div class="bibliography-section" id="CD006383-bib-0013"> <div class="citation-other"><span class="citation-title">A 26‐week randomised, multinational, open‐labelled, 2‐armed, parallel group, treat‐to‐target once‐daily treatment trial with insulin detemir versus insulin glargine, both in combination with metformin in subjects with type 2 diabetes</span>. ClinicalTrials.gov<span class="pubYear">2009</span>. <ul class="citation-link-group"> </ul> </div> </div> </div> </section> <section> <div class="section-header" id="CD006383-bbs1-0004"> <h3 class="title">Additional references</h3> <div class="jump-to"> <p>Jump to: </p> <ul class="jump-to-links"> <li><a class="jump-to" href="#CD006383-bbs1-0001">included studies</a></li> <li><a class="jump-to" href="#CD006383-bbs1-0002">excluded studies</a></li> <li><a class="jump-to" href="#CD006383-bbs1-0003">ongoing studies</a></li> </ul> </div> </div> <div class="bibliographies references_additionalReferences" id="CD006383-bbs2-0014"> <div class="reference-title-banner"> <h4 class="title">Albright 2004</h4> </div> <div class="bibliography-section" id="CD006383-bib-0014"> <div class="citation-journal">Albright ES, Desmond R, Bell DS. <span class="citation-title">Efficacy of conversion from bedtime NPH insulin injection to once‐ or twice‐daily injections of insulin glargine in type 1 diabetic patients using basal/bolus therapy.</span>. <span class="citation"> Diabetes Care </span><span class="pubYear">2004</span>;<span class="volume">27</span>(2):632‐2. [MEDLINE: 14747268] <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/14747268" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Efficacy+of+conversion+from+bedtime+NPH+insulin+injection+to+once%E2%80%90+or+twice%E2%80%90daily+injections+of+insulin+glargine+in+type+1+diabetic+patients+using+basal/bolus+therapy.+&author=ES+Albright&author=R+Desmond&author=DS+Bell&publication_year=2004&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD006383-bbs2-0015"> <div class="reference-title-banner"> <h4 class="title">Ashwell 2006</h4> </div> <div class="bibliography-section" id="CD006383-bib-0015"> <div class="citation-journal">Ashwell SG, Gebbie J, Home PD. <span class="citation-title">Twice‐daily compared with once‐daily insulin glargine in people with Type 1 diabetes using meal‐time insulin aspart</span>. <span class="citation"> Diabetic Medicine </span><span class="pubYear">2006</span>;<span class="volume">23</span>(8):879‐86. [MEDLINE: 16911626] <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/16911626" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Twice%E2%80%90daily+compared+with+once%E2%80%90daily+insulin+glargine+in+people+with+Type+1+diabetes+using+meal%E2%80%90time+insulin+aspart+&author=SG+Ashwell&author=J+Gebbie&author=PD+Home&publication_year=2006&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD006383-bbs2-0016"> <div class="reference-title-banner"> <h4 class="title">Bolli 1999</h4> </div> <div class="bibliography-section" id="CD006383-bib-0016"> <div class="citation-journal">Bolli GB, Marchi RD, Park GD, Pramming S, Koivisto VA. <span class="citation-title">Insulin analogues and their potential in the management of diabetes mellitus</span>. <span class="citation"> Diabetologia </span><span class="pubYear">1999</span>;<span class="volume">42</span>:1151‐67. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/10525654" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Insulin+analogues+and+their+potential+in+the+management+of+diabetes+mellitus&author=GB+Bolli&author=RD+Marchi&author=GD+Park&author=S+Pramming&author=VA+Koivisto&publication_year=1999&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD006383-bbs2-0017"> <div class="reference-title-banner"> <h4 class="title">Chapman 2004</h4> </div> <div class="bibliography-section" id="CD006383-bib-0017"> <div class="citation-journal">Chapman TM, Perry CM. <span class="citation-title">Insulin detemir: A review of its use in the management of type 1 and 2 diabetes mellitus</span>. <span class="citation"> Drugs </span><span class="pubYear">2004</span>;<span class="volume">64</span>:2577‐95. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/15516157" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Insulin+detemir:+A+review+of+its+use+in+the+management+of+type+1+and+2+diabetes+mellitus&author=TM+Chapman&author=CM+Perry&publication_year=2004&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD006383-bbs2-0018"> <div class="reference-title-banner"> <h4 class="title">DeVries 2005</h4> </div> <div class="bibliography-section" id="CD006383-bib-0018"> <div class="citation-journal">DeVries JH. <span class="citation-title">To: Scholtz HE, Pretorius SG, Wessels DH, Becker RHA (2005) Pharmacokinetic and glucodynamic variability: assessment of insulin glargine, NPH insulin and insulin ultralente in healthy volunteers using a euglycaemic clamp technique</span>. <span class="citation"> Diabetologia </span><span class="pubYear">2005</span>;<span class="volume">48</span>(10):1988‐95. [MEDLINE: 16520920] <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/16160867" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=To:+Scholtz+HE,+Pretorius+SG,+Wessels+DH,+Becker+RHA+(2005)+Pharmacokinetic+and+glucodynamic+variability:+assessment+of+insulin+glargine,+NPH+insulin+and+insulin+ultralente+in+healthy+volunteers+using+a+euglycaemic+clamp+technique+&author=JH+DeVries&publication_year=2005&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD006383-bbs2-0019"> <div class="reference-title-banner"> <h4 class="title">Havelund 2004</h4> </div> <div class="bibliography-section" id="CD006383-bib-0019"> <div class="citation-journal">Havelund S, Plum A, Ribel U, Jonassen I, Volund A, Markussen J, et al. <span class="citation-title">The mechanism of protraction of insulin detemir, a long‐acting, acylated analog of human insulin</span>. <span class="citation"> Pharmaceutical research </span><span class="pubYear">2004</span>;<span class="volume">21</span>:1498‐504. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/15359587" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=The+mechanism+of+protraction+of+insulin+detemir,+a+long%E2%80%90acting,+acylated+analog+of+human+insulin+&author=S+Havelund&author=A+Plum&author=U+Ribel&author=I+Jonassen&author=A+Volund&author=J+Markussen&publication_year=2004&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD006383-bbs2-0020"> <div class="reference-title-banner"> <h4 class="title">Heinemann 2000</h4> </div> <div class="bibliography-section" id="CD006383-bib-0020"> <div class="citation-journal">Heinemann L, Linkeschova R, Rave K, Hompesch B, Sedlak M, Heise T. <span class="citation-title">Time‐action profile of the long‐acting insulin analog insulin glargine (HOE901) in comparison with those of NPH insulin and placebo</span>. <span class="citation"> Diabetes Care </span><span class="pubYear">2000</span>;<span class="volume">23</span>(5):644‐9. [MEDLINE: 10834424] <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/10834424" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Time%E2%80%90action+profile+of+the+long%E2%80%90acting+insulin+analog+insulin+glargine+(HOE901)+in+comparison+with+those+of+NPH+insulin+and+placebo+&author=L+Heinemann&author=R+Linkeschova&author=K+Rave&author=B+Hompesch&author=M+Sedlak&author=T+Heise&publication_year=2000&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD006383-bbs2-0021"> <div class="reference-title-banner"> <h4 class="title">Heise 2004</h4> </div> <div class="bibliography-section" id="CD006383-bib-0021"> <div class="citation-journal">Heise T, Nosek L, Ronn BB, Endahl L, Heinemann L, Kapitza C, et al. <span class="citation-title">Lower within‐subject variability of insulin detemir in comparison to NPH insulin and insulin glargine in people with type 1 diabetes</span>. <span class="citation"> Diabetes </span><span class="pubYear">2004</span>;<span class="volume">53</span>:1614‐20. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/15161770" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Lower+within%E2%80%90subject+variability+of+insulin+detemir+in+comparison+to+NPH+insulin+and+insulin+glargine+in+people+with+type+1+diabetes+&author=T+Heise&author=L+Nosek&author=BB+Ronn&author=L+Endahl&author=L+Heinemann&author=C+Kapitza&publication_year=2004&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD006383-bbs2-0022"> <div class="reference-title-banner"> <h4 class="title">Hermansen 2006</h4> </div> <div class="bibliography-section" id="CD006383-bib-0022"> <div class="citation-journal">Hermansen K, Davies M, Derezinski T, Martinez G, Clauson P, Home P. <span class="citation-title">A 26‐week, randomized, parallel, treat‐to‐target trial comparing insulin detemir with NPH insulin as add‐on therapy to oral glucose‐lowering drugs in insulin‐naïve people with type 2 diabetes</span>. <span class="citation"> Diabetes Care </span><span class="pubYear">2006</span>;<span class="volume">29</span>:1269‐74. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/16732007" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=A+26%E2%80%90week,+randomized,+parallel,+treat%E2%80%90to%E2%80%90target+trial+comparing+insulin+detemir+with+NPH+insulin+as+add%E2%80%90on+therapy+to+oral+glucose%E2%80%90lowering+drugs+in+insulin%E2%80%90na%C3%AFve+people+with+type+2+diabetes+&author=K+Hermansen&author=M+Davies&author=T+Derezinski&author=G+Martinez&author=P+Clauson&author=P+Home&publication_year=2006&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD006383-bbs2-0023"> <div class="reference-title-banner"> <h4 class="title">Higgins 2002</h4> </div> <div class="bibliography-section" id="CD006383-bib-0023"> <div class="citation-journal">Higgins JP, Thompson SG. <span class="citation-title">Quantifying heterogeneity in a meta‐analysis</span>. <span class="citation"> Statistics in Medicine </span><span class="pubYear">2002</span>;<span class="volume">21</span>(11):1539‐58. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/12111919" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Quantifying+heterogeneity+in+a+meta%E2%80%90analysis&author=JP+Higgins&author=SG+Thompson&publication_year=2002&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD006383-bbs2-0024"> <div class="reference-title-banner"> <h4 class="title">Higgins 2003</h4> </div> <div class="bibliography-section" id="CD006383-bib-0024"> <div class="citation-journal">Higgins JPT, Thompson SG, Deeks JJ, Altman DG. <span class="citation-title">Measuring inconsistency in meta‐analysis</span>. <span class="citation"> BMJ </span><span class="pubYear">2003</span>;<span class="volume">327</span>:557‐60. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/12958120" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Measuring+inconsistency+in+meta%E2%80%90analysis&author=JPT+Higgins&author=SG+Thompson&author=JJ+Deeks&author=DG+Altman&publication_year=2003&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD006383-bbs2-0025"> <div class="reference-title-banner"> <h4 class="title">Higgins 2008</h4> </div> <div class="bibliography-section" id="CD006383-bib-0025"> <div class="citation-other">Higgins JPT, Green S (editors). <span class="citation-title">Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.0 [updated February 2008]</span>. The Cochrane Collaboration, 2008. Available from www.cochrane‐handbook.org. <ul class="citation-link-group"> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD006383-bbs2-0026"> <div class="reference-title-banner"> <h4 class="title">Holleman 2007</h4> </div> <div class="bibliography-section" id="CD006383-bib-0026"> <div class="citation-journal">Holleman F, Gale EA. <span class="citation-title">Nice insulins, pity about the evidence</span>. <span class="citation"> Diabetologia </span><span class="pubYear">2007</span>;<span class="volume">51</span>(4):689‐91. [MEDLINE: 17634918] <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Nice+insulins,+pity+about+the+evidence&author=F+Holleman&author=EA+Gale&publication_year=2007&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD006383-bbs2-0027"> <div class="reference-title-banner"> <h4 class="title">Holman 2008</h4> </div> <div class="bibliography-section" id="CD006383-bib-0027"> <div class="citation-journal">Holman RR, Paul SK, Bethel MA, Matthews DR, Neil HA. <span class="citation-title">10‐year follow‐up of intensive glucose control in type 2 diabetes</span>. <span class="citation"> The New England Journal of Medicine </span><span class="pubYear">2008</span>;<span class="volume">359</span>(15):1577‐89. [MEDLINE: 18784090] <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/18784090" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=10%E2%80%90year+follow%E2%80%90up+of+intensive+glucose+control+in+type+2+diabetes&author=RR+Holman&author=SK+Paul&author=MA+Bethel&author=DR+Matthews&author=HA+Neil&publication_year=2008&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD006383-bbs2-0028"> <div class="reference-title-banner"> <h4 class="title">Horvath 2007</h4> </div> <div class="bibliography-section" id="CD006383-bib-0028"> <div class="citation-journal">Horvath K, Jeitler K, Berghold A, Plank J, Pieber TR, Siebenhofer A. <span class="citation-title">Long acting insulin analogues versus NPH insulin (human isophane insulin) for type 2 diabetes mellitus</span>. <span class="citation"> Cochrane Database of Systematic Reviews </span><span class="pubYear">2007</span>, Issue 2. [DOI: <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MS6C63DQNEYG86UH/10.1002/14651858.CD005613.pub3" target="_blank"><span>10.1002/14651858.CD005613.pub3</span></a>] <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/17443605" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Long+acting+insulin+analogues+versus+NPH+insulin+(human+isophane+insulin)+for+type+2+diabetes+mellitus+&author=K+Horvath&author=K+Jeitler&author=A+Berghold&author=J+Plank&author=TR+Pieber&author=A+Siebenhofer&publication_year=2007&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD006383-bbs2-0029"> <div class="reference-title-banner"> <h4 class="title">Lau 2006</h4> </div> <div class="bibliography-section" id="CD006383-bib-0029"> <div class="citation-journal">Lau J, Ioannidis JPA, Terrin N, Schmid CH, Olkin I. <span class="citation-title">The case of the misleading funnel plot</span>. <span class="citation"> BMJ </span><span class="pubYear">2006</span>;<span class="volume">333</span>:597‐600. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/16974018" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=The+case+of+the+misleading+funnel+plot&author=J+Lau&author=JPA+Ioannidis&author=N+Terrin&author=CH+Schmid&author=I+Olkin&publication_year=2006&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD006383-bbs2-0030"> <div class="reference-title-banner"> <h4 class="title">Liberati 2009</h4> </div> <div class="bibliography-section" id="CD006383-bib-0030"> <div class="citation-journal">Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gøtzsche PC, Ioannidis JPA, et al. <span class="citation-title">The PRISMA Statement for Reporting Systematic and Meta‐Analyses of Studies That Evaluate Interventions: Explanation and Elaboration</span>. <span class="citation"> PLoS Med </span><span class="pubYear">1999</span>;<span class="volume">6</span>(7):1‐28. [DOI: <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MS6C63DQNEYG86UH/10.1371/journal.pmed.1000100" target="_blank"><span>10.1371/journal.pmed.1000100</span></a>] <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=The+PRISMA+Statement+for+Reporting+Systematic+and+Meta%E2%80%90Analyses+of+Studies+That+Evaluate+Interventions:+Explanation+and+Elaboration+&author=A+Liberati&author=DG+Altman&author=J+Tetzlaff&author=C+Mulrow&author=PC+G%C3%B8tzsche&author=JPA+Ioannidis&publication_year=1999&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD006383-bbs2-0031"> <div class="reference-title-banner"> <h4 class="title">Mullins 2007</h4> </div> <div class="bibliography-section" id="CD006383-bib-0031"> <div class="citation-journal">Mullins P, Sharplin P, Yki‐Jarvinen H, Riddle MC, Haring HU. <span class="citation-title">Negative binomial meta‐regression analysis of combined glycosylated hemoglobin and hypoglycemia outcomes across eleven Phase III and IV studies of insulin glargine compared with neutral protamine Hagedorn insulin in type 1 and type 2 diabetes mellitus</span>. <span class="citation"> Clinical Therapeutics </span><span class="pubYear">2007</span>;<span class="volume">29</span>(8):1607‐19. [MEDLINE: 17919543] <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/17919543" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Negative+binomial+meta%E2%80%90regression+analysis+of+combined+glycosylated+hemoglobin+and+hypoglycemia+outcomes+across+eleven+Phase+III+and+IV+studies+of+insulin+glargine+compared+with+neutral+protamine+Hagedorn+insulin+in+type+1+and+type+2+diabetes+mellitus+&author=P+Mullins&author=P+Sharplin&author=H+Yki%E2%80%90Jarvinen&author=MC+Riddle&author=HU+Haring&publication_year=2007&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD006383-bbs2-0032"> <div class="reference-title-banner"> <h4 class="title">Nathan 2006</h4> </div> <div class="bibliography-section" id="CD006383-bib-0032"> <div class="citation-journal">Nathan DM, Buse JB, Davidson MB, Heine RJ, Holman RR, Sherwin R, et al. <span class="citation-title">Management of hyperglycaemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy</span>. <span class="citation"> Diabetologia </span><span class="pubYear">2006</span>;<span class="volume">49</span>:1711‐21. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/16802130" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Management+of+hyperglycaemia+in+type+2+diabetes:+a+consensus+algorithm+for+the+initiation+and+adjustment+of+therapy+&author=DM+Nathan&author=JB+Buse&author=MB+Davidson&author=RJ+Heine&author=RR+Holman&author=R+Sherwin&publication_year=2006&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD006383-bbs2-0033"> <div class="reference-title-banner"> <h4 class="title">Nathan 2009</h4> </div> <div class="bibliography-section" id="CD006383-bib-0033"> <div class="citation-journal">Nathan DM, Buse JB, Davidson MB, Ferrannini E, Holman RR, Sherwin R, et al. <span class="citation-title">Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy</span>. <span class="citation"> Diabetes Care </span><span class="pubYear">2009</span>;<span class="volume">32</span>(1):193‐203. [MEDLINE: 18945920] <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/18945920" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Medical+management+of+hyperglycemia+in+type+2+diabetes:+a+consensus+algorithm+for+the+initiation+and+adjustment+of+therapy+&author=DM+Nathan&author=JB+Buse&author=MB+Davidson&author=E+Ferrannini&author=RR+Holman&author=R+Sherwin&publication_year=2009&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD006383-bbs2-0034"> <div class="reference-title-banner"> <h4 class="title">Plank 2005</h4> </div> <div class="bibliography-section" id="CD006383-bib-0034"> <div class="citation-journal">Plank J, Bodenlenz M, Sinner F, Magnes C, Görzer E, Regittnig W, et al. <span class="citation-title">A double‐blind, randomized, dose‐response study investigating the pharmacodynamic and pharmacokinetic properties of the long‐acting insulin analog detemir</span>. <span class="citation"> Diabetes Care </span><span class="pubYear">2005</span>;<span class="volume">28</span>:1107‐12. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/15855574" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=A+double%E2%80%90blind,+randomized,+dose%E2%80%90response+study+investigating+the+pharmacodynamic+and+pharmacokinetic+properties+of+the+long%E2%80%90acting+insulin+analog+detemir+&author=J+Plank&author=M+Bodenlenz&author=F+Sinner&author=C+Magnes&author=E+G%C3%B6rzer&author=W+Regittnig&publication_year=2005&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD006383-bbs2-0035"> <div class="reference-title-banner"> <h4 class="title">Riddle 2003</h4> </div> <div class="bibliography-section" id="CD006383-bib-0035"> <div class="citation-journal">Riddle MC, Rosenstock J, Gerich J, Insulin Glargine 4002 Study Investigators. <span class="citation-title">The treat‐to‐target trial: randomized addition of glargine or human NPH insulin to oral therapy of type 2 diabetic patients</span>. <span class="citation"> Diabetes Care </span><span class="pubYear">2003</span>;<span class="volume">26</span>(11):3080‐6. [MEDLINE: 14578243] <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/14578243" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=The+treat%E2%80%90to%E2%80%90target+trial:+randomized+addition+of+glargine+or+human+NPH+insulin+to+oral+therapy+of+type+2+diabetic+patients+&author=MC+Riddle&author=J+Rosenstock&author=J+Gerich&publication_year=2003&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD006383-bbs2-0036"> <div class="reference-title-banner"> <h4 class="title">Rosenstock 2005</h4> </div> <div class="bibliography-section" id="CD006383-bib-0036"> <div class="citation-journal">Rosenstock J, Dailey G, Massi‐Benedetti M, Fritsche A, Lin Z, Salzman A. <span class="citation-title">Reduced hypoglycemia risk with insulin glargine: a meta‐analysis comparing insulin glargine with human NPH insulin in type 2 diabetes</span>. <span class="citation"> Diabetes Care </span><span class="pubYear">2005</span>;<span class="volume">28</span>:950‐5. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/15793205" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Reduced+hypoglycemia+risk+with+insulin+glargine:+a+meta%E2%80%90analysis+comparing+insulin+glargine+with+human+NPH+insulin+in+type+2+diabetes+&author=J+Rosenstock&author=G+Dailey&author=M+Massi%E2%80%90Benedetti&author=A+Fritsche&author=Z+Lin&author=A+Salzman&publication_year=2005&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD006383-bbs2-0037"> <div class="reference-title-banner"> <h4 class="title">Sterne 2001</h4> </div> <div class="bibliography-section" id="CD006383-bib-0037"> <div class="citation-book">Sterne JAC, Egger M, Davey Smith G. <span class="citation-title">Investigating and dealing with publication and other biases</span>. In: Egger M, Davey Smith G, Altman DG editor(s). <span class="citation">Systematic Reviews in Health Care; Meta‐analysis in Context</span>. London: BMJ Publishing Group, <span class="pubYear">2001</span>:189‐208. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Investigating+and+dealing+with+publication+and+other+biases&author=JAC+Sterne&author=M+Egger&author=G+DaveySmith&publication_year=2001&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD006383-bbs2-0038"> <div class="reference-title-banner"> <h4 class="title">Swinnen 2009</h4> </div> <div class="bibliography-section" id="CD006383-bib-0038"> <div class="citation-journal">Swinnen SG, Hoekstra JB, DeVries JH. <span class="citation-title">Insulin therapy for type 2 diabetes</span>. <span class="citation"> Diabetes Care </span><span class="pubYear">2009</span>;<span class="volume">32 Suppl 2</span>:S253‐9. [MEDLINE: 19875560] <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/19875560" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Insulin+therapy+for+type+2+diabetes&author=SG+Swinnen&author=JB+Hoekstra&author=JH+DeVries&publication_year=2009&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD006383-bbs2-0039"> <div class="reference-title-banner"> <h4 class="title">Swinnen 2010b</h4> </div> <div class="bibliography-section" id="CD006383-bib-0039"> <div class="citation-journal">Swinnen SG, Dain MP, Mauricio D, DeVries JH, Hoekstra JB, Holleman F. <span class="citation-title">Continuation versus discontinuation of insulin secretagogues when initiating insulin in type 2 diabetes</span>. <span class="citation"> Diabetes, obesity &amp; metabolism </span><span class="pubYear">2010</span>;<span class="volume">12</span>(10):923‐5. [MEDLINE: 20920046] <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/20920046" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Continuation+versus+discontinuation+of+insulin+secretagogues+when+initiating+insulin+in+type+2+diabetes+&author=SG+Swinnen&author=MP+Dain&author=D+Mauricio&author=JH+DeVries&author=JB+Hoekstra&author=F+Holleman&publication_year=2010&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD006383-bbs2-0040"> <div class="reference-title-banner"> <h4 class="title">UKPDS 33 1998</h4> </div> <div class="bibliography-section" id="CD006383-bib-0040"> <div class="citation-journal">UK Prospective Diabetes Study Group. <span class="citation-title">Intensive blood‐glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)</span>. <span class="citation"> Lancet </span><span class="pubYear">1998</span>;<span class="volume">352</span>:837‐53. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/9742976" target="_blank"> <span>PubMed</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD006383-bbs2-0041"> <div class="reference-title-banner"> <h4 class="title">UKPDS 34 1998</h4> </div> <div class="bibliography-section" id="CD006383-bib-0041"> <div class="citation-journal">UK Prospective Diabetes Study Group. <span class="citation-title">Effect of intensive blood‐glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34)</span>. <span class="citation"> Lancet </span><span class="pubYear">1998</span>;<span class="volume">352</span>:854‐65. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/9742977" target="_blank"> <span>PubMed</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD006383-bbs2-0042"> <div class="reference-title-banner"> <h4 class="title">Wild 2004</h4> </div> <div class="bibliography-section" id="CD006383-bib-0042"> <div class="citation-journal">Wild S, Roglic G, Green A, Sicree R, King H. <span class="citation-title">Global prevalence of diabetes: estimates for the year 2000 and projections for 2030</span>. <span class="citation"> Diabetes Care </span><span class="pubYear">2004</span>;<span class="volume">27</span>:1047‐53. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/15111519" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Global+prevalence+of+diabetes:+estimates+for+the+year+2000+and+projections+for+2030&author=S+Wild&author=G+Roglic&author=A+Green&author=R+Sicree&author=H+King&publication_year=2004&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> </section> </section> <section class="characteristicStudies" id="characteristicStudies"> <div class="section-header section-collapse-header"> <h2 class="title section-collapse-title"> Characteristics of studies <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="characteristicIncludedStudiesContent" lang=""> <div class="section-header" id="CD006383-sec2-0020"> <h3 class="title">Characteristics of included studies [ordered by study ID]</h3> <div class="jump-to"> <p>Jump to: </p> <ul class="jump-to-links"> <li><a href="#CD006383-sec2-0021" class="jump-to">excluded studies</a></li> <li><a href="#CD006383-sec2-0022" class="jump-to">ongoing studies</a></li> </ul> </div> </div> <p> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Hollander 2008 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>RANDOMISED CONTROLLED CLINICAL TRIAL (RCT): Yes.</p> <p>RANDOMISATION RATIO: 2:1.</p> <p>NON‐INFERIORITY DESIGN: Yes.</p> <p>EQUIVALENCE DESIGN: No.</p> <p>PARALLEL / CROSSOVER / FACTORIAL RCT: Parallel.</p> <p>CONTROLLED CLINICAL TRIAL (CCT): Yes.</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>WHO PARTCIPATED:</p> <p>SEX (female% / male%): 34 (42.0%) / 185 (58.0%).</p> <p>AGE (mean years (SD)): Insulin detemir: 59 (11.0); Insulin glargine: 58 (11.0). Novo Nordisk A/S web site: All: 58 (11.0). </p> <p>ETHNIC GROUPS (%): 250 (78.4%) white, 38 (11.9%) black, 26 (8.2%) Hispanic, 5 (1.5%) other. </p> <p>DURATION OF DISEASE (mean years (SD)): Insulin detemir: 13.6 (8.1); Insulin glargine: 13.4 (7.8). Novo Nordisk A/S web site: All: 13.6 (8.0). </p> <p>INCLUSION CRITERIA: Men and women aged ≥ 18 years who had a diagnosis of type 2 diabetes for ≥ 12 months, BMI ≤ 40.0 kg/m<sup>2</sup>, HbA1c of ≥ 7.0% to ≤ 11.0% at screening and had been receiving any OGLD regimen or insulin with or without OGLDs for &gt; 4 months. </p> <p>EXCLUSION CRITERIA: Not reported in Clinical Therapeutics paper. Novo Nordisk A/S web site: Proliferative retinopathy or maculopathy, recurrent major hypoglycaemia, impaired hepatic or renal function, cardiac problems or uncontrolled hypertension. </p> <p>DIAGNOSTIC CRITERIA: Not specified.</p> <p>CO‐MORBIDITIES: Not reported.</p> <p>CO‐MEDICATIONS: Insulin detemir: 42 (19.6%) OGLDs only, 79 (36.9%) insulin only, 93 (43.5%) insulin + OGLDs; Insulin glargine: 17 (16.2%) OGLDs only, 34 (32.4%) insulin only, 54 (51.4%) insulin + OGLDs; All: 59 (18.5%) OGLDs only, 113 (35.4%) insulin only, 147 (46.1%) insulin + OGLDs. </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>NUMBER OF STUDY CENTRES: 56.</p> <p>COUNTRY/ LOCATION: Europe (Finland, France, Norway, Sweden) and United States.</p> <p>SETTING: Not reported.</p> <p>INTERVENTION (ROUTE, TOTAL DOSE/DAY, FREQUENCY): Insulin detemir: Initiated once‐daily in the evening, titrated according to structured algorithm to FPG ≤ 6.0 mmol/L and (if needed) to pre‐dinner PG ≤ 6.0 mmol/L without hypoglycaemia, additional morning insulin dose if titration of evening dose did not result in pre‐dinner PG ≤ 6.0 mmol/L, but only if FPG ≤ 6.0 mmol/L. Pen‐injector (Flexpen), between 1 hour before dinner and bedtime. Insulin aspart injected immediately before each main meal (Flexpen), initiated and adjusted according to local practice to achieve 2‐hour post‐prandial PG ≤ 9.0 mmol/L, no algorithm for bolus insulin. </p> <p>CONTROL (ROUTE, TOTAL DOSE/DAY, FREQUENCY): Insulin glargine: Initiated once‐daily in the evening, titrated according to structured algorithm to FPG ≤ 6.0 mmol/L without hypoglycaemia. Pen‐injector (OptiPen Pro 1 in Europa and syringes and vials in United States), between 1 hour before dinner and bedtime. Insulin aspart injected immediately before each main meal (Flexpen), initiated and adjusted according to local practice to achieve 2‐hour post‐prandial PG ≤ 9.0 mmol/L, no algorithm for bolus insulin. </p> <p>TREATMENT BEFORE STUDY: Insulin secretagogues and α‐glucosidase inhibitors were stopped at study entry, thiazolidinediones were also stopped in Europe, other existing OGLD regimens were continued. </p> <p>TITRATION PERIOD: 52 weeks, 13 scheduled visits, occurring biweekly initially, then every 4 weeks, and eventually every 8 weeks, and 16 scheduled telephone contacts. Patients were instructed to monitor FPG and pre‐dinner PG on the 3 days before each of 13 visits. Titration algorithm is given. </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>PRIMARY OUTCOME(S) (as stated in the publication): HbA1c at 52 weeks.</p> <p>SECONDARY OUTCOMES (as stated in the publication): Change in weight, proportion of patients achieving HbA1c ≤ 7.0% at 52 weeks, proportion of patients achieving HbA1c ≤ 7.0% with or without symptomatic hypoglycaemia confirmed by PG &lt; 4.0 mmol/L or any PG &lt; 3.1 mmol/L in the last 3 months of treatment, glycaemic control at 52 weeks based on FPG and 10‐point PG profiles, insulin doses, and within‐subject variation in self‐measured FPG and pre‐dinner PG. </p> <p>Major hypoglycaemia = if patients were not able to treat the episode themselves; Minor hypoglycaemia = confirmed by PG &lt; 3.1 mmol/L; Symptoms only = if PG ≥ 3.1 mmol/L or no measurement was made; All = all episodes occurring over 24 hours; Nocturnal = between 11 p.m. and 6 a.m. </p> <p>ADDITIONAL OUTCOMES: Novo Nordisk A/S web site: Adverse events, body weight, hypoglycaemia, PG, basal and bolus insulin doses, insulin treatment satisfaction (ITSQ), laboratory safety parameters, physical examination, vital signs, funduscopy, proportion of patients on once‐daily basal insulin in insulin detemir group, time to change from once‐ to twice‐daily in insulin detemir group, correlation between endogenous insulin and C‐peptide and insulin requirements in insulin‐naive subjects and serum adiponectin levels. </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Study details</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>DURATION OF INTERVENTION: 52 weeks.</p> <p>DURATION OF FOLLOW‐UP: 52 weeks.</p> <p>RUN‐IN PERIOD: Not specified, but Novo Nordisk A/S web site: Randomisation visit maximum 2 weeks after screening visit. </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Publication details</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>LANGUAGE OF PUBLICATION: English.</p> <p>COMMERCIAL FUNDING: Yes: "This study was supported by Novo Nordisk A/S, Bagsvaerd, Denmark". </p> <p>NON‐COMMERCIAL FUNDING: No.</p> <p>PUBLICATION STATUS (PEER REVIEW JOURNAL): Yes.</p> <p>PUBLICATION STATUS (JOURNAL SUPPLEMENT): No.</p> <p>PUBLICATION STATUS (ABSTRACT): No.</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Stated aim of study</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Quote: "This trial compared the efficacy and safety profiles of detemir and glargine as the basal insulin component of a basal‐bolus regimen in patients with type 2 diabetes who were being treated with OGLDs or insulin, with or without OGLDs". </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Trialnumbers: NN304‐1431 and NCT00097084.</p> <p>Contact information: Priscilla Hollander (<a href="/cdn-cgi/l/email-protection" class="__cf_email__" data-cfemail="ce9ebca7bdada7a2868eacafb7a2a1bca6abafa2baa6e0abaabb">[email&#160;protected]</a>).</p> </td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Random sequence generation (selection bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Quote: "A telephone randomisation system prepared by Clinical Trial Supplies, Novo Nordisk A/S, Bagsvaerd, Denmark, was used to randomise patients". </p> <p>Comment: Probably done, as the "telephone randomisation system" probably used a computer random number generator. </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment (selection bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Quote: "A telephone randomisation system prepared by Clinical Trial Supplies, Novo Nordisk A/S, Bagsvaerd, Denmark, was used to randomise patients". </p> <p>Comment: Done, as central allocation (by means of a telephone system) was used.</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding (performance bias and detection bias) <br> All outcomes </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>High risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Quote: "It is possible that the open‐label design of this trial, although necessary given the different dosing schemes for the two insulins, could have introduced some bias". </p> <p>Comment: Neither study participants nor study personnel were blinded and this may have influenced outcome measurements. </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Incomplete outcome data (attrition bias) <br> All outcomes </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Number of missing data or number of patients used for the calculation of outcomes are not reported. </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Selective reporting (reporting bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Probably, as all of the study's pre‐specified outcomes (as listed on www.ClinicalTrials.gov) are reported (except for insulin treatment satisfaction, which was a pre‐specified secondary outcome). </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Other bias</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>High risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Quote: "Patients who had been randomised to receive detemir were to be transferred to twice‐daily dosing if..." and "Irrespective of pre‐dinner PG levels, patients randomised to the glargine group continued to receive a once‐daily evening dose, according to the approved labelling". Also, all patients randomised to insulin detemir used a pen‐injector, whereas United States patients randomised to insulin glargine used syringes and vials. </p> <p>Comment: The study has a potential source of bias related to the specific study design used, i.e. different frequency of injection and different injection devices across treatments. </p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Raskin 2009 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>RANDOMISED CONTROLLED CLINICAL TRIAL (RCT): Yes.</p> <p>RANDOMISATION RATIO: 2:1.</p> <p>NON‐INFERIORITY DESIGN: Yes.</p> <p>EQUIVALENCE DESIGN: No.</p> <p>PARALLEL / CROSSOVER / FACTORIAL RCT: Parallel.</p> <p>CONTROLLED CLINICAL TRIAL (CCT): Yes.</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>WHO PARTCIPATED:</p> <p>SEX (female% / male%): 175 (45.5%) / 210 (54.5%).</p> <p>AGE (mean years (SD)): Insulin det: 55.8 (10.0); Insulin glargine: 55.9 (11.0); All: 55.8 (10.3). </p> <p>ETHNIC GROUPS (%): Insulin detemir: 193 (76.0%) Caucasian, 37 (14.6%) African‐American, 7 (2.8%) Asian, 4 (1.6%) American Indian or Alaskan Native, 13 (5.1%) other; Insulin glargine: 108 (82.4%) Caucasian, 14 (10.7%) African‐American, 3 (2.3%) Asian, 0 (0%) American Indian or Alaskan Native, 6 (4.6%) other; All: 301 (78.2%) Caucasian, 51 (13.2%) African‐American, 10 (2.6%) Asian, 4 (1.0%) American Indian or Alaskan Native, 19 (4.9%) other. </p> <p>DURATION OF DISEASE (mean years (SD)): Insulin detemir: 12.5 (6.8); Insulin glargine: 11.9 (7.4); All: 12.3 (7.0). </p> <p>INCLUSION CRITERIA: Patients with type 2 diabetes, who were at least 18 years old, with a BMI of ≤ 40 kg/m<sup>2</sup>, an HbA1c ranging from 7% to 11% and who had previously received any OGLD, insulin, or insulin + OGLD treatment regimens. Novo Nordisk A/S web site: Type 2 diabetes ≥ 12 months, currently on any OGLD therapy or on any insulin in any regimen with or without OGLDs ≥ 4 months, age ≥ 18 years, BMI ≤ 40 kg/m<sup>2</sup> and HbA1c ≥ 7.0% and ≤ 11.0%. </p> <p>EXCLUSION CRITERIA: Proliferative retinopathy or maculopathy that required acute treatment 6 months before the start of the study, recurrent major hypoglycaemia, anticipated change in medication known to interfere with glucose metabolism, impaired hepatic or renal function believed to interfere with study participation, cardiac problems or uncontrolled hypertension. </p> <p>DIAGNOSTIC CRITERIA: Not specified.</p> <p>CO‐MORBIDITIES: Not reported.</p> <p>CO‐MEDICATIONS: Insulin detemir: 9 (3.5%) OGLD monotherapy, 42 (16.5%) OGLD combination therapy, 83 (32.7%) insulin without OGLDs, 120 (47.2%) insulin with OGLDs; Insulin glargine: 6 (4.6%) OGLD monotherapy, 20 (15.3%) OGLD combination therapy, 41 (31.3%) insulin without OGLDs, 64 (48.9%) insulin with OGLDs; All: 15 (3.9%) OGLD monotherapy, 62 (16.1%) OGLD combination therapy, 124 (32.2%) insulin without OGLDs, 184 (47.8%) insulin with OGLDs. </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>NUMBER OF STUDY CENTRES: 68.</p> <p>COUNTRY/ LOCATION: Canada (8 sites) and United States (60 sites).</p> <p>SETTING: Not reported.</p> <p>INTERVENTION (ROUTE, TOTAL DOSE/DAY, FREQUENCY): Insulin detemir: Initiated once‐daily in the evening at the same time each day, titrated according to structured algorithm to FPG ≤ 6.0 mmol/L and (if needed) to pre‐dinner PG ≤ 6.0 mmol/L without significant hypoglycaemia, additional morning insulin dose if titration of evening dose did not result in pre‐dinner PG ≤ 6.0 mmol/L, but only if FPG ≤ 6.0 mmol/L and after optimisation of bolus doses. Pen‐injector (Flexpen), between 1 hour before dinner and bedtime. Insulin aspart injected in abdomen (Flexpen). </p> <p>CONTROL (ROUTE, TOTAL DOSE/DAY, FREQUENCY): Insulin glargine: Initiated once‐daily in the evening at the same time each day, titrated according to structured algorithm to FPG ≤ 6.0 mmol/L without significant hypoglycaemia. Syringes and vials, between 1 hour before dinner and bedtime. Insulin aspart injected in abdomen (Flexpen). </p> <p>TREATMENT BEFORE STUDY: Insulin secretagogues and α‐glucosidase inhibitors were discontinued prior to initiating trial drug, thiazolidinediones and metformin were continued unchanged. </p> <p>TITRATION PERIOD: 26 weeks, 9 visits and 13 telephone contacts. "Basal insulin was titrated at the instruction of the investigator according to titration guidelines". Titration algorithm is given but the titration frequency is not reported. </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>PRIMARY OUTCOME(S) (as stated in the publication): HbA1c after 26 weeks.</p> <p>SECONDARY OUTCOMES (as stated in the publication): FPG during the trial and body weight. Safety endpoints were the incidence of hypoglycaemic events and adverse events. </p> <p>Nocturnal hypoglycaemia = between 23:00 and 06:00 hour; Daytime hypoglycaemia = between 06:00 and 23:00 hour. </p> <p>ADDITIONAL OUTCOMES: Novo Nordisk A/S web site: Proportion of subjects achieving HbA1c ≤ 7% after 26 weeks, proportion of subjects with HbA1c ≤ 7% without symptomatic hypoglycaemia confirmed by PG &lt; 4.0 mmol/L or any single PG &lt; 3.1 mmol/L in the last 3 months of the treatment, FPG, within‐subject variation of self‐measured FPG and pre‐dinner PG, 9‐point PG profiles, body weight, difference in weight change, basal and bolus insulin doses, time to start detemir twice‐daily, proportion of detemir‐treated subjects on once‐daily basal insulin, insulin treatment satisfaction (ITSQ), incidence of hypoglycaemia (all, minor, major, symptoms only, nocturnal and during the day), adverse events, laboratory assessments, physical examination, fundoscopy, vital signs and ECG. </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Study details</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>DURATION OF INTERVENTION: 26 weeks.</p> <p>DURATION OF FOLLOW‐UP: 26 weeks.</p> <p>RUN‐IN PERIOD: Not specified.</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Publication details</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>LANGUAGE OF PUBLICATION: English.</p> <p>COMMERCIAL FUNDING: Yes: "This trial was funded and monitored by Novo Nordisk".</p> <p>NON‐COMMERCIAL FUNDING: No.</p> <p>PUBLICATION STATUS (PEER REVIEW JOURNAL): Yes.</p> <p>PUBLICATION STATUS (JOURNAL SUPPLEMENT): No.</p> <p>PUBLICATION STATUS (ABSTRACT):No.</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Stated aim of study</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Quote: "The current study compared the efficacy and safety of the basal insulin insulin detemir and insulin glargine used in combination with insulin aspart as bolus insulin in patients with type 2 diabetes". </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Trialnumbers: NN304‐2175 and NCT00106366.</p> <p>Contact information: Philip Raskin (<a href="/cdn-cgi/l/email-protection" class="__cf_email__" data-cfemail="09596160656079275b687a626067495c5d5a667c7d617e6c7a7d6c7b67276c6d7c">[email&#160;protected]</a>).</p> </td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Random sequence generation (selection bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Quote: "were randomised 2:1 to insulin detemir and insulin glargine treatment groups".</p> <p>Comment: Besides this quote the paper gives no information about the randomisation process. </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment (selection bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Quote: "were randomised 2:1 to insulin detemir and insulin glargine treatment groups".</p> <p>Comment: Besides this quote the paper gives no information about the randomisation process. </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding (performance bias and detection bias) <br> All outcomes </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>High risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Quote: "open‐label".</p> <p>Comment: Neither study participants nor study personnel were blinded and this may have influenced outcome measurements. </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Incomplete outcome data (attrition bias) <br> All outcomes </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Number of missing data or number of patients used for the calculation of outcomes are not reported. </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Selective reporting (reporting bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>High risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not all of the study's pre‐specified secondary outcomes as listed on the Novo Nordisk A/S web site are reported (time to start insulin detemir twice‐daily, insulin treatment satisfaction, and hypoglycaemia with symptoms only are not reported). </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Other bias</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>High risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Quote: "For patients randomised to insulin detemir, an optional second daily morning dose could be added at the discretion of the investigator". Also, patients randomised to insulin detemir used a pen‐injector, whereas patients randomised to insulin glargine used syringes and vials. </p> <p>Comment: The study has a potential source of bias related to the specific study design used, i.e. different frequency of injection and different injection devices across treatments. </p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Rosenstock 2008 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>RANDOMISED CONTROLLED CLINICAL TRIAL (RCT): Yes.</p> <p>RANDOMISATION RATIO: 1:1.</p> <p>NON‐INFERIORITY DESIGN: Yes.</p> <p>EQUIVALENCE DESIGN: No.</p> <p>PARALLEL / CROSSOVER / FACTORIAL RCT: Parallel.</p> <p>CONTROLLED CLINICAL TRIAL (CCT): Yes.</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>WHO PARTCIPATED:</p> <p>SEX (female% / male%): 245 (42.1%) / 337 (57.9%).</p> <p>AGE (mean years (SD)): Insulin detemir: 58.4 (10.2); Insulin glargine: 59.4 (9.6).</p> <p>ETHNIC GROUPS (%): Insulin detemir: 22 (7.6%) black, 250 (85.9%) white, 7 (2.4%) Asian‐Pacific islander, 12 (4.1%) other; Insulin glargine: 12 (4.1%) black, 263 (90.4%) white, 7 (2.4%) Asian‐Pacific islander, 9 (3.1%) other.&nbsp; </p> <p>DURATION OF DISEASE (mean years (SD)): Insulin detemir: 9.1 (6.1); Insulin glargine: 9.1 (6.4). </p> <p>INCLUSION CRITERIA: Insulin‐naive men and women with type 2 diabetes, ≥ 18 years old, ≥ 12 months disease duration, BMI ≤ 40.0 kg/m<sup>2</sup>, HbA1c between 7.5% and 10.0% and 1 or 2 OGLDs (metformin, insulin secretagogues, α‐glucosidase inhibitors) for ≥ 4 months on at least half the maximum recommended dose. </p> <p>EXCLUSION CRITERIA: Treatment with thiazolidinediones, use of &gt; 2 OGLDs within 6 months, hypoglycaemic unawareness or other medical conditions likely to interfere with trial conduct. Novo Nordisk A/S web site: Current or previous treatment with thiazolidinediones within last 6 months, OGLD treatment with combination of ≥ 3 OGLDs within last 6 months, proliferative retinopathy or maculopathy or known hypoglycaemia unawareness. </p> <p>DIAGNOSTIC CRITERIA: Not specified.</p> <p>CO‐MORBIDITIES: Not reported.</p> <p>CO‐MEDICATIONS: Insulin detemir: 32 (11.0%) metformin monotherapy, 41 (14.1%) insulin secretagogue monotherapy, 212 (72.9%) metformin + insulin secretagogue, 3 (1.0%) metformin + α‐glucosidase inhibitor, 3 (1.0%) insulin secretagogue + α‐glucosidase inhibitor; Insulin glargine: 33 (11.3%) metformin monotherapy, 37 (12.7%) insulin secretagogue monotherapy, 215 (73.9%) metformin + insulin secretagogue, 1 metformin + α‐glucosidase inhibitor (0.3%), 4 insulin secretagogue + α‐glucosidase inhibitor (1.4%), 1 (0.3%) insulin secretagogue + insulin secretagogue. </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>NUMBER OF STUDY CENTRES: 80.</p> <p>COUNTRY/ LOCATION: Europe (Austria, Belgium, France, Germany, Ireland, UK) and United States. </p> <p>SETTING: Not reported.</p> <p>INTERVENTION (ROUTE, TOTAL DOSE/DAY, FREQUENCY): Insulin detemir: Initiated once‐daily in the evening at a dose of 12 units/day, titrated according to structured algorithm to FPG ≤ 6.0 mmol/L in the absence of hypoglycaemia and (if needed) to pre‐dinner PG ≤ 6.0 mmol/L, additional morning insulin dose if pre‐dinner PG &gt; 7.0 mmol/L, but only if FPG &lt; 7.0 mmol/L or nocturnal hypoglycaemia precluded achievement of the FPG target. Pen‐injector (Flexpen), 1 hour before to 1 hour after dinner and (if needed) within 30 minutes of breakfast. </p> <p>CONTROL (ROUTE, TOTAL DOSE/DAY, FREQUENCY): Insulin glargine: Initiated once‐daily in the evening at a dose of 12 units/day, titrated according to a structured algorithm to FPG ≤ 6.0 mmol/L in the absence of hypoglycaemia. Pen‐injector in Europe (OptiPen Pro 1) and syringes and vials in United States, at bedtime. </p> <p>TREATMENT BEFORE STUDY: Insulin‐naive, 1 or 2 OGLDs (metformin, insulin secretagogues, α‐glucosidase inhibitors) ≥ 4 months on at least half the maximum recommended dose, according to local guidelines. Insulin added to OGLDs, OGLDs were recommended to remain stable during the study. </p> <p>TITRATION PERIOD: 52 weeks, 16 clinical visits and 9 telephone contacts. Dose adjustments were to be based on the average of 3 self‐measurements, during the first 12 weeks weekly investigator contact. Titration algorithm is given. Titration committee. </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>PRIMARY OUTCOME(S) (as stated in the publication): Baseline‐adjusted HbA1c at end of treatment. </p> <p>SECONDARY OUTCOMES (as stated in the publication): Clinic FPG, within‐subject variation in PG, 10‐point self‐measured PG profiles, proportion of subjects achieving HbA1c ≤ 7.0% with and without hypoglycaemia, change in body weight, incidence of hypoglycaemia, adverse events and standard safety parameters. </p> <p>Major hypoglycaemia = if assistance of another person was required; Minor hypoglycaemia = confirmed by PG &lt; 3.1 mmol/L; Symptoms only = if PG ≥ 3.1 mmol/L or no measurement was made. </p> <p>ADDITIONAL OUTCOMES: Novo Nordisk A/S web site: Primary outcome: HbA1c after 52 weeks; Secondary outcomes: Insulin antibodies, incidence of hypoglycaemic episodes and adverse events, plasma glucose profiles and change in body weight. </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Study details</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>DURATION OF INTERVENTION: 52 weeks.</p> <p>DURATION OF FOLLOW‐UP: 52 weeks.</p> <p>RUN‐IN PERIOD: Not specified.</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Publication details</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>LANGUAGE OF PUBLICATION: English.</p> <p>COMMERCIAL FUNDING: Yes: "The study was funded and monitored by Novo Nordisk".</p> <p>NON‐COMMERCIAL FUNDING: No.</p> <p>PUBLICATION STATUS (PEER REVIEW JOURNAL): Yes.</p> <p>PUBLICATION STATUS (JOURNAL SUPPLEMENT): Yes: American Diabetes Association Scientific Sessions 2004 + American Diabetes Association Scientific Sessions 2006. </p> <p>PUBLICATION STATUS (ABSTRACT): No.</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Stated aim of study</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Quote: "The objective of the current study was to compare treatment with insulin detemir and insulin glargine in line with their licensed indications as add‐on therapy to oral glucose‐lowering agents in insulin‐naive patients with type 2 diabetes". </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Trialnumbers: NN304‐1373 and NCT00283751.</p> <p>Contact information: Julio Rosenstock (<a href="/cdn-cgi/l/email-protection" class="__cf_email__" data-cfemail="d1bba4bdb8bea3bea2b4bfa2a5beb2ba91b5b0bdbdb0a2b5b8b0b3b4a5b4a2ffb2bebc">[email&#160;protected]</a>).</p> </td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Random sequence generation (selection bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Quote: "Concealed randomisation was carried out by an automatic telephone system and was stratified according to OGLD monotherapy or combination therapy at study entry". </p> <p>Comment: Probably done, as the "automatic telephone system" probably used a computer random number generator. </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment (selection bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Quote: "Concealed randomisation was carried out by an automatic telephone system and was stratified according to OGLD monotherapy or combination therapy at study entry". </p> <p>Comment: Done, as central allocation (by means of telephone) was used.</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding (performance bias and detection bias) <br> All outcomes </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>High risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Quote: "An open‐label design was required to allow twice daily‐daily administration of insulin detemir if needed" and "To reduce potential bias, HbA1c results were only disclosed to investigators at randomisation and at trial end". </p> <p>Comment: Neither study participants nor study personnel were blinded and this may have influenced outcome measurements. </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Incomplete outcome data (attrition bias) <br> All outcomes </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>High risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Safety analysis: no missing data in either intervention group (291/291 analysed).</p> <p>Primary analysis: 23/291 (=7.9%) excluded from intervention group as no post‐baseline information and 16/291 (=5.5%) excluded from control group as no post‐baseline information. Thus, no imbalance in number of missing data. </p> <p>Primary weight analysis: 60/291 (=20.6%) excluded from intervention group and 39/291 (=13.4%) excluded from control group. Imbalance in numbers and reasons for missing data across intervention groups. </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Selective reporting (reporting bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Probably, as all of the study's pre‐specified outcomes (as listed on www.ClinicalTrials.gov) are reported (except for insulin antibodies, which was a pre‐specified secondary outcome). </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Other bias</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>High risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Quote: "In line with its license, people allocated to insulin detemir were allowed to receive an additional morning insulin dose if" and "Glargine was given once‐daily". Also, all patients randomised to insulin detemir used a pen‐injector, whereas United States patients randomised to insulin glargine used syringes and vials. </p> <p>Comment: The study has a potential source of bias related to the specific study design used, i.e. different frequency of injection and different injection devices across treatments. </p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Swinnen 2010a </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>RANDOMISED CONTROLLED CLINICAL TRIAL (RCT): Yes.</p> <p>RANDOMISATION RATIO: 1:1.</p> <p>NON‐INFERIORITY DESIGN: Yes.</p> <p>EQUIVALENCE DESIGN: No.</p> <p>PARALLEL / CROSSOVER / FACTORIAL RCT: Parallel.</p> <p>CONTROLLED CLINICAL TRIAL (CCT): Yes.</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>WHO PARTCIPATED:</p> <p>SEX (female% / male%): 437 (45.3%) / 527 (54.7%).</p> <p>AGE (mean years (SD)): Insulin detemir: 58.0 (8.0); Insulin glargine: 58.7 (8.5); All: 58.4 (8.3). </p> <p>ETHNIC GROUPS (%): Insulin detemir: 382 (78.6%) white, 80 (16.5%) asian/oriental, 6 (1.2%) black, 9 (1.9%) multiracial, 9 (1.9%) other; Insulin glargine: 368 (77.0%) white, 77 (16.1%) asian/oriental, 12 (2.5%) black, 7 (1.5%) multiracial, 14 (2.9%) other; All: 750 (77.8%) white, 157 (16.3%) asian/oriental, 18 (1.9%) black, 16 (1.7%) multiracial, 23 (2.4%) other. </p> <p>DURATION OF DISEASE (mean years (SD)): Insulin detemir: 9.7 (5.6); Insulin glargine: 10.1 (5.9); All: 9.9 (5.8). </p> <p>INCLUSION CRITERIA: Insulin‐naive people, aged 40 to 75 years, with type 2 diabetes for ≥ 1 year and treated for ≥ 3 months prior to study start with stable doses of OGLDs (including at least metformin ≥ 1 g/day), BMI &lt; 40.0 kg/m<sup>2</sup>, HbA1c between 7.0% and 10.5% and ability and willingness to perform home glucose monitoring and to use a patient diary. </p> <p>EXCLUSION CRITERIA: Exclusion criteria included previous use of insulin, treatment with GLP‐1 analogues or DPP‐4 inhibitors, active proliferative retinopathy, pregnancy or lactation, treatment with systemic corticosteroids in the preceding 3 months, treatment with investigational products in the preceding 2 months, impaired hepatic or renal function or any major somatic or mental condition that might preclude implementation of the study protocol. Study protocol: Type 1 diabetes, history of hypersensitivity to the study drugs or to drugs with a similar chemical structure, likelihood of requiring treatment during the study period with drugs not permitted by the clinical trial protocol, clinically relevant cardiovascular, hepatic, neurological, endocrine, or other major disease making implementation of the protocol or interpretation of the study results difficult, history of drug or alcohol abuse in the last year or mental condition rendering the patient unable to understand the nature, scope and possible consequences of the study. </p> <p>DIAGNOSTIC CRITERIA: Not used.</p> <p>CO‐MORBIDITIES: Insulin detemir: 79 (16.3%) macroangiopathy, 48 (9.9%) nephropathy, 123 (25.3%) neuropathy, 92 (18.9%) retinopathy; Insulin glargine: 84 (17.6%) macroangiopathy, 71 (14.9%) nephropathy, 134 (28.0%) neuropathy, 105 (22.0%) retinopathy; All: 163 (16.9%) macroangiopathy, 119 (12.3%) nephropathy, 257 (26.7%) neuropathy, 197 (20.4%) retinopathy. </p> <p>CO‐MEDICATIONS: Insulin detemir: 486 (100%) metformin, 417 (85.8%) sulfonylureas, 89 (18.3%) thiazolidinediones, 28 (5.8%) α‐glucosidase inhibitors, 22 (4.5%) glinides, 1 (0.2%) other; Insulin glargine: 478 (100%) metformin, 410 (85.8%) sulfonylureas, 74 (15.5%) thiazolidinediones, 32 (6.7%) α‐glucosidase inhibitors, 27 (5.6%) glinides, 0 (0%) other; All: 964 (100%) metformin, 827 (85.8%) sulfonylureas, 163 (16.9%) thiazolidinediones, 60 (6.2%) α‐glucosidase inhibitors, 49 (5.1%) glinides, 1 (0.1%) other. </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>NUMBER OF STUDY CENTRES: 122.</p> <p>COUNTRY/ LOCATION: 20 countries (Australia, Brazil, Canada, Europe, India, Korea, Russia, Serbia, Taiwan, Turkey). </p> <p>SETTING: Hospitals and diabetes centres (endocrinologists and diabetologists).</p> <p>INTERVENTION (ROUTE, TOTAL DOSE/DAY, FREQUENCY): Insulin detemir: Initiated twice‐daily, at breakfast and dinner, using NovoPen3 injector pen, starting dose 0.2 units/kg/day. Titrated to FPG and pre‐dinner PG &lt; 5.6 mmol/L, increase both doses by 1 unit every 2 days until fasting and pre‐dinner PG ≤ 6.9 mmol/L, subsequently increase evening dose by 2 units every 2 days until FPG &lt; 5.6 mmol/L, finally increase breakfast dose by 2 units every 2 days until pre‐dinner PG &lt; 5.6 mmol/L. </p> <p>CONTROL (ROUTE, TOTAL DOSE/DAY, FREQUENCY): Insulin glargine: Initiated once‐daily, at dinner or bedtime, but at the same time every day throughout the study, using OptiClik injector pen, starting dose 0.2 units/kg/day. Titrated to FPG &lt; 5.6 mmol/L, increase dose by 2 units every 2 days until FPG &lt; 5.6 mmol/L. </p> <p>TREATMENT BEFORE STUDY: Insulin‐naive, treated for ≥ 3 months prior to study start with stable doses of OGLDs (including at least metformin ≥ 1 g/day), GLP‐1 analogues and DPP‐4 inhibitors were exclusion criteria. Metformin continued at stable dose throughout study, thiazolidinediones stopped at randomisation, insulin secretagogues stopped at randomisation or continued at stable dose throughout (decision made by site‐investigator, considering local guidelines). </p> <p>TITRATION PERIOD: 24 weeks, 8 clinical visits and 8 telephone contacts. Insulin detemir: Increase both doses by 1 unit every 2 days until FPG and pre‐dinner PG ≤ 6.9 mmol/L, subsequently increase evening dose by 2 units every 2 days until FPG &lt; 5.6 mmol/L, finally increase breakfast dose by 2 units every 2 days until pre‐dinner PG &lt; 5.6 mmol/L; Insulin glargine: Increase insulin dose by 2 units every 2 days until FPG &lt; 5.6 mmol/L. </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>PRIMARY OUTCOME(S) (as stated in the publication): Percentage of patients reaching HbA1c &lt; 7% at the end of the treatment period without symptomatic hypoglycaemia confirmed by PG ≤ 3.1 mmol/L during these 24 weeks. </p> <p>SECONDARY OUTCOMES (as stated in the publication): Secondary outcomes included proportions of patients achieving HbA1c &lt; 7% and &lt; 6.5%, changes in HbA1c, FPG, 8‐point PG profiles and weight, hypoglycaemia, insulin dose, adverse events and quality of life and treatment satisfaction. </p> <p>Incidence and rates for all symptomatic, symptomatic daytime, symptomatic nocturnal (both with PG ≤3.1 mmol/L and ≤3.9 mmol/L), asymptomatic ≤3.1 mmol/L, and severe (an event with symptoms consistent with hypoglycaemia, requiring the assistance of another person, and associated with measured PG &lt;2.0 mmol/L or recovery after carbohydrate or glucagon administration) hypoglycaemia were assessed. </p> <p>ADDITIONAL OUTCOMES: Statistical analysis plan: Day‐to‐day FPG variability, change in waist circumference, change in hip circumference, change in BMI, change in waist‐to‐hip ratio, HbA1c &lt; 7% without symptomatic hypo ≤ 3.1 mmol/L in last 12 weeks, and mean and SD of 24‐hour profiles. </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Study details</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>DURATION OF INTERVENTION: 24 weeks.</p> <p>DURATION OF FOLLOW‐UP: Study protocol: 25 weeks (1 telephone contact to be made within the week after the completion visit). </p> <p>RUN‐IN PERIOD: No (1‐ to 4‐week screening phase).</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Publication details</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>LANGUAGE OF PUBLICATION: English.</p> <p>COMMERCIAL FUNDING: Yes: "This study was sponsored by sanofi‐aventis, Paris, France".</p> <p>NON‐COMMERCIAL FUNDING: No.</p> <p>PUBLICATION STATUS (PEER REVIEW JOURNAL): No.</p> <p>PUBLICATION STATUS (JOURNAL SUPPLEMENT): Yes, Diabetologia 2009 Supplement 1.</p> <p>PUBLICATION STATUS (ABSTRACT): Yes, abstract only.</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Stated aim of study</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Quote: "Our primary objective was to demonstrate the non‐inferiority of glargine once‐daily compared to detemir twice‐daily with respect to the percentage of patients reaching HbA1c &lt; 7% without symptomatic hypoglycaemia confirmed by PG ≤ 3.1 mmol/L". </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Trialnumbers: LANTU‐C‐00579 and NCT00405418.</p> <p>Contact information: Sanne Swinnen (<a href="/cdn-cgi/l/email-protection" class="__cf_email__" data-cfemail="d4a7fab3faa7a3bdbabab1ba94b5b9b7faa1a2b5fabab8">[email&#160;protected]</a>).</p> </td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Random sequence generation (selection bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Quote: "Randomisation was stratified by centre and treatment allocation was concealed by using an interactive voice‐response system". </p> <p>Comment: Probably done, as the "interactive voice‐response system" probably used a computer random number generator. </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment (selection bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Quote: "Randomisation was stratified by centre and treatment allocation was concealed by using an interactive voice‐response system". </p> <p>Comment: Done, as central allocation (by means of interactive voice‐response system) was used. </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding (performance bias and detection bias) <br> All outcomes </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>High risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Quote: "A limitation of our study was its open‐label design. This design was necessary, however, as detemir was dosed twice‐daily with a separate titration target before dinner". </p> <p>Comment: Neither study participants nor study personnel were blinded and this may have influenced outcome measurements. </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Incomplete outcome data (attrition bias) <br> All outcomes </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Safety analysis: 8/486 (=1.6%) excluded from intervention group and 1/487 (=0.2%) excluded from control group. Imbalance in reasons for missing data across intervention groups. However, plausible effect size among missing outcomes not enough to have a clinically relevant impact on observed effect size. </p> <p>Primary analysis: 13/486 (=2.7%) excluded from intervention group and 15/487 (=3.1%) excluded from control group. Reasons for missing data not reported. However, (virtually) no imbalance in number of missing data and plausible effect size among missing outcomes not enough to have a clinically relevant impact on observed effect size. </p> <p>Quality of life analysis: Number of missing data or number of patients used for the calculation of outcomes are not reported. </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Selective reporting (reporting bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>High risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not all of the study's pre‐specified secondary outcomes as listed in the study protocol are reported (change in BMI, waist circumference, hip circumference, waist‐to‐hip ratio, and mean and SD of 24‐hour PG profiles and the proportions of patients achieving HbA1c &lt; 7% without symptomatic hypoglycaemia with PG ≤ 3.1 mmol/L in the last 12 weeks of the study are not reported). </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Other bias</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>High risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Quote: "Insulin glargine was administered at dinner or bedtime" and "Insulin detemir was administered at breakfast and dinner" and "Patients randomised to insulin glargine were instructed to perform daily fasting home glucose measurements and to increase their insulin dose by 2 units every 2 days until they reached the titration target of fasting PG &lt; 5.6 mmol/L. Patients randomised to insulin detemir were instructed to measure their glucose before breakfast and before dinner. The goal was to obtain both fasting and pre‐dinner PG &lt; 5.6 mmol/L. The systematic titration of insulin detemir followed three steps. First, both doses were increased by 1 unit every 2 days until FPG and pre‐dinner PG ≤ 6.9 mmol/L. Subsequently, patients were instructed to achieve fasting PG &lt; 5.6 mmol/L by increasing their dinner dose by 2 units every 2 days. Finally, the breakfast dose was increased by 2 units every 2 days until pre‐dinner PG &lt; 5.6 mmol/". </p> <p>Comment: The study has a potential source of bias related to the specific study design used, i.e. insulin detemir was dosed twice‐daily (and insulin glargine once‐daily), patients in the insulin detemir group measured their glucose level twice‐daily (insulin glargine‐treated patients once‐daily) and the titration scheme for insulin detemir may have been more complicated than that for insulin glargine. </p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p>Anti‐GAD = anti‐Glutamic Acid Decarboxylase; BMI = body mass index; DPP‐4 = dipeptidyl peptidase‐4; FPG = fasting plasma glucose; GLP‐1 = glucagon‐like peptide‐1; HbA1c = glycosylated haemoglobin A1c; OGLD = oral glucose‐lowering drug; PG = plasma glucose; SD = standard deviation. </p> </div> </div> </p> </section> <section class="characteristicsOfExcludedStudies" lang=""> <div class="section-header" id="CD006383-sec2-0021"> <h3 class="title">Characteristics of excluded studies [ordered by study ID]</h3> <div class="jump-to"> <p>Jump to: </p> <ul class="jump-to-links"> <li><a href="#CD006383-sec2-0020" class="jump-to">included studies</a></li> <li><a href="#CD006383-sec2-0022" class="jump-to">ongoing studies</a></li> </ul> </div> </div> <p> <div class="table" id=""> <table> <div class="table-heading"><span class="table-title"></span></div> <thead> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Study</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Reason for exclusion</p> </td> </tr> </thead> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD006383-bbs2-0005">King 2009</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Study duration &lt;12 weeks.</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD006383-bbs2-0006">Klein 2007</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Study duration &lt;12 weeks.</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD006383-bbs2-0007">Lucidi 2010</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Study duration &lt;12 weeks.</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD006383-bbs2-0008">Matsuura K 2009</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Study duration &lt;12 weeks.</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD006383-bbs2-0009">NCT00566124</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Study duration &lt;12 weeks.</p> </td> </tr> </tbody> </table> </div> </p> </section> <section class="characteristicsOfOngoingStudies" lang=""> <div class="section-header" id="CD006383-sec2-0022"> <h3 class="title">Characteristics of ongoing studies [ordered by study ID]</h3> <div class="jump-to"> <p>Jump to: </p> <ul class="jump-to-links"> <li><a href="#CD006383-sec2-0020" class="jump-to">included studies</a></li> <li><a href="#CD006383-sec2-0021" class="jump-to">excluded studies</a></li> </ul> </div> </div> <p> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">NCT00656422 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Trial name or title</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Weight gain, eating patterns and development of body composition during initiation of basal insulin therapy in patients with type 2 diabetes: a comparison of insulin detemir and insulin glargine. </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Intervention study, supportive care, randomised, open‐label, active‐control, parallel assignment. </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Inclusion criteria: Age &gt; 18 years and &lt; 80 years, type 2 diabetes, BMI between 20.0 and 38.0 kg/m<sup>2</sup>, anti‐GAD antibody negative, FBG &gt; 126 mg/dl, HbA1c between 7.0% and 11.0% and need for insulin therapy. </p> <p>Exclusion criteria: Previous therapy with insulin within the last 3 months prior to inclusion into the study, previous therapy with glitazones within the last 6 months prior to inclusion into the study, change in therapy with lipid‐lowering or anti‐hypertensive agent within one month prior to inclusion into the study, concomitant participation in other clinical trials, type 1 diabetes, cardiac and macrovascular disease, malignancy including leukaemia and lymphoma within the last 5 years, liver disease (cirrhosis or chronic active hepatitis, except fat liver), significant renal dysfunction, other endocrine disease, significant laboratory abnormalities, history of active substance abuse (including an average alcohol consume of &gt; 40g/day and drugs) within the past 2 years, pregnancy or childbearing potential without adequate contraception, present therapy with systemic steroids, presence of psychiatric disorder or intake of anti‐depressive or anti‐psychotic agents with the exception of benzodiazepines and SSRIs/SNRIs, use of anti‐obesity drugs 3 months prior or during the trial, subjects judged by the investigator to be unsuitable for the study, contraindications for MRI scanning (cardiac pacemaker, implants out of metal or claustrophobia) or known hypersensitivity to insulin detemir, insulin glargine or to any of the other components. </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Insulin detemir: the participant will receive an insulin dose of insulin detemir at dinner subcutaneously according to a dosing algorithm. </p> <p>Insulin glargine: the participant will receive an insulin dose of the insulin glargine at dinner subcutaneously according to a dosing algorithm. </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Changes in hepatic fat content, weight, body fat, visceral adipose tissue, waist circumference, hip circumference, eating behaviour, food selection, well‐being and disease perception. Also, daily insulin dose, fasting BG, hypoglycaemia and safety. </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Starting date</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>November 2007.</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Contact information</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Prof. dr. Andreas Fritsche (<a href="/cdn-cgi/l/email-protection" class="__cf_email__" data-cfemail="8beae5eff9eeeaf8a5edf9e2fff8e8e3eecbe6eeefa5fee5e2">[email&#160;protected]</a>‐tuebingen.de).</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Estimated completion date: October 2010..</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">NCT00699686 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Trial name or title</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Effects of adding basal insulin on endothelial progenitor cell levels in poorly‐controlled type 2 diabetic patients with cardiovascular disease. A randomised cross‐over study comparing insulin detemir and glargine. </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Intervention study, randomised, open‐label, active‐control, cross‐over assignment, pharmacodynamics study. </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Inclusion criteria: Type 2 diabetes, 35 to 80 years, macroangiopathy (coronary, peripheral or cerebrovascular), on oral antidiabetic therapy, and HbA1c &gt; 7.0%. </p> <p>Exclusion criteria: Type 1 diabetes, acute diabetic decompensation, use of glitazones, cancer, acute disease or infection, chronic renal failure (serum creatinine &gt; 2.0 mg/dl), advanced liver disease (Child B‐C), immune disease, organ transplantation, immunosuppression, recent surgery (within 3 months), recent cardiovascular events (within 3 months), inability to provide informed consent, pregnancy or lactation. </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Insulin detemir: Daily bedtime subcutaneous insulin detemir in individualized doses.</p> <p>Insulin glargine: Daily bedtime subcutaneous insulin glargine in individualized doses.</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Changes in endothelial progenitor cell count and in markers of endothelial damage.</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Starting date</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>May 2008.</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Contact information</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Angelo Avogaro (<a href="/cdn-cgi/l/email-protection" class="__cf_email__" data-cfemail="3b5a555c5e5754155a4d545c5a49547b4e55524b5f15524f">[email&#160;protected]</a>) or Gian Paolo Fadini (<a href="/cdn-cgi/l/email-protection" class="__cf_email__" data-cfemail="086f6169667869676467266e696c616661487d6661786c26617c">[email&#160;protected]</a>).</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Estimated completion date: March 2010.</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">NCT00862875 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Trial name or title</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Effects of basal insulin analogue detemir on body composition, epicardial fat and energy metabolism. </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Intervention study, randomised, open‐label, parallel assignment, pharmacodynamics study. </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Inclusion criteria: Type 2 diabetic patients who require basal (long‐acting) insulin for the control of hyperglycaemia according to the opinion of the investigator, age 18 to 80 years, BMI from 27 to 40 kg/m<sup>2</sup>, HbA1c ≥ 8.0% to 12.0%, stable body weight for previous 3 months (± 5 kg), structured exercise &lt; 4 hours per week, and metformin ≥ 1.5 g/day. </p> <p>Exclusion criteria: Any medical, social or geographic condition, which, in the opinion of the investigator would not allow safe or reliable completion of the protocol, type 1 diabetes, previous treatment with insulin (&lt; 6 months prior inclusion), secondary diabetes (i.e. steroid induced, Cushing syndrome, chronic pancreatitis, cystic fibrosis, etc.), maturity‐onset diabetes of the young, proliferative retinopathy/maculopathy requiring treatment, hypoglycaemia unawareness or recurrent major hypoglycaemia, pregnancy or breast‐feeding, unstable coronary artery disease, heart failure as defined by class IV according to NYHA classification, recent (&lt; 6 months) history of myocardial infarction, stroke, TIA, ventricular arrhythmias, or unstable supra‐ventricular arrhythmias, renal insufficiency (creatinine clearance &lt; 40 ml/min), acute (&lt; 2 months) or chronic infectious diseases requiring either hospitalisation or antibiotic treatment for &gt; 2 weeks, recent (&lt; 1 year) diagnosis of systemic malignancies except thyroid and skin cancer, major psychiatric diseases, history of drug addiction, previous bariatric surgery or medication that affects weight. </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Insulin detemir: Initial dose of 10 units of insulin at bedtime. The insulin dose will be increased by 1 unit per day until FPG levels are 5.0 mmol/L. </p> <p>Insulin glargine: Initial dose of 10 units of insulin at bedtime. The insulin dose will be increased by 1 unit per day until FPG levels are 5.0 mmol/L. </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Changes in total fat mass, and epicardial fat, trunk fat, total fat free mass, weight and waist circumference, HbA1c, fasting glucose, RMR, TEF, PAEE and TEE and energy intake. </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Starting date</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>March 2009.</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Contact information</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Sylvie Blaquiere (<a href="/cdn-cgi/l/email-protection" class="__cf_email__" data-cfemail="4f3c362339262a612d232e3e3a262a3d2a0f263d2c22613e2c612c2e">[email&#160;protected]</a>) or Stephanie Potvin (<a href="/cdn-cgi/l/email-protection" class="__cf_email__" data-cfemail="bbc8cfdecbd3dad5d2de95cbd4cfcdd2d5fbd2c9d8d695cad895d8da">[email&#160;protected]</a>).</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Estimated completion date: December 2011.</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">NCT00909480 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Trial name or title</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>A 26‐week randomised, multinational, open‐labelled, 2‐armed, parallel group, treat‐to‐target once‐daily treatment trial with insulin detemir versus insulin glargine, both in combination with metformin in subjects with type 2 diabetes. </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Intervention study, randomised, open‐label, active‐control, parallel assignment, safety/efficacy study. </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Inclusion criteria: diagnosed with type 2 diabetes for at least 6 months, age 18 years and older, stable treatment with a total daily dose of at least 1500 mg metformin or maximum tolerated dose (minimum 1000 mg) with or without one other OGLD (sulphonylureas, meglitinides, thiazolidinediones or DPP‐4 inhibitors) for at least 3 months, insulin‐naive (short‐term insulin treatment of up to 14 days is allowed), HbA1c between 7.0% and 9.0 % (both inclusive), and BMI ≤ 35.0 kg/m<sup>2</sup>. </p> <p>Exclusion criteria: Any contraindication to insulin detemir or insulin glargine according to the local labelling, receipt of any investigational product within 4 weeks, anticipated change of dose of any systemic treatment with products, which in the investigator's opinion could interfere with glucose metabolism (e.g. systemic corticosteroids), clinically significant diseases which, in the Investigator's opinion may confound the results of the trial or pose additional risk in administering trial product or any other condition that the Investigator feels would interfere with trial participation or evaluation of results. </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Insulin detemir: Treat‐to‐target titration according to titration algorithm. Subcutaneous injection once‐daily. </p> <p>Insulin glargine: Treat‐to‐target titration according to titration algorithm. Subcutaneous injection once‐daily. </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Change in HbA1C from baseline, proportion of subjects achieving HbA1c ≤ 7.0%, proportion of subjects achieving HbA1c ≤ 6.5%, FPG, within‐subject variation of self‐measured PG, 9‐point PG profile, incidence of hypoglycaemic episodes during the trial (nocturnal and over 24 hours) and change in body weight. </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Starting date</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>May 2009.</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Contact information</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Novo Nordisk clinical trial call centre (866‐867‐7178).</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Estimated completion date: June 2010.</p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p>Anti‐GAD = anti‐Glutamic Acid Decarboxylase; BMI = body mass index; DPP‐4 = dipeptidyl peptidase‐4; FBG = fasting blood glucose, FPG = fasting plasma glucose; HbA1c = glycosylated haemoglobin A1c; MRI = magnetic resonance imaging; NYHA = New York Heart Association; OGLD = oral glucose‐lowering drug; PAEE = physical activity energy expenditure; PG = plasma glucose; RMR = resting metabolic rate; SNRIs = serotonin‐norepinephrine reuptake inhibitors; SSRIs = selective serotonin reuptake inhibitors; TEE = total energy expenditure; TEF = thermic effects of food; TIA = transient ischaemic attack. </p> </div> </div> </p> </section> </section> <section class="dataAndAnalyses" id="dataAndAnalyses"> <section class="dataAndAnalyses" lang="en"> <div class="section-header section-collapse-header" id="CD006383-sec1-0011"> <h2 class="title section-collapse-title">Data and analyses<i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i></h2> </div> <div class="table" id="CD006383-tbl-0002"> <table class="comparison"><a href="#0" class="open-table-viewer open-in-figure-viewer">Open in table viewer</a><div class="table-heading"><span class="table-label">Comparison 1.</span>&nbsp;<span class="table-title">Detemir versus Glargine</span></div> <thead> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcome or subgroup title</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>No. of studies</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>No. of participants</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Statistical method</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">1 HbA1c at study endpoint <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>4</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2250</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.08 [‐0.10, 0.27]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"> <div class="figure" id="CD006383-fig-00101"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <li><a href="#0" class="open-in-figure-viewer">Open in figure viewer</a></li> <li><a class="btn btn-link" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006383.pub2/ppt/CDSR/CD006383/image_n/nCD006383-CMP-001-01.png?filename=nCD006383-CMP-001-01.ppt&amp;title=1.1&amp;caption=Comparison%201%20Detemir%20versus%20Glargine%2C%20Outcome%201%20HbA1c%20at%20study%20endpoint.&amp;citation=Swinnen SG, Simon ACR, Holleman F, Hoekstra JB, DeVries JH. Insulin detemir versus insulin glargine for type 2 diabetes mellitus. Cochrane Database of Systematic Reviews 2011, 7. Art. No.: CD006383. DOI: http://dx.doi.org/10.1002/14651858.CD006383.pub2"> Download as PowerPoint </a></li> </nav> <div class="figure-label">Analysis 1.1</div> </div> <hr class="top"><img data-id="CD006383-fig-00101" src="/cdsr/doi/10.1002/14651858.CD006383.pub2/media/CDSR/CD006383/image_n/nCD006383-CMP-001-01.png" alt="Comparison 1 Detemir versus Glargine, Outcome 1 HbA1c at study endpoint."><hr class="bottom"> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Comparison 1 Detemir versus Glargine, Outcome 1 HbA1c at study endpoint.</p> </div> </div> </div> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">2 Change in HbA1c <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>4</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2250</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.07 [‐0.10, 0.24]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"> <div class="figure" id="CD006383-fig-00102"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <li><a href="#0" class="open-in-figure-viewer">Open in figure viewer</a></li> <li><a class="btn btn-link" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006383.pub2/ppt/CDSR/CD006383/image_n/nCD006383-CMP-001-02.png?filename=nCD006383-CMP-001-02.ppt&amp;title=1.2&amp;caption=Comparison%201%20Detemir%20versus%20Glargine%2C%20Outcome%202%20Change%20in%20HbA1c.&amp;citation=Swinnen SG, Simon ACR, Holleman F, Hoekstra JB, DeVries JH. Insulin detemir versus insulin glargine for type 2 diabetes mellitus. Cochrane Database of Systematic Reviews 2011, 7. Art. No.: CD006383. DOI: http://dx.doi.org/10.1002/14651858.CD006383.pub2"> Download as PowerPoint </a></li> </nav> <div class="figure-label">Analysis 1.2</div> </div> <hr class="top"><img data-id="CD006383-fig-00102" src="/cdsr/doi/10.1002/14651858.CD006383.pub2/media/CDSR/CD006383/image_n/nCD006383-CMP-001-02.png" alt="Comparison 1 Detemir versus Glargine, Outcome 2 Change in HbA1c."><hr class="bottom"> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Comparison 1 Detemir versus Glargine, Outcome 2 Change in HbA1c.</p> </div> </div> </div> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">3 Percentage of participants achieving HbA1c ≤7% <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>4</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2078</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Risk Ratio (IV, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.96 [0.81, 1.14]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"> <div class="figure" id="CD006383-fig-00103"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <li><a href="#0" class="open-in-figure-viewer">Open in figure viewer</a></li> <li><a class="btn btn-link" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006383.pub2/ppt/CDSR/CD006383/image_n/nCD006383-CMP-001-03.png?filename=nCD006383-CMP-001-03.ppt&amp;title=1.3&amp;caption=Comparison%201%20Detemir%20versus%20Glargine%2C%20Outcome%203%20Percentage%20of%20participants%20achieving%20HbA1c%20%E2%89%A47%25.&amp;citation=Swinnen SG, Simon ACR, Holleman F, Hoekstra JB, DeVries JH. Insulin detemir versus insulin glargine for type 2 diabetes mellitus. Cochrane Database of Systematic Reviews 2011, 7. Art. No.: CD006383. DOI: http://dx.doi.org/10.1002/14651858.CD006383.pub2"> Download as PowerPoint </a></li> </nav> <div class="figure-label">Analysis 1.3</div> </div> <hr class="top"><img data-id="CD006383-fig-00103" src="/cdsr/doi/10.1002/14651858.CD006383.pub2/media/CDSR/CD006383/image_n/nCD006383-CMP-001-03.png" alt="Comparison 1 Detemir versus Glargine, Outcome 3 Percentage of participants achieving HbA1c ≤7%."><hr class="bottom"> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Comparison 1 Detemir versus Glargine, Outcome 3 Percentage of participants achieving HbA1c ≤7%. </p> </div> </div> </div> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">4 Percentage of participants achieving HbA1c ≤ 7% without hypoglycaemia <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>4</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2080</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Risk Ratio (IV, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.87 [0.76, 1.00]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"> <div class="figure" id="CD006383-fig-00104"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <li><a href="#0" class="open-in-figure-viewer">Open in figure viewer</a></li> <li><a class="btn btn-link" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006383.pub2/ppt/CDSR/CD006383/image_n/nCD006383-CMP-001-04.png?filename=nCD006383-CMP-001-04.ppt&amp;title=1.4&amp;caption=Comparison%201%20Detemir%20versus%20Glargine%2C%20Outcome%204%20Percentage%20of%20participants%20achieving%20HbA1c%20%E2%89%A4%207%25%20without%20hypoglycaemia.&amp;citation=Swinnen SG, Simon ACR, Holleman F, Hoekstra JB, DeVries JH. Insulin detemir versus insulin glargine for type 2 diabetes mellitus. Cochrane Database of Systematic Reviews 2011, 7. Art. No.: CD006383. DOI: http://dx.doi.org/10.1002/14651858.CD006383.pub2"> Download as PowerPoint </a></li> </nav> <div class="figure-label">Analysis 1.4</div> </div> <hr class="top"><img data-id="CD006383-fig-00104" src="/cdsr/doi/10.1002/14651858.CD006383.pub2/media/CDSR/CD006383/image_n/nCD006383-CMP-001-04.png" alt="Comparison 1 Detemir versus Glargine, Outcome 4 Percentage of participants achieving HbA1c ≤ 7% without hypoglycaemia."><hr class="bottom"> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Comparison 1 Detemir versus Glargine, Outcome 4 Percentage of participants achieving HbA1c ≤ 7% without hypoglycaemia. </p> </div> </div> </div> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">5 Fasting plasma glucose at study endpoint <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>4</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2250</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.34 [0.01, 0.67]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"> <div class="figure" id="CD006383-fig-00105"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <li><a href="#0" class="open-in-figure-viewer">Open in figure viewer</a></li> <li><a class="btn btn-link" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006383.pub2/ppt/CDSR/CD006383/image_n/nCD006383-CMP-001-05.png?filename=nCD006383-CMP-001-05.ppt&amp;title=1.5&amp;caption=Comparison%201%20Detemir%20versus%20Glargine%2C%20Outcome%205%20Fasting%20plasma%20glucose%20at%20study%20endpoint.&amp;citation=Swinnen SG, Simon ACR, Holleman F, Hoekstra JB, DeVries JH. Insulin detemir versus insulin glargine for type 2 diabetes mellitus. Cochrane Database of Systematic Reviews 2011, 7. Art. No.: CD006383. DOI: http://dx.doi.org/10.1002/14651858.CD006383.pub2"> Download as PowerPoint </a></li> </nav> <div class="figure-label">Analysis 1.5</div> </div> <hr class="top"><img data-id="CD006383-fig-00105" src="/cdsr/doi/10.1002/14651858.CD006383.pub2/media/CDSR/CD006383/image_n/nCD006383-CMP-001-05.png" alt="Comparison 1 Detemir versus Glargine, Outcome 5 Fasting plasma glucose at study endpoint."><hr class="bottom"> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Comparison 1 Detemir versus Glargine, Outcome 5 Fasting plasma glucose at study endpoint.</p> </div> </div> </div> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">6 Change in fasting plasma glucose <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>3</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1668</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.18 [‐0.10, 0.47]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"> <div class="figure" id="CD006383-fig-00106"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <li><a href="#0" class="open-in-figure-viewer">Open in figure viewer</a></li> <li><a class="btn btn-link" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006383.pub2/ppt/CDSR/CD006383/image_n/nCD006383-CMP-001-06.png?filename=nCD006383-CMP-001-06.ppt&amp;title=1.6&amp;caption=Comparison%201%20Detemir%20versus%20Glargine%2C%20Outcome%206%20Change%20in%20fasting%20plasma%20glucose.&amp;citation=Swinnen SG, Simon ACR, Holleman F, Hoekstra JB, DeVries JH. Insulin detemir versus insulin glargine for type 2 diabetes mellitus. Cochrane Database of Systematic Reviews 2011, 7. Art. No.: CD006383. DOI: http://dx.doi.org/10.1002/14651858.CD006383.pub2"> Download as PowerPoint </a></li> </nav> <div class="figure-label">Analysis 1.6</div> </div> <hr class="top"><img data-id="CD006383-fig-00106" src="/cdsr/doi/10.1002/14651858.CD006383.pub2/media/CDSR/CD006383/image_n/nCD006383-CMP-001-06.png" alt="Comparison 1 Detemir versus Glargine, Outcome 6 Change in fasting plasma glucose."><hr class="bottom"> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Comparison 1 Detemir versus Glargine, Outcome 6 Change in fasting plasma glucose.</p> </div> </div> </div> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">7 Percentage of participants having at least one hypoglycaemic event <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>4</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2252</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Risk Ratio (IV, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.98 [0.92, 1.05]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"> <div class="figure" id="CD006383-fig-00107"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <li><a href="#0" class="open-in-figure-viewer">Open in figure viewer</a></li> <li><a class="btn btn-link" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006383.pub2/ppt/CDSR/CD006383/image_n/nCD006383-CMP-001-07.png?filename=nCD006383-CMP-001-07.ppt&amp;title=1.7&amp;caption=Comparison%201%20Detemir%20versus%20Glargine%2C%20Outcome%207%20Percentage%20of%20participants%20having%20at%20least%20one%20hypoglycaemic%20event.&amp;citation=Swinnen SG, Simon ACR, Holleman F, Hoekstra JB, DeVries JH. Insulin detemir versus insulin glargine for type 2 diabetes mellitus. Cochrane Database of Systematic Reviews 2011, 7. Art. No.: CD006383. DOI: http://dx.doi.org/10.1002/14651858.CD006383.pub2"> Download as PowerPoint </a></li> </nav> <div class="figure-label">Analysis 1.7</div> </div> <hr class="top"><img data-id="CD006383-fig-00107" src="/cdsr/doi/10.1002/14651858.CD006383.pub2/media/CDSR/CD006383/image_n/nCD006383-CMP-001-07.png" alt="Comparison 1 Detemir versus Glargine, Outcome 7 Percentage of participants having at least one hypoglycaemic event."><hr class="bottom"> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Comparison 1 Detemir versus Glargine, Outcome 7 Percentage of participants having at least one hypoglycaemic event. </p> </div> </div> </div> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">8 Event rate for overall hypoglycaemia per patient‐year <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>4</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Rate Ratio (Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1.00 [0.90, 1.11]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"> <div class="figure" id="CD006383-fig-00108"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <li><a href="#0" class="open-in-figure-viewer">Open in figure viewer</a></li> <li><a class="btn btn-link" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006383.pub2/ppt/CDSR/CD006383/image_n/nCD006383-CMP-001-08.png?filename=nCD006383-CMP-001-08.ppt&amp;title=1.8&amp;caption=Comparison%201%20Detemir%20versus%20Glargine%2C%20Outcome%208%20Event%20rate%20for%20overall%20hypoglycaemia%20per%20patient%E2%80%90year.&amp;citation=Swinnen SG, Simon ACR, Holleman F, Hoekstra JB, DeVries JH. Insulin detemir versus insulin glargine for type 2 diabetes mellitus. Cochrane Database of Systematic Reviews 2011, 7. Art. No.: CD006383. DOI: http://dx.doi.org/10.1002/14651858.CD006383.pub2"> Download as PowerPoint </a></li> </nav> <div class="figure-label">Analysis 1.8</div> </div> <hr class="top"><img data-id="CD006383-fig-00108" src="/cdsr/doi/10.1002/14651858.CD006383.pub2/media/CDSR/CD006383/image_n/nCD006383-CMP-001-08.png" alt="Comparison 1 Detemir versus Glargine, Outcome 8 Event rate for overall hypoglycaemia per patient‐year."><hr class="bottom"> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Comparison 1 Detemir versus Glargine, Outcome 8 Event rate for overall hypoglycaemia per patient‐year. </p> </div> </div> </div> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">9 Percentage of participants having at least one nocturnal hypoglycaemic event <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>4</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2242</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Risk Ratio (IV, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1.02 [0.90, 1.16]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"> <div class="figure" id="CD006383-fig-00109"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <li><a href="#0" class="open-in-figure-viewer">Open in figure viewer</a></li> <li><a class="btn btn-link" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006383.pub2/ppt/CDSR/CD006383/image_n/nCD006383-CMP-001-09.png?filename=nCD006383-CMP-001-09.ppt&amp;title=1.9&amp;caption=Comparison%201%20Detemir%20versus%20Glargine%2C%20Outcome%209%20Percentage%20of%20participants%20having%20at%20least%20one%20nocturnal%20hypoglycaemic%20event.&amp;citation=Swinnen SG, Simon ACR, Holleman F, Hoekstra JB, DeVries JH. Insulin detemir versus insulin glargine for type 2 diabetes mellitus. Cochrane Database of Systematic Reviews 2011, 7. Art. No.: CD006383. DOI: http://dx.doi.org/10.1002/14651858.CD006383.pub2"> Download as PowerPoint </a></li> </nav> <div class="figure-label">Analysis 1.9</div> </div> <hr class="top"><img data-id="CD006383-fig-00109" src="/cdsr/doi/10.1002/14651858.CD006383.pub2/media/CDSR/CD006383/image_n/nCD006383-CMP-001-09.png" alt="Comparison 1 Detemir versus Glargine, Outcome 9 Percentage of participants having at least one nocturnal hypoglycaemic event."><hr class="bottom"> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Comparison 1 Detemir versus Glargine, Outcome 9 Percentage of participants having at least one nocturnal hypoglycaemic event. </p> </div> </div> </div> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">10 Event rate for nocturnal hypoglycaemia per patient‐year <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>4</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Rate Ratio (Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1.00 [0.93, 1.09]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"> <div class="figure" id="CD006383-fig-00110"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <li><a href="#0" class="open-in-figure-viewer">Open in figure viewer</a></li> <li><a class="btn btn-link" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006383.pub2/ppt/CDSR/CD006383/image_n/nCD006383-CMP-001-10.png?filename=nCD006383-CMP-001-10.ppt&amp;title=1.10&amp;caption=Comparison%201%20Detemir%20versus%20Glargine%2C%20Outcome%2010%20Event%20rate%20for%20nocturnal%20hypoglycaemia%20per%20patient%E2%80%90year.&amp;citation=Swinnen SG, Simon ACR, Holleman F, Hoekstra JB, DeVries JH. Insulin detemir versus insulin glargine for type 2 diabetes mellitus. Cochrane Database of Systematic Reviews 2011, 7. Art. No.: CD006383. DOI: http://dx.doi.org/10.1002/14651858.CD006383.pub2"> Download as PowerPoint </a></li> </nav> <div class="figure-label">Analysis 1.10</div> </div> <hr class="top"><img data-id="CD006383-fig-00110" src="/cdsr/doi/10.1002/14651858.CD006383.pub2/media/CDSR/CD006383/image_n/nCD006383-CMP-001-10.png" alt="Comparison 1 Detemir versus Glargine, Outcome 10 Event rate for nocturnal hypoglycaemia per patient‐year."><hr class="bottom"> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Comparison 1 Detemir versus Glargine, Outcome 10 Event rate for nocturnal hypoglycaemia per patient‐year. </p> </div> </div> </div> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">11 Percentage of participants having at least one severe hypoglycaemic event <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>4</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2252</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.82 [0.51, 1.32]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"> <div class="figure" id="CD006383-fig-00111"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <li><a href="#0" class="open-in-figure-viewer">Open in figure viewer</a></li> <li><a class="btn btn-link" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006383.pub2/ppt/CDSR/CD006383/image_n/nCD006383-CMP-001-11.png?filename=nCD006383-CMP-001-11.ppt&amp;title=1.11&amp;caption=Comparison%201%20Detemir%20versus%20Glargine%2C%20Outcome%2011%20Percentage%20of%20participants%20having%20at%20least%20one%20severe%20hypoglycaemic%20event.&amp;citation=Swinnen SG, Simon ACR, Holleman F, Hoekstra JB, DeVries JH. Insulin detemir versus insulin glargine for type 2 diabetes mellitus. Cochrane Database of Systematic Reviews 2011, 7. Art. No.: CD006383. DOI: http://dx.doi.org/10.1002/14651858.CD006383.pub2"> Download as PowerPoint </a></li> </nav> <div class="figure-label">Analysis 1.11</div> </div> <hr class="top"><img data-id="CD006383-fig-00111" src="/cdsr/doi/10.1002/14651858.CD006383.pub2/media/CDSR/CD006383/image_n/nCD006383-CMP-001-11.png" alt="Comparison 1 Detemir versus Glargine, Outcome 11 Percentage of participants having at least one severe hypoglycaemic event."><hr class="bottom"> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Comparison 1 Detemir versus Glargine, Outcome 11 Percentage of participants having at least one severe hypoglycaemic event. </p> </div> </div> </div> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">12 Event rate for severe hypoglycaemia per patient‐year <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>4</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Rate Ratio (Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.88 [0.59, 1.30]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"> <div class="figure" id="CD006383-fig-00112"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <li><a href="#0" class="open-in-figure-viewer">Open in figure viewer</a></li> <li><a class="btn btn-link" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006383.pub2/ppt/CDSR/CD006383/image_n/nCD006383-CMP-001-12.png?filename=nCD006383-CMP-001-12.ppt&amp;title=1.12&amp;caption=Comparison%201%20Detemir%20versus%20Glargine%2C%20Outcome%2012%20Event%20rate%20for%20severe%20hypoglycaemia%20per%20patient%E2%80%90year.&amp;citation=Swinnen SG, Simon ACR, Holleman F, Hoekstra JB, DeVries JH. Insulin detemir versus insulin glargine for type 2 diabetes mellitus. Cochrane Database of Systematic Reviews 2011, 7. Art. No.: CD006383. DOI: http://dx.doi.org/10.1002/14651858.CD006383.pub2"> Download as PowerPoint </a></li> </nav> <div class="figure-label">Analysis 1.12</div> </div> <hr class="top"><img data-id="CD006383-fig-00112" src="/cdsr/doi/10.1002/14651858.CD006383.pub2/media/CDSR/CD006383/image_n/nCD006383-CMP-001-12.png" alt="Comparison 1 Detemir versus Glargine, Outcome 12 Event rate for severe hypoglycaemia per patient‐year."><hr class="bottom"> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Comparison 1 Detemir versus Glargine, Outcome 12 Event rate for severe hypoglycaemia per patient‐year. </p> </div> </div> </div> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">13 Weight gain <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>4</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2250</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.91 [‐1.21, ‐0.61]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"> <div class="figure" id="CD006383-fig-00113"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <li><a href="#0" class="open-in-figure-viewer">Open in figure viewer</a></li> <li><a class="btn btn-link" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006383.pub2/ppt/CDSR/CD006383/image_n/nCD006383-CMP-001-13.png?filename=nCD006383-CMP-001-13.ppt&amp;title=1.13&amp;caption=Comparison%201%20Detemir%20versus%20Glargine%2C%20Outcome%2013%20Weight%20gain.&amp;citation=Swinnen SG, Simon ACR, Holleman F, Hoekstra JB, DeVries JH. Insulin detemir versus insulin glargine for type 2 diabetes mellitus. Cochrane Database of Systematic Reviews 2011, 7. Art. No.: CD006383. DOI: http://dx.doi.org/10.1002/14651858.CD006383.pub2"> Download as PowerPoint </a></li> </nav> <div class="figure-label">Analysis 1.13</div> </div> <hr class="top"><img data-id="CD006383-fig-00113" src="/cdsr/doi/10.1002/14651858.CD006383.pub2/media/CDSR/CD006383/image_n/nCD006383-CMP-001-13.png" alt="Comparison 1 Detemir versus Glargine, Outcome 13 Weight gain."><hr class="bottom"> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Comparison 1 Detemir versus Glargine, Outcome 13 Weight gain.</p> </div> </div> </div> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">14 Percentage of participants having at least one injection site reaction <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>4</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2252</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>3.31 [1.13, 9.73]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"> <div class="figure" id="CD006383-fig-00114"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <li><a href="#0" class="open-in-figure-viewer">Open in figure viewer</a></li> <li><a class="btn btn-link" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006383.pub2/ppt/CDSR/CD006383/image_n/nCD006383-CMP-001-14.png?filename=nCD006383-CMP-001-14.ppt&amp;title=1.14&amp;caption=Comparison%201%20Detemir%20versus%20Glargine%2C%20Outcome%2014%20Percentage%20of%20participants%20having%20at%20least%20one%20injection%20site%20reaction.&amp;citation=Swinnen SG, Simon ACR, Holleman F, Hoekstra JB, DeVries JH. Insulin detemir versus insulin glargine for type 2 diabetes mellitus. Cochrane Database of Systematic Reviews 2011, 7. Art. No.: CD006383. DOI: http://dx.doi.org/10.1002/14651858.CD006383.pub2"> Download as PowerPoint </a></li> </nav> <div class="figure-label">Analysis 1.14</div> </div> <hr class="top"><img data-id="CD006383-fig-00114" src="/cdsr/doi/10.1002/14651858.CD006383.pub2/media/CDSR/CD006383/image_n/nCD006383-CMP-001-14.png" alt="Comparison 1 Detemir versus Glargine, Outcome 14 Percentage of participants having at least one injection site reaction."><hr class="bottom"> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Comparison 1 Detemir versus Glargine, Outcome 14 Percentage of participants having at least one injection site reaction. </p> </div> </div> </div> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">15 Daily basal insulin dose in units per kg <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>4</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2250</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.26 [0.11, 0.41]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"> <div class="figure" id="CD006383-fig-00115"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <li><a href="#0" class="open-in-figure-viewer">Open in figure viewer</a></li> <li><a class="btn btn-link" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006383.pub2/ppt/CDSR/CD006383/image_n/nCD006383-CMP-001-15.png?filename=nCD006383-CMP-001-15.ppt&amp;title=1.15&amp;caption=Comparison%201%20Detemir%20versus%20Glargine%2C%20Outcome%2015%20Daily%20basal%20insulin%20dose%20in%20units%20per%20kg.&amp;citation=Swinnen SG, Simon ACR, Holleman F, Hoekstra JB, DeVries JH. Insulin detemir versus insulin glargine for type 2 diabetes mellitus. Cochrane Database of Systematic Reviews 2011, 7. Art. No.: CD006383. DOI: http://dx.doi.org/10.1002/14651858.CD006383.pub2"> Download as PowerPoint </a></li> </nav> <div class="figure-label">Analysis 1.15</div> </div> <hr class="top"><img data-id="CD006383-fig-00115" src="/cdsr/doi/10.1002/14651858.CD006383.pub2/media/CDSR/CD006383/image_n/nCD006383-CMP-001-15.png" alt="Comparison 1 Detemir versus Glargine, Outcome 15 Daily basal insulin dose in units per kg."><hr class="bottom"> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Comparison 1 Detemir versus Glargine, Outcome 15 Daily basal insulin dose in units per kg. </p> </div> </div> </div> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">16 Variability of fasting plasma glucose at study endpoint <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>4</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2250</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.00 [‐0.03, 0.02]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"> <div class="figure" id="CD006383-fig-00116"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <li><a href="#0" class="open-in-figure-viewer">Open in figure viewer</a></li> <li><a class="btn btn-link" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006383.pub2/ppt/CDSR/CD006383/image_n/nCD006383-CMP-001-16.png?filename=nCD006383-CMP-001-16.ppt&amp;title=1.16&amp;caption=Comparison%201%20Detemir%20versus%20Glargine%2C%20Outcome%2016%20Variability%20of%20fasting%20plasma%20glucose%20at%20study%20endpoint.&amp;citation=Swinnen SG, Simon ACR, Holleman F, Hoekstra JB, DeVries JH. Insulin detemir versus insulin glargine for type 2 diabetes mellitus. Cochrane Database of Systematic Reviews 2011, 7. Art. No.: CD006383. DOI: http://dx.doi.org/10.1002/14651858.CD006383.pub2"> Download as PowerPoint </a></li> </nav> <div class="figure-label">Analysis 1.16</div> </div> <hr class="top"><img data-id="CD006383-fig-00116" src="/cdsr/doi/10.1002/14651858.CD006383.pub2/media/CDSR/CD006383/image_n/nCD006383-CMP-001-16.png" alt="Comparison 1 Detemir versus Glargine, Outcome 16 Variability of fasting plasma glucose at study endpoint."><hr class="bottom"> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Comparison 1 Detemir versus Glargine, Outcome 16 Variability of fasting plasma glucose at study endpoint. </p> </div> </div> </div> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">17 Variability of plasma glucose profiles at study endpoint <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>3</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1286</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.01 [‐0.03, 0.06]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"> <div class="figure" id="CD006383-fig-00117"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <li><a href="#0" class="open-in-figure-viewer">Open in figure viewer</a></li> <li><a class="btn btn-link" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006383.pub2/ppt/CDSR/CD006383/image_n/nCD006383-CMP-001-17.png?filename=nCD006383-CMP-001-17.ppt&amp;title=1.17&amp;caption=Comparison%201%20Detemir%20versus%20Glargine%2C%20Outcome%2017%20Variability%20of%20plasma%20glucose%20profiles%20at%20study%20endpoint.&amp;citation=Swinnen SG, Simon ACR, Holleman F, Hoekstra JB, DeVries JH. Insulin detemir versus insulin glargine for type 2 diabetes mellitus. Cochrane Database of Systematic Reviews 2011, 7. Art. No.: CD006383. DOI: http://dx.doi.org/10.1002/14651858.CD006383.pub2"> Download as PowerPoint </a></li> </nav> <div class="figure-label">Analysis 1.17</div> </div> <hr class="top"><img data-id="CD006383-fig-00117" src="/cdsr/doi/10.1002/14651858.CD006383.pub2/media/CDSR/CD006383/image_n/nCD006383-CMP-001-17.png" alt="Comparison 1 Detemir versus Glargine, Outcome 17 Variability of plasma glucose profiles at study endpoint."><hr class="bottom"> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Comparison 1 Detemir versus Glargine, Outcome 17 Variability of plasma glucose profiles at study endpoint. </p> </div> </div> </div> </td> </tr> </tbody> </table> </div> </section> </section> <div class="figures-list"> <div class="figure" id="CD006383-fig-0001"> <img data-id="CD006383-fig-0001" src="/cdsr/doi/10.1002/14651858.CD006383.pub2/media/CDSR/CD006383/image_n/nCD006383-AFig-FIG01.png" alt="original image"> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 1</div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD006383.pub2/full#CD006383-fig-0001" class="figureList">Navigate to figure in Review</a><button href="#" class="print-figure">Print figure</button><a class="" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006383.pub2/ppt/CDSR/CD006383/image_n/nCD006383-AFig-FIG01.png?filename=nCD006383-AFig-FIG01.ppt&amp;title=1&amp;caption=&amp;citation=Swinnen SG, Simon ACR, Holleman F, Hoekstra JB, DeVries JH. Insulin detemir versus insulin glargine for type 2 diabetes mellitus. Cochrane Database of Systematic Reviews 2011, 7. Art. No.: CD006383. DOI: http://dx.doi.org/10.1002/14651858.CD006383.pub2"> Download as PowerPoint </a><a class="figure-viewer-isolate" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006383.pub2/media/CDSR/CD006383/image_n/nCD006383-AFig-FIG01.png">Open in new tab</a></div> </div> <div class="figure" id="CD006383-fig-0002"><img data-id="CD006383-fig-0002" src="/cdsr/doi/10.1002/14651858.CD006383.pub2/media/CDSR/CD006383/image_n/nCD006383-AFig-FIG02.png" alt="Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies."> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 2</div> <div class="figure-caption"> <p>Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies. </p> </div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD006383.pub2/full#CD006383-fig-0002" class="figureList">Navigate to figure in Review</a><button href="#" class="print-figure">Print figure</button><a class="" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006383.pub2/ppt/CDSR/CD006383/image_n/nCD006383-AFig-FIG02.png?filename=nCD006383-AFig-FIG02.ppt&amp;title=2&amp;caption=Risk%20of%20bias%20graph%3A%20review%20authors%27%20judgements%20about%20each%20risk%20of%20bias%20item%20presented%20as%20percentages%20across%20all%20included%20studies.&amp;citation=Swinnen SG, Simon ACR, Holleman F, Hoekstra JB, DeVries JH. Insulin detemir versus insulin glargine for type 2 diabetes mellitus. Cochrane Database of Systematic Reviews 2011, 7. Art. No.: CD006383. DOI: http://dx.doi.org/10.1002/14651858.CD006383.pub2"> Download as PowerPoint </a><a class="figure-viewer-isolate" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006383.pub2/media/CDSR/CD006383/image_n/nCD006383-AFig-FIG02.png">Open in new tab</a></div> </div> <div class="figure" id="CD006383-fig-0003"><img data-id="CD006383-fig-0003" src="/cdsr/doi/10.1002/14651858.CD006383.pub2/media/CDSR/CD006383/image_n/nCD006383-AFig-FIG03.png" alt="Risk of bias summary: review authors' judgements about each risk of bias item for each included study."> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 3</div> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD006383.pub2/full#CD006383-fig-0003" class="figureList">Navigate to figure in Review</a><button href="#" class="print-figure">Print figure</button><a class="" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006383.pub2/ppt/CDSR/CD006383/image_n/nCD006383-AFig-FIG03.png?filename=nCD006383-AFig-FIG03.ppt&amp;title=3&amp;caption=Risk%20of%20bias%20summary%3A%20review%20authors%27%20judgements%20about%20each%20risk%20of%20bias%20item%20for%20each%20included%20study.&amp;citation=Swinnen SG, Simon ACR, Holleman F, Hoekstra JB, DeVries JH. Insulin detemir versus insulin glargine for type 2 diabetes mellitus. Cochrane Database of Systematic Reviews 2011, 7. Art. No.: CD006383. DOI: http://dx.doi.org/10.1002/14651858.CD006383.pub2"> Download as PowerPoint </a><a class="figure-viewer-isolate" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006383.pub2/media/CDSR/CD006383/image_n/nCD006383-AFig-FIG03.png">Open in new tab</a></div> </div> <div class="figure" id="CD006383-fig-00101"><img data-id="CD006383-fig-00101" src="/cdsr/doi/10.1002/14651858.CD006383.pub2/media/CDSR/CD006383/image_n/nCD006383-CMP-001-01.png" alt="Comparison 1 Detemir versus Glargine, Outcome 1 HbA1c at study endpoint."> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.1</div> <div class="figure-caption"> <p>Comparison 1 Detemir versus Glargine, Outcome 1 HbA1c at study endpoint.</p> </div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD006383.pub2/references#CD006383-fig-00101" class="figureList">Navigate to figure in Review</a><button href="#" class="print-figure">Print figure</button><a class="" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006383.pub2/ppt/CDSR/CD006383/image_n/nCD006383-CMP-001-01.png?filename=nCD006383-CMP-001-01.ppt&amp;title=1.1&amp;caption=Comparison%201%20Detemir%20versus%20Glargine%2C%20Outcome%201%20HbA1c%20at%20study%20endpoint.&amp;citation=Swinnen SG, Simon ACR, Holleman F, Hoekstra JB, DeVries JH. Insulin detemir versus insulin glargine for type 2 diabetes mellitus. Cochrane Database of Systematic Reviews 2011, 7. Art. No.: CD006383. DOI: http://dx.doi.org/10.1002/14651858.CD006383.pub2"> Download as PowerPoint </a><a class="figure-viewer-isolate" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006383.pub2/media/CDSR/CD006383/image_n/nCD006383-CMP-001-01.png">Open in new tab</a></div> </div> <div class="figure" id="CD006383-fig-00102"><img data-id="CD006383-fig-00102" src="/cdsr/doi/10.1002/14651858.CD006383.pub2/media/CDSR/CD006383/image_n/nCD006383-CMP-001-02.png" alt="Comparison 1 Detemir versus Glargine, Outcome 2 Change in HbA1c."> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.2</div> <div class="figure-caption"> <p>Comparison 1 Detemir versus Glargine, Outcome 2 Change in HbA1c.</p> </div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD006383.pub2/references#CD006383-fig-00102" class="figureList">Navigate to figure in Review</a><button href="#" class="print-figure">Print figure</button><a class="" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006383.pub2/ppt/CDSR/CD006383/image_n/nCD006383-CMP-001-02.png?filename=nCD006383-CMP-001-02.ppt&amp;title=1.2&amp;caption=Comparison%201%20Detemir%20versus%20Glargine%2C%20Outcome%202%20Change%20in%20HbA1c.&amp;citation=Swinnen SG, Simon ACR, Holleman F, Hoekstra JB, DeVries JH. Insulin detemir versus insulin glargine for type 2 diabetes mellitus. Cochrane Database of Systematic Reviews 2011, 7. Art. No.: CD006383. DOI: http://dx.doi.org/10.1002/14651858.CD006383.pub2"> Download as PowerPoint </a><a class="figure-viewer-isolate" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006383.pub2/media/CDSR/CD006383/image_n/nCD006383-CMP-001-02.png">Open in new tab</a></div> </div> <div class="figure" id="CD006383-fig-00103"><img data-id="CD006383-fig-00103" src="/cdsr/doi/10.1002/14651858.CD006383.pub2/media/CDSR/CD006383/image_n/nCD006383-CMP-001-03.png" alt="Comparison 1 Detemir versus Glargine, Outcome 3 Percentage of participants achieving HbA1c ≤7%."> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.3</div> <div class="figure-caption"> <p>Comparison 1 Detemir versus Glargine, Outcome 3 Percentage of participants achieving HbA1c ≤7%. </p> </div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD006383.pub2/references#CD006383-fig-00103" class="figureList">Navigate to figure in Review</a><button href="#" class="print-figure">Print figure</button><a class="" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006383.pub2/ppt/CDSR/CD006383/image_n/nCD006383-CMP-001-03.png?filename=nCD006383-CMP-001-03.ppt&amp;title=1.3&amp;caption=Comparison%201%20Detemir%20versus%20Glargine%2C%20Outcome%203%20Percentage%20of%20participants%20achieving%20HbA1c%20%E2%89%A47%25.&amp;citation=Swinnen SG, Simon ACR, Holleman F, Hoekstra JB, DeVries JH. Insulin detemir versus insulin glargine for type 2 diabetes mellitus. Cochrane Database of Systematic Reviews 2011, 7. Art. No.: CD006383. DOI: http://dx.doi.org/10.1002/14651858.CD006383.pub2"> Download as PowerPoint </a><a class="figure-viewer-isolate" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006383.pub2/media/CDSR/CD006383/image_n/nCD006383-CMP-001-03.png">Open in new tab</a></div> </div> <div class="figure" id="CD006383-fig-00104"><img data-id="CD006383-fig-00104" src="/cdsr/doi/10.1002/14651858.CD006383.pub2/media/CDSR/CD006383/image_n/nCD006383-CMP-001-04.png" alt="Comparison 1 Detemir versus Glargine, Outcome 4 Percentage of participants achieving HbA1c ≤ 7% without hypoglycaemia."> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.4</div> <div class="figure-caption"> <p>Comparison 1 Detemir versus Glargine, Outcome 4 Percentage of participants achieving HbA1c ≤ 7% without hypoglycaemia. </p> </div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD006383.pub2/references#CD006383-fig-00104" class="figureList">Navigate to figure in Review</a><button href="#" class="print-figure">Print figure</button><a class="" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006383.pub2/ppt/CDSR/CD006383/image_n/nCD006383-CMP-001-04.png?filename=nCD006383-CMP-001-04.ppt&amp;title=1.4&amp;caption=Comparison%201%20Detemir%20versus%20Glargine%2C%20Outcome%204%20Percentage%20of%20participants%20achieving%20HbA1c%20%E2%89%A4%207%25%20without%20hypoglycaemia.&amp;citation=Swinnen SG, Simon ACR, Holleman F, Hoekstra JB, DeVries JH. Insulin detemir versus insulin glargine for type 2 diabetes mellitus. Cochrane Database of Systematic Reviews 2011, 7. Art. No.: CD006383. DOI: http://dx.doi.org/10.1002/14651858.CD006383.pub2"> Download as PowerPoint </a><a class="figure-viewer-isolate" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006383.pub2/media/CDSR/CD006383/image_n/nCD006383-CMP-001-04.png">Open in new tab</a></div> </div> <div class="figure" id="CD006383-fig-00105"><img data-id="CD006383-fig-00105" src="/cdsr/doi/10.1002/14651858.CD006383.pub2/media/CDSR/CD006383/image_n/nCD006383-CMP-001-05.png" alt="Comparison 1 Detemir versus Glargine, Outcome 5 Fasting plasma glucose at study endpoint."> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.5</div> <div class="figure-caption"> <p>Comparison 1 Detemir versus Glargine, Outcome 5 Fasting plasma glucose at study endpoint.</p> </div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD006383.pub2/references#CD006383-fig-00105" class="figureList">Navigate to figure in Review</a><button href="#" class="print-figure">Print figure</button><a class="" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006383.pub2/ppt/CDSR/CD006383/image_n/nCD006383-CMP-001-05.png?filename=nCD006383-CMP-001-05.ppt&amp;title=1.5&amp;caption=Comparison%201%20Detemir%20versus%20Glargine%2C%20Outcome%205%20Fasting%20plasma%20glucose%20at%20study%20endpoint.&amp;citation=Swinnen SG, Simon ACR, Holleman F, Hoekstra JB, DeVries JH. Insulin detemir versus insulin glargine for type 2 diabetes mellitus. Cochrane Database of Systematic Reviews 2011, 7. Art. No.: CD006383. DOI: http://dx.doi.org/10.1002/14651858.CD006383.pub2"> Download as PowerPoint </a><a class="figure-viewer-isolate" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006383.pub2/media/CDSR/CD006383/image_n/nCD006383-CMP-001-05.png">Open in new tab</a></div> </div> <div class="figure" id="CD006383-fig-00106"><img data-id="CD006383-fig-00106" src="/cdsr/doi/10.1002/14651858.CD006383.pub2/media/CDSR/CD006383/image_n/nCD006383-CMP-001-06.png" alt="Comparison 1 Detemir versus Glargine, Outcome 6 Change in fasting plasma glucose."> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.6</div> <div class="figure-caption"> <p>Comparison 1 Detemir versus Glargine, Outcome 6 Change in fasting plasma glucose.</p> </div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD006383.pub2/references#CD006383-fig-00106" class="figureList">Navigate to figure in Review</a><button href="#" class="print-figure">Print figure</button><a class="" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006383.pub2/ppt/CDSR/CD006383/image_n/nCD006383-CMP-001-06.png?filename=nCD006383-CMP-001-06.ppt&amp;title=1.6&amp;caption=Comparison%201%20Detemir%20versus%20Glargine%2C%20Outcome%206%20Change%20in%20fasting%20plasma%20glucose.&amp;citation=Swinnen SG, Simon ACR, Holleman F, Hoekstra JB, DeVries JH. Insulin detemir versus insulin glargine for type 2 diabetes mellitus. Cochrane Database of Systematic Reviews 2011, 7. Art. No.: CD006383. DOI: http://dx.doi.org/10.1002/14651858.CD006383.pub2"> Download as PowerPoint </a><a class="figure-viewer-isolate" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006383.pub2/media/CDSR/CD006383/image_n/nCD006383-CMP-001-06.png">Open in new tab</a></div> </div> <div class="figure" id="CD006383-fig-00107"><img data-id="CD006383-fig-00107" src="/cdsr/doi/10.1002/14651858.CD006383.pub2/media/CDSR/CD006383/image_n/nCD006383-CMP-001-07.png" alt="Comparison 1 Detemir versus Glargine, Outcome 7 Percentage of participants having at least one hypoglycaemic event."> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.7</div> <div class="figure-caption"> <p>Comparison 1 Detemir versus Glargine, Outcome 7 Percentage of participants having at least one hypoglycaemic event. </p> </div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD006383.pub2/references#CD006383-fig-00107" class="figureList">Navigate to figure in Review</a><button href="#" class="print-figure">Print figure</button><a class="" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006383.pub2/ppt/CDSR/CD006383/image_n/nCD006383-CMP-001-07.png?filename=nCD006383-CMP-001-07.ppt&amp;title=1.7&amp;caption=Comparison%201%20Detemir%20versus%20Glargine%2C%20Outcome%207%20Percentage%20of%20participants%20having%20at%20least%20one%20hypoglycaemic%20event.&amp;citation=Swinnen SG, Simon ACR, Holleman F, Hoekstra JB, DeVries JH. Insulin detemir versus insulin glargine for type 2 diabetes mellitus. Cochrane Database of Systematic Reviews 2011, 7. Art. No.: CD006383. DOI: http://dx.doi.org/10.1002/14651858.CD006383.pub2"> Download as PowerPoint </a><a class="figure-viewer-isolate" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006383.pub2/media/CDSR/CD006383/image_n/nCD006383-CMP-001-07.png">Open in new tab</a></div> </div> <div class="figure" id="CD006383-fig-00108"><img data-id="CD006383-fig-00108" src="/cdsr/doi/10.1002/14651858.CD006383.pub2/media/CDSR/CD006383/image_n/nCD006383-CMP-001-08.png" alt="Comparison 1 Detemir versus Glargine, Outcome 8 Event rate for overall hypoglycaemia per patient‐year."> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.8</div> <div class="figure-caption"> <p>Comparison 1 Detemir versus Glargine, Outcome 8 Event rate for overall hypoglycaemia per patient‐year. </p> </div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD006383.pub2/references#CD006383-fig-00108" class="figureList">Navigate to figure in Review</a><button href="#" class="print-figure">Print figure</button><a class="" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006383.pub2/ppt/CDSR/CD006383/image_n/nCD006383-CMP-001-08.png?filename=nCD006383-CMP-001-08.ppt&amp;title=1.8&amp;caption=Comparison%201%20Detemir%20versus%20Glargine%2C%20Outcome%208%20Event%20rate%20for%20overall%20hypoglycaemia%20per%20patient%E2%80%90year.&amp;citation=Swinnen SG, Simon ACR, Holleman F, Hoekstra JB, DeVries JH. Insulin detemir versus insulin glargine for type 2 diabetes mellitus. Cochrane Database of Systematic Reviews 2011, 7. Art. No.: CD006383. DOI: http://dx.doi.org/10.1002/14651858.CD006383.pub2"> Download as PowerPoint </a><a class="figure-viewer-isolate" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006383.pub2/media/CDSR/CD006383/image_n/nCD006383-CMP-001-08.png">Open in new tab</a></div> </div> <div class="figure" id="CD006383-fig-00109"><img data-id="CD006383-fig-00109" src="/cdsr/doi/10.1002/14651858.CD006383.pub2/media/CDSR/CD006383/image_n/nCD006383-CMP-001-09.png" alt="Comparison 1 Detemir versus Glargine, Outcome 9 Percentage of participants having at least one nocturnal hypoglycaemic event."> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.9</div> <div class="figure-caption"> <p>Comparison 1 Detemir versus Glargine, Outcome 9 Percentage of participants having at least one nocturnal hypoglycaemic event. </p> </div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD006383.pub2/references#CD006383-fig-00109" class="figureList">Navigate to figure in Review</a><button href="#" class="print-figure">Print figure</button><a class="" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006383.pub2/ppt/CDSR/CD006383/image_n/nCD006383-CMP-001-09.png?filename=nCD006383-CMP-001-09.ppt&amp;title=1.9&amp;caption=Comparison%201%20Detemir%20versus%20Glargine%2C%20Outcome%209%20Percentage%20of%20participants%20having%20at%20least%20one%20nocturnal%20hypoglycaemic%20event.&amp;citation=Swinnen SG, Simon ACR, Holleman F, Hoekstra JB, DeVries JH. Insulin detemir versus insulin glargine for type 2 diabetes mellitus. Cochrane Database of Systematic Reviews 2011, 7. Art. No.: CD006383. DOI: http://dx.doi.org/10.1002/14651858.CD006383.pub2"> Download as PowerPoint </a><a class="figure-viewer-isolate" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006383.pub2/media/CDSR/CD006383/image_n/nCD006383-CMP-001-09.png">Open in new tab</a></div> </div> <div class="figure" id="CD006383-fig-00110"><img data-id="CD006383-fig-00110" src="/cdsr/doi/10.1002/14651858.CD006383.pub2/media/CDSR/CD006383/image_n/nCD006383-CMP-001-10.png" alt="Comparison 1 Detemir versus Glargine, Outcome 10 Event rate for nocturnal hypoglycaemia per patient‐year."> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.10</div> <div class="figure-caption"> <p>Comparison 1 Detemir versus Glargine, Outcome 10 Event rate for nocturnal hypoglycaemia per patient‐year. </p> </div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD006383.pub2/references#CD006383-fig-00110" class="figureList">Navigate to figure in Review</a><button href="#" class="print-figure">Print figure</button><a class="" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006383.pub2/ppt/CDSR/CD006383/image_n/nCD006383-CMP-001-10.png?filename=nCD006383-CMP-001-10.ppt&amp;title=1.10&amp;caption=Comparison%201%20Detemir%20versus%20Glargine%2C%20Outcome%2010%20Event%20rate%20for%20nocturnal%20hypoglycaemia%20per%20patient%E2%80%90year.&amp;citation=Swinnen SG, Simon ACR, Holleman F, Hoekstra JB, DeVries JH. Insulin detemir versus insulin glargine for type 2 diabetes mellitus. Cochrane Database of Systematic Reviews 2011, 7. Art. No.: CD006383. DOI: http://dx.doi.org/10.1002/14651858.CD006383.pub2"> Download as PowerPoint </a><a class="figure-viewer-isolate" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006383.pub2/media/CDSR/CD006383/image_n/nCD006383-CMP-001-10.png">Open in new tab</a></div> </div> <div class="figure" id="CD006383-fig-00111"><img data-id="CD006383-fig-00111" src="/cdsr/doi/10.1002/14651858.CD006383.pub2/media/CDSR/CD006383/image_n/nCD006383-CMP-001-11.png" alt="Comparison 1 Detemir versus Glargine, Outcome 11 Percentage of participants having at least one severe hypoglycaemic event."> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.11</div> <div class="figure-caption"> <p>Comparison 1 Detemir versus Glargine, Outcome 11 Percentage of participants having at least one severe hypoglycaemic event. </p> </div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD006383.pub2/references#CD006383-fig-00111" class="figureList">Navigate to figure in Review</a><button href="#" class="print-figure">Print figure</button><a class="" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006383.pub2/ppt/CDSR/CD006383/image_n/nCD006383-CMP-001-11.png?filename=nCD006383-CMP-001-11.ppt&amp;title=1.11&amp;caption=Comparison%201%20Detemir%20versus%20Glargine%2C%20Outcome%2011%20Percentage%20of%20participants%20having%20at%20least%20one%20severe%20hypoglycaemic%20event.&amp;citation=Swinnen SG, Simon ACR, Holleman F, Hoekstra JB, DeVries JH. Insulin detemir versus insulin glargine for type 2 diabetes mellitus. Cochrane Database of Systematic Reviews 2011, 7. Art. No.: CD006383. DOI: http://dx.doi.org/10.1002/14651858.CD006383.pub2"> Download as PowerPoint </a><a class="figure-viewer-isolate" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006383.pub2/media/CDSR/CD006383/image_n/nCD006383-CMP-001-11.png">Open in new tab</a></div> </div> <div class="figure" id="CD006383-fig-00112"><img data-id="CD006383-fig-00112" src="/cdsr/doi/10.1002/14651858.CD006383.pub2/media/CDSR/CD006383/image_n/nCD006383-CMP-001-12.png" alt="Comparison 1 Detemir versus Glargine, Outcome 12 Event rate for severe hypoglycaemia per patient‐year."> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.12</div> <div class="figure-caption"> <p>Comparison 1 Detemir versus Glargine, Outcome 12 Event rate for severe hypoglycaemia per patient‐year. </p> </div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD006383.pub2/references#CD006383-fig-00112" class="figureList">Navigate to figure in Review</a><button href="#" class="print-figure">Print figure</button><a class="" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006383.pub2/ppt/CDSR/CD006383/image_n/nCD006383-CMP-001-12.png?filename=nCD006383-CMP-001-12.ppt&amp;title=1.12&amp;caption=Comparison%201%20Detemir%20versus%20Glargine%2C%20Outcome%2012%20Event%20rate%20for%20severe%20hypoglycaemia%20per%20patient%E2%80%90year.&amp;citation=Swinnen SG, Simon ACR, Holleman F, Hoekstra JB, DeVries JH. Insulin detemir versus insulin glargine for type 2 diabetes mellitus. Cochrane Database of Systematic Reviews 2011, 7. Art. No.: CD006383. DOI: http://dx.doi.org/10.1002/14651858.CD006383.pub2"> Download as PowerPoint </a><a class="figure-viewer-isolate" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006383.pub2/media/CDSR/CD006383/image_n/nCD006383-CMP-001-12.png">Open in new tab</a></div> </div> <div class="figure" id="CD006383-fig-00113"><img data-id="CD006383-fig-00113" src="/cdsr/doi/10.1002/14651858.CD006383.pub2/media/CDSR/CD006383/image_n/nCD006383-CMP-001-13.png" alt="Comparison 1 Detemir versus Glargine, Outcome 13 Weight gain."> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.13</div> <div class="figure-caption"> <p>Comparison 1 Detemir versus Glargine, Outcome 13 Weight gain.</p> </div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD006383.pub2/references#CD006383-fig-00113" class="figureList">Navigate to figure in Review</a><button href="#" class="print-figure">Print figure</button><a class="" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006383.pub2/ppt/CDSR/CD006383/image_n/nCD006383-CMP-001-13.png?filename=nCD006383-CMP-001-13.ppt&amp;title=1.13&amp;caption=Comparison%201%20Detemir%20versus%20Glargine%2C%20Outcome%2013%20Weight%20gain.&amp;citation=Swinnen SG, Simon ACR, Holleman F, Hoekstra JB, DeVries JH. Insulin detemir versus insulin glargine for type 2 diabetes mellitus. Cochrane Database of Systematic Reviews 2011, 7. Art. No.: CD006383. DOI: http://dx.doi.org/10.1002/14651858.CD006383.pub2"> Download as PowerPoint </a><a class="figure-viewer-isolate" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006383.pub2/media/CDSR/CD006383/image_n/nCD006383-CMP-001-13.png">Open in new tab</a></div> </div> <div class="figure" id="CD006383-fig-00114"><img data-id="CD006383-fig-00114" src="/cdsr/doi/10.1002/14651858.CD006383.pub2/media/CDSR/CD006383/image_n/nCD006383-CMP-001-14.png" alt="Comparison 1 Detemir versus Glargine, Outcome 14 Percentage of participants having at least one injection site reaction."> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.14</div> <div class="figure-caption"> <p>Comparison 1 Detemir versus Glargine, Outcome 14 Percentage of participants having at least one injection site reaction. </p> </div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD006383.pub2/references#CD006383-fig-00114" class="figureList">Navigate to figure in Review</a><button href="#" class="print-figure">Print figure</button><a class="" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006383.pub2/ppt/CDSR/CD006383/image_n/nCD006383-CMP-001-14.png?filename=nCD006383-CMP-001-14.ppt&amp;title=1.14&amp;caption=Comparison%201%20Detemir%20versus%20Glargine%2C%20Outcome%2014%20Percentage%20of%20participants%20having%20at%20least%20one%20injection%20site%20reaction.&amp;citation=Swinnen SG, Simon ACR, Holleman F, Hoekstra JB, DeVries JH. Insulin detemir versus insulin glargine for type 2 diabetes mellitus. Cochrane Database of Systematic Reviews 2011, 7. Art. No.: CD006383. DOI: http://dx.doi.org/10.1002/14651858.CD006383.pub2"> Download as PowerPoint </a><a class="figure-viewer-isolate" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006383.pub2/media/CDSR/CD006383/image_n/nCD006383-CMP-001-14.png">Open in new tab</a></div> </div> <div class="figure" id="CD006383-fig-00115"><img data-id="CD006383-fig-00115" src="/cdsr/doi/10.1002/14651858.CD006383.pub2/media/CDSR/CD006383/image_n/nCD006383-CMP-001-15.png" alt="Comparison 1 Detemir versus Glargine, Outcome 15 Daily basal insulin dose in units per kg."> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.15</div> <div class="figure-caption"> <p>Comparison 1 Detemir versus Glargine, Outcome 15 Daily basal insulin dose in units per kg. </p> </div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD006383.pub2/references#CD006383-fig-00115" class="figureList">Navigate to figure in Review</a><button href="#" class="print-figure">Print figure</button><a class="" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006383.pub2/ppt/CDSR/CD006383/image_n/nCD006383-CMP-001-15.png?filename=nCD006383-CMP-001-15.ppt&amp;title=1.15&amp;caption=Comparison%201%20Detemir%20versus%20Glargine%2C%20Outcome%2015%20Daily%20basal%20insulin%20dose%20in%20units%20per%20kg.&amp;citation=Swinnen SG, Simon ACR, Holleman F, Hoekstra JB, DeVries JH. Insulin detemir versus insulin glargine for type 2 diabetes mellitus. Cochrane Database of Systematic Reviews 2011, 7. Art. No.: CD006383. DOI: http://dx.doi.org/10.1002/14651858.CD006383.pub2"> Download as PowerPoint </a><a class="figure-viewer-isolate" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006383.pub2/media/CDSR/CD006383/image_n/nCD006383-CMP-001-15.png">Open in new tab</a></div> </div> <div class="figure" id="CD006383-fig-00116"><img data-id="CD006383-fig-00116" src="/cdsr/doi/10.1002/14651858.CD006383.pub2/media/CDSR/CD006383/image_n/nCD006383-CMP-001-16.png" alt="Comparison 1 Detemir versus Glargine, Outcome 16 Variability of fasting plasma glucose at study endpoint."> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.16</div> <div class="figure-caption"> <p>Comparison 1 Detemir versus Glargine, Outcome 16 Variability of fasting plasma glucose at study endpoint. </p> </div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD006383.pub2/references#CD006383-fig-00116" class="figureList">Navigate to figure in Review</a><button href="#" class="print-figure">Print figure</button><a class="" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006383.pub2/ppt/CDSR/CD006383/image_n/nCD006383-CMP-001-16.png?filename=nCD006383-CMP-001-16.ppt&amp;title=1.16&amp;caption=Comparison%201%20Detemir%20versus%20Glargine%2C%20Outcome%2016%20Variability%20of%20fasting%20plasma%20glucose%20at%20study%20endpoint.&amp;citation=Swinnen SG, Simon ACR, Holleman F, Hoekstra JB, DeVries JH. Insulin detemir versus insulin glargine for type 2 diabetes mellitus. Cochrane Database of Systematic Reviews 2011, 7. Art. No.: CD006383. DOI: http://dx.doi.org/10.1002/14651858.CD006383.pub2"> Download as PowerPoint </a><a class="figure-viewer-isolate" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006383.pub2/media/CDSR/CD006383/image_n/nCD006383-CMP-001-16.png">Open in new tab</a></div> </div> <div class="figure" id="CD006383-fig-00117"><img data-id="CD006383-fig-00117" src="/cdsr/doi/10.1002/14651858.CD006383.pub2/media/CDSR/CD006383/image_n/nCD006383-CMP-001-17.png" alt="Comparison 1 Detemir versus Glargine, Outcome 17 Variability of plasma glucose profiles at study endpoint."> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.17</div> <div class="figure-caption"> <p>Comparison 1 Detemir versus Glargine, Outcome 17 Variability of plasma glucose profiles at study endpoint. </p> </div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD006383.pub2/references#CD006383-fig-00117" class="figureList">Navigate to figure in Review</a><button href="#" class="print-figure">Print figure</button><a class="" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006383.pub2/ppt/CDSR/CD006383/image_n/nCD006383-CMP-001-17.png?filename=nCD006383-CMP-001-17.ppt&amp;title=1.17&amp;caption=Comparison%201%20Detemir%20versus%20Glargine%2C%20Outcome%2017%20Variability%20of%20plasma%20glucose%20profiles%20at%20study%20endpoint.&amp;citation=Swinnen SG, Simon ACR, Holleman F, Hoekstra JB, DeVries JH. Insulin detemir versus insulin glargine for type 2 diabetes mellitus. Cochrane Database of Systematic Reviews 2011, 7. Art. No.: CD006383. DOI: http://dx.doi.org/10.1002/14651858.CD006383.pub2"> Download as PowerPoint </a><a class="figure-viewer-isolate" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006383.pub2/media/CDSR/CD006383/image_n/nCD006383-CMP-001-17.png">Open in new tab</a></div> </div> </div> <div class="tables-list"> <div class="table"> <table data-id="CD006383-tbl-0001" class="summary-of-findings framed"> <div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span>&nbsp;<span class="table-title">Insulin detemir (intervention) vs. Insulin glargin (control) for type 2 diabetes mellitus</span></div> <tbody> <tr class="separated"> <td align="" valign="" colspan="7" rowspan="1" bgcolor="#ffffff"> <p><b>Insulin detemir (intervention) vs. Insulin glargin (control) for type 2 diabetes mellitus</b> </p> </td> </tr> <tr class="separated"> <td align="" valign="" colspan="7" rowspan="1" bgcolor="#ffffff"> <p><b>Patient or population:</b> patients with type 2 diabetes mellitus <br> <b>Settings:</b> <br> <b>Intervention:</b> Insulin detemir (intervention) vs. Insulin glargin (control) </p> </td> </tr> <tr class="table-header separated"> <td align="left" valign="top" colspan="1" rowspan="3" class="table-header"> <p><b>Outcomes</b> </p> </td> <td align="left" valign="top" colspan="2" rowspan="1" class="table-tint table-highlight"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="left" valign="top" colspan="1" rowspan="3" class="table-header"> <p><b>Relative effect <br> (95% CI)</b> </p> </td> <td align="left" valign="top" colspan="1" rowspan="3" class="table-header"> <p><b>No of Participants <br> (studies)</b> </p> </td> <td align="left" valign="top" colspan="1" rowspan="3" class="table-header"> <p><b>Quality of the evidence <br> (GRADE)</b> </p> </td> <td align="left" valign="top" colspan="1" rowspan="3" class="table-header"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>Assumed risk</b> </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>Corresponding risk</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>Control</b> </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>Insulin detemir (intervention) vs. Insulin glargin (control)</b> </p> </td> </tr> <tr class="separated"> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Mortality</b> ‐ not reported </p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>See comment</p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>See comment</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not estimable</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>See comment</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not investigated</p> </td> </tr> <tr class="separated"> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Quality of life and treatment satisfaction</b> ‐ not reported </p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>See comment</p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>See comment</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not estimable</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>See comment</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Insufficient information as only one included study reported on health‐related quality of life. </p> </td> </tr> <tr class="separated"> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Change in HbA1c</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>The mean change in HbA1c ranged across control groups from <br> <b>‐1.25 to ‐1.68 %</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>The mean change in HbA1c in the intervention groups was <br> <b>0.07 higher</b> <br> (0.14 lower to 0.24 higher) </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2250 <br> (4 studies) </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>⊕⊕⊝⊝ <br> <b>low</b><sup>1,2</sup> </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr class="separated"> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Percentage of participants having at least one severe hypoglycaemic event</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>33 per 1000</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>27 per 1000</b> <br> (17 to 43) </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>RR 0.82</b> <br> (0.51 to 1.32) </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2252 <br> (4 studies) </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>⊕⊕⊝⊝ <br> <b>low</b><sup>3,4</sup> </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr class="separated"> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Percentage of participants having at least one hypoglycaemic event</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>544 per 1000</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>533 per 1000</b> <br> (501 to 571) </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>RR 0.98</b> <br> (0.92 to 1.05) </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2252 <br> (4 studies) </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>⊕⊕⊝⊝ <br> <b>low</b><sup>3</sup> </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr class="separated"> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Weight gain</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>The mean weight gain ranged across control groups from <br> <b>1.4 to 3.8 kg</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>The mean weight gain in the intervention groups was <br> <b>0.91 lower</b> <br> (1.21 to 0.61 lower) </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2250 <br> (4 studies) </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>⊕⊕⊕⊕ <br> <b>high</b> </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr class="separated"> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Percentage of participants having at least one injection site reaction</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>4 per 1000</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>13 per 1000</b> <br> (4 to 39) </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>RR 3.31</b> <br> (1.13 to 9.73) </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2252 <br> (4 studies) </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>⊕⊕⊝⊝ <br> <b>low</b><sup>1,3</sup> </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr class="separated"> <td align="" valign="" colspan="7" rowspan="1" bgcolor="#ffffff"> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI). <br> <b>CI:</b> Confidence interval; <b>RR:</b> Risk ratio; </p> </td> </tr> <tr class="separated"> <td align="" valign="" colspan="7" rowspan="1" bgcolor="#ffffff"> <p>GRADE Working Group grades of evidence <br> <b>High quality:</b> Further research is very unlikely to change our confidence in the estimate of effect. <br> <b>Moderate quality:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate. <br> <b>Low quality:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate. <br> <b>Very low quality:</b> We are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup> Low number of events <br> <sup>2</sup> HbA1c is only a weak surrogate for mortality and diabetes‐associated morbidity <br> <sup>3</sup> Due to (i) lack of blinding and (ii) different frequency of injection and different injection devices across treatments <br> <sup>4</sup> Wide confidence interval and low number of total events </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span>&nbsp;<span class="table-title">Insulin detemir (intervention) vs. Insulin glargin (control) for type 2 diabetes mellitus</span></div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD006383.pub2/full#CD006383-tbl-0001" class="tableList">Navigate to table in Review</a></div> </div> <div class="table"> <table data-id="CD006383-tbl-0003"> <div class="table-heading"><span class="table-label">Table 1.</span>&nbsp;<span class="table-title">Overview of study populations</span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>study ID</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>intervention</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>[n] screened</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>[n] randomised</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>[n] safety</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>[n] ITT</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>[n]/% finishing study</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>comments</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Hollander 2008</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Intervention (I): Insulin detemir once‐ or twice‐daily + insulin aspart at mealtime</p> <p>Control (C): Insulin glargine once‐daily + insulin aspart at mealtime</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>I: ‐</p> <p>C: ‐</p> <p>Total: 460</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>I: 216</p> <p>C: 107</p> <p>Total: 323</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>I: 214</p> <p>C: 105</p> <p>Total: 319</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>I: 214</p> <p>C: 105</p> <p>Total: 319</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>I: 173 (80.1%)</p> <p>C: 84 (78.5%)</p> <p>Total: 257</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Insulin detemir: 92 (43.0%) patients used once‐daily and 122 (57.0%) twice‐daily at study completion. </p> <p>Novo Nordisk A/S web site: Trial report synopsis: "Safety analyses were only performed on the ITT analysis. ITT = all randomised subjects exposed to at least one dose of trial product". </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Raskin 2009</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Intervention (I): Insulin detemir once‐ or twice‐daily + insulin aspart at mealtime</p> <p>Control (C): Insulin glargine once‐daily + insulin aspart at mealtime</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>I: ‐</p> <p>C: ‐</p> <p>Total: ‐</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>I: 256</p> <p>C: 131</p> <p>Total: 387</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>I: 256</p> <p>C: 131</p> <p>Total: 387</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>I: 254</p> <p>C: 131</p> <p>Total: 385</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>I: 210 (82.0% of n=256)</p> <p>C: 113 (86.3%)</p> <p>Total: 323</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Insulin detemir: 222 (87.4%) patients used once‐daily and 32 (12.6%) twice‐daily at study completion. </p> <p>Total: 385 = ITT = randomised and exposed to at least one dose of trial product.</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Rosenstock 2008</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Intervention (I): Insulin detemir once‐ or twice‐daily</p> <p>Control (C): Insulin glargine once‐daily</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>I: ‐</p> <p>C: ‐</p> <p>Total: 892</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>I: 291</p> <p>C: 291</p> <p>Total: 582</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>I: 291</p> <p>C: 291</p> <p>Total: 582</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>I: 291</p> <p>C: 291</p> <p>Total: 582</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>I: 231 (79%)</p> <p>C: 252 (87%)</p> <p>Total: 483</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Insulin detemir: 104 (45.0%) patients used once‐daily and 127 (55.0%) twice‐daily at study completion. </p> <p>Total: 582 = ITT = randomised = exposed.</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Swinnen 2010</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Intervention (I):Insulin detemir twice‐daily</p> <p>Control (C): Insulin glargine once‐daily</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>I: ‐</p> <p>C: ‐</p> <p>Total: 1230</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>I: 487</p> <p>C: 486</p> <p>Total: 973</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>I: 486</p> <p>C: 478</p> <p>Total: 964</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>I: 472</p> <p>C: 473</p> <p>Total: 945</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>I: 437 (89.7% of n=487)</p> <p>C: 456 (93.8% of n=486)</p> <p>Total: 893</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Safety population = all randomised and treated subjects. mITT for primary outcome = randomised and treated subjects with a post‐baseline HbA1c measurement and information on hypoglycaemia, or with either a last HbA1c &gt; 7% or symptomatic hypoglycaemia ≤ 3.1 mmol/L. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="8"> <div class="table-footnote"> <p>‐ denotes 'not reported'</p> <p>HbA1c = glycosylated haemoglobin A1c; ITT = intention‐to‐treat; mITT = modified intention‐to‐treat.</p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 1.</span>&nbsp;<span class="table-title">Overview of study populations</span></div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD006383.pub2/full#CD006383-tbl-0003" class="tableList">Navigate to table in Review</a></div> </div> <div class="table"> <table data-id="CD006383-tbl-0002" class="comparison"> <div class="table-heading"><span class="table-label">Comparison 1.</span>&nbsp;<span class="table-title">Detemir versus Glargine</span></div> <thead> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcome or subgroup title</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>No. of studies</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>No. of participants</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Statistical method</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">1 HbA1c at study endpoint <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>4</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2250</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.08 [‐0.10, 0.27]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">2 Change in HbA1c <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>4</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2250</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.07 [‐0.10, 0.24]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">3 Percentage of participants achieving HbA1c ≤7% <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>4</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2078</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Risk Ratio (IV, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.96 [0.81, 1.14]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">4 Percentage of participants achieving HbA1c ≤ 7% without hypoglycaemia <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>4</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2080</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Risk Ratio (IV, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.87 [0.76, 1.00]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">5 Fasting plasma glucose at study endpoint <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>4</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2250</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.34 [0.01, 0.67]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">6 Change in fasting plasma glucose <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>3</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1668</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.18 [‐0.10, 0.47]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">7 Percentage of participants having at least one hypoglycaemic event <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>4</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2252</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Risk Ratio (IV, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.98 [0.92, 1.05]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">8 Event rate for overall hypoglycaemia per patient‐year <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>4</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Rate Ratio (Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1.00 [0.90, 1.11]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">9 Percentage of participants having at least one nocturnal hypoglycaemic event <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>4</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2242</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Risk Ratio (IV, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1.02 [0.90, 1.16]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">10 Event rate for nocturnal hypoglycaemia per patient‐year <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>4</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Rate Ratio (Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1.00 [0.93, 1.09]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">11 Percentage of participants having at least one severe hypoglycaemic event <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>4</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2252</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.82 [0.51, 1.32]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">12 Event rate for severe hypoglycaemia per patient‐year <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>4</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Rate Ratio (Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.88 [0.59, 1.30]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">13 Weight gain <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>4</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2250</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.91 [‐1.21, ‐0.61]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">14 Percentage of participants having at least one injection site reaction <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>4</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2252</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>3.31 [1.13, 9.73]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">15 Daily basal insulin dose in units per kg <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>4</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2250</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.26 [0.11, 0.41]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">16 Variability of fasting plasma glucose at study endpoint <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>4</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2250</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.00 [‐0.03, 0.02]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">17 Variability of plasma glucose profiles at study endpoint <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>3</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1286</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.01 [‐0.03, 0.06]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 1.</span>&nbsp;<span class="table-title">Detemir versus Glargine</span></div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD006383.pub2/references#CD006383-tbl-0002" class="tableList">Navigate to table in Review</a></div> </div> </div> <section class="translation-notes-modal" style="display: none" data-modal-title="Translation notes" data-modal-class="translation-notes" data-ok-btn-selector=".ok-btn"> <div class="translation-notes"> <div class="section-language-toggles"> <nav class="section-languages"> <ul> <li class="section-languages-legend">Available in</li> <li class="section-language"> <a class="" href="es#CD006383-note-1207">Español</a> </li> <li class="section-language"> <a class="" href="fr#CD006383-note-1206">Français</a> </li> <li class="section-language"> <a class="" href="ja#CD006383-note-1201">日本語</a> </li> <li class="section-language"> <a class="" href="ms#CD006383-note-1205">Bahasa Malaysia</a> </li> </ul> </nav> </div> <section class="translation-notes-content"> </section> <button class="btn primary ok-btn pull-right" type="button">Close</button> </div> </section></article> </div> <div class="citation-modal" style="display: none"> <div class="export-citation-header"> <p class="inset-message" id="citeProcText" data-load-error="Unable to load citation data"></p> </div> <div class="export-citation-body row-fluid"> <div class="span12"> <div class="addthis_toolbox addthis_default_style addthis_16x16_style"> <nav class="inline-nav-list is-bordered"> <li> <h4 class="heading">Save citation to:</h4> </li> <li><a href="#" class="addthis_button_citeulike at300b btn btn-link">CiteULike</a></li> <li><a href="#" class="addthis_button_mendeley at300b btn btn-link">Mendeley</a></li> <li><a href="#" class="citation-btn-refworks at300b btn btn-link" id="refWorksCitationBtn"><span class="citation-icon refworks"></span>RefWorks</a></li> </nav> </div> </div> </div> <div class="row-fluid"> <div class="span12"> <h4>Copy or download citation</h4> <nav class="inline-nav-list has-dividers"> <li class="citation-option" data-option="plain"><button type="button" class="btn btn-link">Plain text</button></li> <li class="citation-option" data-option="endnote"><button type="button" class="btn btn-link">EndNote</button></li> <li class="citation-option" data-option="refmanager"><button type="button" class="btn btn-link">Reference Manager</button></li> <li class="citation-option" data-option="procite"><button type="button" class="btn btn-link">ProCite</button></li> <li class="citation-option" data-option="bibtex"><button type="button" class="btn btn-link">BibteX</button></li> </nav> <div class="citation-content"> <pre id="citationContent" tabindex="0" data-load-error="Unable to load citation data"></pre> </div> <div class="clearfix"> <form class="download-citation-form" method="GET" target="citation-download-iframe" data-citation-citeproc-url="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=citation-citeproc&p_p_cacheability=cacheLevelPage&p_p_col_id=column-1&p_p_col_count=1"> <input type="hidden" id="siteId" name="siteId" value="" /> <input type="hidden" id="downloadType" name="downloadType" value="" /> <input type="hidden" id="style" name="style" value="" /> <input type="hidden" id="articleId" name="articleId" value="" /> <input name="p_p_id" type="hidden" value="scolariscontentdisplay_WAR_scolariscontentdisplay" /><input name="p_p_lifecycle" type="hidden" value="2" /><input name="p_p_state" type="hidden" value="normal" /><input name="p_p_mode" type="hidden" value="view" /><input name="p_p_resource_id" type="hidden" value="citation-download" /><input name="p_p_cacheability" type="hidden" value="cacheLevelPage" /><input name="p_p_col_id" type="hidden" value="column-1" /><input name="p_p_col_count" type="hidden" value="1" /> <button class="btn primary wide pull-right" type="submit">Download</button> <div class="inline-checkbox pull-right"> <label title=" for=" withAbstract"> <input class="checkbox" type="checkbox" name="withAbstract" /> <span class="checkbox-label">Include abstract</span> </label> </div> </form> <iframe title="Citation download frame" name="citation-download-iframe" src="" style="display: none; visibility: hidden" aria-hidden="true"></iframe> </div> </div> </div> </div> <div class="print-modal" style="display: none;" data-modal-title="Print this review"> <div class="print-options-wrapper"> <p><strong>All sections are selected by default</strong>, please select the sections you do not wish to print or use the select or deselect all button to add or remove sections.</p> <div class="print-options-controls"> <input title="Select/deselect all" type="checkbox" class="print-options-select-all" checked="checked" /> <span class="checkbox-label">Select/deselect all</span> </div> <ul class="print-options checkbox-list"> </ul> <button class="btn primary print-article pull-right"><i class="fa fa-print" aria-hidden="true"></i> Print</button> </div> </div> <div class="download-stats-data-modal" style="display: none;" data-modal-title="Download statistical data"> <div> <p> The data available are protected by copyright and may only be used in accordance with the <a class="external" href="/about/data-download" target="_blank">Terms and Conditions.</a> </p> <p> Downloaded data can only be viewed using <a class="external" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MNYX45LWN3VYI8JPMNYXG4DTMFYGKLUQPJUB/tools/review-production-tools/revman-5" target="_blank">Review Manager software.</a> </p> <p> Please note that: <ul> <li>data are only available for Cochrane Reviews that contain one or more forest plots; and</li> <li>data in the downloaded RevMan file are editable and therefore the review data can be amended without warning.</li> </ul> </p> <form class="download-stats-data-form" method="GET" target="_blank"> <input type="hidden" name="content-disposition" value="attachment" /> <input type="hidden" name="mime-type" value="application/octet-stream" /> <p class="print-options-controls"> <input type="checkbox" class="download-stats-data-toc-check-box" aria-label="I agree to these terms and conditions" /> <span class="checkbox-label" aria-hidden="true">I agree to these terms and conditions</span> <button class="btn primary download-stats-data pull-right" disabled=""><i class="fa fa-download" aria-hidden="true"></i> Download data</button> </p> </form> </div> </div> <div class="share-modal" style="display:none;" data-modal-title="Share this review"> <div class="add-this"> <div class="addthis_toolbox addthis_default_style addthis_32x32_style"> <nav class="stacked-nav-list"> <li> <a href="#" class="addthis_button_twitter at300b" title="Tweet">Twitter</a> </li> <li> <a href="#" class="addthis_button_mendeley at300b" target="_blank" title="Mendeley">Mendeley</a> </li> <li> <a href="#" class="addthis_button_facebook at300b" title="Facebook">Facebook</a> </li> <li> <a href="#" class="addthis_button_linkedin at300b" target="_blank" title="LinkedIn">LinkedIn</a> </li> <li> <a href="#" class="addthis_button_email at300b" target="_blank" title="Email">Email</a> </li> <li> <a href="#" class="addthis_button_whatsapp at300b" target="_blank" title="WhatsApp">WhatsApp</a> </li> <li class="clearfix"> <a href="#" class="addthis_button_more btn primary pull-right" target="_blank" title="View more"> <i class="fa fa-plus" aria-hidden="true"></i> View more</a> </li> </ul> </div> </div> </div> <div class="viewer-thumbnail-pane-html" style="display:none;"> <div class="figure-viewer-options"> <nav class="inline-nav-list"> <li class="figure-options-btn-container"><button type="button" class="btn btn-link" id="figureOptionBtn">Figures</button></li> <li class="table-options-btn-container"><button type="button" class="btn btn-link" id="tableOptionBtn">Tables</button></li> </nav> </div> <div class="figure-viewer-thumbnails"> <div id="figureThumbnails" class="figure-thumbnails is-visible"></div> <div id="tableThumbnails" class="table-thumbnails"></div> </div> </div> <div class="utilities-html" style="display:none;"> <div class="figure-viewer-utilities"> <a href="#" class="figure-viewer-menu-toggle"> <i class="fa fa-chevron-left"></i><span class="toggle-label" data-table-show-text="Show table list" data-table-hide-text="Hide table list" data-figure-show-text="Show thumbnails" data-figure-hide-text="Hide thumbnails">Hide thumbnails</span> </a> <a href="#" class="figure-viewer-zoomin"> <i class="fa fa-plus"></i><span>zoom in</span> </a> <a href="#" class="figure-viewer-zoomout"> <i class="fa fa-minus"></i><span>zoom out</span> </a> </div> </div> <div class="controls-html" style="display:none;"> <div class="figure-viewer-navigation"> <a href="#" class="figure-viewer-nav previous"> <i class="fa fa-chevron-left"></i><span>left</span> </a> <a href="#" class="figure-viewer-nav next"> <i class="fa fa-chevron-right"></i><span>right</span> </a> </div> </div> <div class="mobile-thumbnail-selector-html" style="display:none;"> <div class="figure-viewer-mobile-thumbnails"> <select class="figure-selection"> <option>Figures</option> </select> <select class="table-selection"> <option>Tables</option> </select> </div> </div> </div> </div> </div> <div style="display:none"> <input type="hidden" name="freelabel" id="freelabel" value='Free access'>
<input type="hidden" name="openlabel" id="openlabel" value='Open access'>
</div>
</section>
</div>
</div>
</div>
</div>
</div>
<div class="portlet-boundary portlet-boundary_1_WAR_kaleodesignerportlet_  portlet-static portlet-static-end kaleo-designer-portlet " id="p_p_id_1_WAR_kaleodesignerportlet_">
<span id="p_1_WAR_kaleodesignerportlet"></span>
</div>
<form action="#" id="hrefFm" method="post" name="hrefFm">
<span></span>
</form>
</div>
<footer class="footer">
<div class="main-footer">
<div class="main-footer-wrapper container">
<div class="brand">
<p class="brand-name">Cochrane</p>
<a title="Cochrane logo" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/P75YPLUDN7SXR6UBN3TT655TMH/">
<img class="footer-logo logo-part-1" src="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/cochrane-theme/images/footer-logo-part-1.png" alt="Cochrane logo" /> <img class="footer-logo logo-part-2" src="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/cochrane-theme/images/footer-logo-part-2.png" alt="" /> </a> </div> <nav class="footer-links"> <ul class="root"> <li class="footer-item"> <a class="footer-item-link" href="/about-cochrane1">About Cochrane</a> <ul class="child"> <li class="footer-item"> <a class="footer-item-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TT655TMH/evidence" target="_blank">Cochrane.org</a> </li> <li class="footer-item"> <a class="footer-item-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TT655TMH/about-us" target="_blank">Who we are</a> </li> <li class="footer-item"> <a class="footer-item-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/NJYXT5SPMNYXG4DTMFYGKLUQPJUB/" target="_blank">Get involved</a> </li> <li class="footer-item"> <a class="footer-item-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/MNYX665WNWTYE63PMNYXG4DTMFYGKLUQPJUB/" target="_blank">Consumer Network</a> </li> <li class="footer-item"> <a class="footer-item-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TT655TMH/about-us/our-funders-and-partners" target="_blank">Partners</a> </li> <li class="footer-item"> <a class="footer-item-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/MNYXZ5DQPF4XT7LNF3SX8Z5IPJRX63JPN73GH/" target="_blank">Colloquium</a> </li> <li class="footer-item"> <a class="footer-item-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TT655TMH/news" target="_blank">In the news</a> </li> </ul> </li> <li class="footer-item"> <a class="footer-item-link" href="/publications">Publications</a> <ul class="child"> <li class="footer-item"> <a class="footer-item-link" href="/library">Cochrane Library</a> <ul class="child"> <li class="footer-item"> <a class="footer-item-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/" target="_blank">Library Homepage</a> </li> <li class="footer-item"> <a class="footer-item-link" href="cdsr/about-cdsr" target="_blank">Cochrane Reviews (CDSR)</a> </li> <li class="footer-item"> <a class="footer-item-link" href="/central" target="_blank">Trials (CENTRAL)</a> </li> <li class="footer-item"> <a class="footer-item-link" href="/cca/about" target="_blank">Cochrane Clinical Answers</a> </li> </ul> </li> <li class="footer-item"> <a class="footer-item-link" href="/about/cochrane-library-app" target="_blank">Cochrane Library App</a> </li> <li class="footer-item"> <a class="footer-item-link" href="/cdsr/journal-club" target="_blank">Journal Club</a> </li> <li class="footer-item"> <a class="footer-item-link" href="/about/podcasts" target="_blank">Podcasts</a> </li> </ul> </li> <li class="footer-item"> <a class="footer-item-link" href="/community">Community</a> <ul class="child"> <li class="footer-item"> <a class="footer-item-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MNYX45LWN3VYI8JPMNYXG4DTMFYGKLUQPJUB/" target="_blank">Community</a> </li> <li class="footer-item"> <a class="footer-item-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/MF3GG4DJMVYGG55DNB3GC5UFF3YYE3D/" target="_blank">Archie log-in</a> </li> <li class="footer-item"> <a class="footer-item-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/PS3GC4LPNFYGPLUDN7SXR6UBN3TT655TMH/" target="_blank">Training and support</a> </li> <li class="footer-item"> <a class="footer-item-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/NWTYI4DQMS3T6Z5QMNVHEZLPMVYG86UH/" target="_blank">Methods</a> </li> <li class="footer-item"> <a class="footer-item-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/MNYX45LWN3VYI8JPMNYXG4DTMFYGKLUQPJUB/help" target="_blank">Software</a> </li> <li class="footer-item"> <a class="footer-item-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TT655TMH/news/jobs" target="_blank">Jobs and opportunities</a> </li> </ul> </li> <li class="footer-item"> <a class="footer-item-link" href="/contact-us">Contact Us</a> <ul class="child"> <li class="footer-item"> <a class="footer-item-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/P75YPLUDN7SXR6UBN3TT655TMH/contact" target="_blank">General enquiries</a> </li> <li class="footer-item"> <a class="footer-item-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/help/contact-us" target="_blank">Cochrane Library support</a> </li> <li class="footer-item"> <a class="footer-item-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/MNYX45LWN3VYI8JPMNYXG4DTMFYGKLUQPJUB/organizational-info/people/central-executive-team/chief-executive-officers-office/team" target="_blank">Chief Executive Officer</a> </li> <li class="footer-item"> <a class="footer-item-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MNYX45LWN3VYI8JPMNYXG4DTMFYGKLUQPJUB/organizational-info/people/central-executive-team/editorial-methods/team" target="_blank">Editor in Chief</a> </li> <li class="footer-item"> <a class="footer-item-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TT655TMH/about-us/our-global-community" target="_blank">Cochrane groups</a> </li> <li class="footer-item"> <a class="footer-item-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/P75YPLUDN7SXR6UBN3TT655TMH/media" target="_blank">Media</a> </li> <li class="footer-item"> <a class="footer-item-link" href="/accessibility" target="_blank">Accessibility</a> </li> </ul> </li> </ul> </nav> </div> </div> <div class="aux-footer"> <div class="aux-footer-nav-container container"> <nav class="aux-footer-nav"> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/N7YGZ4LPMWXGTZUTMF3HTLUYNFXGK8JPMNYXN/">Browse Publications</a></li> <li><a class="aux-footer-nav-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/N7YGZ4LPMWXGTZUTMF3HTLUYNFXGK8JPMNYXN/">Browse by Subject</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/N7YGZ4LPMWXGTZUTMF3HTLUYNFXGK8JPMNYXN/advertisers">Advertisers & Agents</a></li> <li><a class="aux-footer-nav-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/NB4XELUYNFXGK8JPMNYXN/community/support/cochrane-library">Contact Us</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/NB4XELUYNFXGK8JPMNYXN/community/support/cochrane-library">Help & Support</a></li> <li><a class="aux-footer-nav-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/N7YGZ4LPMWXGTZUTMF3HTLUYNFXGK8JPMNYXN/terms-and-conditions">Terms & Conditions</a></li> </ul> </nav> </div> <div class="brand"> <div class="brand-container container"> <p class="copyright"> Copyright &copy; 2000 - 2020 by <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/P75YPLUYNFXGK8JPMNYXN/" class="">John Wiley &amp; Sons, Inc.</a> All Rights Reserved <br /> Review our <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUYNFXGK8JPMNYXN/en-gb/privacy"><strong>Privacy Policy</strong></a> </p> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MW4T675JNSTYTLUDN7XB/"><img class="logo" src="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/cochrane-theme/images/en-US_wiley-footer-logo.png" alt="Wiley logo" /></a> </div> </div> <span class="wiley-semi-circle"></span> </div> </footer> <div class="scolaris-modal-overlay"></div> <div class="scolaris-modal"> <div class="scolaris-modal-titlebar clearfix"> <p class="scolaris-modal-title"></p> <a class="scolaris-modal-close" href="#"><span>close</span><span class="icon fa fa-times"></span></a> <div class="scolaris-modal-ui"></div> </div> <div class="scolaris-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="english-only-modal-wrapper" style="display: none" data-modal-title="Feature in English only" data-modal-class="english-only-modal"> <div class="english-only-modal"> <p class="message"></p> <button class="btn primary ok-btn pull-right" type="button">OK</button> <button class="btn primary border-only cancel-btn pull-right" type="button">Cancel</button> </div> </div> <!--[if gte IE 9]><!--> <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script src="/cochrane-theme/vendor/ie9.js?t=1581423095000" type="text/javascript"></script> <!--<![endif]--> <script src="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/cochrane-theme/js/theme.js?t=1581423095000" type="text/javascript"></script> <script src="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/MNYX67DFN34C66UFMFTGG7LCMVYGG55N/cochrane/checkout.js"></script> <script src="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/MNYX67DFN34C66UFMFTGG7LCMVYGG55N/cochrane/epdf_linker.js" type="text/javascript"></script> <script src="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/MN3G865UNWRYE43NMNTG6LUDPJYYG65TMWUC655TMH/widget/v2.0/widget.js" type="text/javascript"></script> <script src="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/MRZXE8DIHB4XC63SNWYHPN3PMNXG87LEM33G85UVF3YGK7A/assets/embed.js" type="text/javascript"></script> <script src="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/scolaris-content-display/js/hit-highlighting.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1581717691000" type="text/javascript"></script> <script src="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/scolaris-content-display/js/topics-lookup.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1581717691000" type="text/javascript"></script> <script src="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/scolaris-content-display/js/institution.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1581717691000" type="text/javascript"></script> <script src="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/scolaris-content-display/js/api-manager.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1581717691000" type="text/javascript"></script> <script src="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/scolaris-content-display/js/reference-linking.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1581717691000" type="text/javascript"></script> <script src="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/scolaris-content-display/js/rightsLink.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1581717691000" type="text/javascript"></script> <script src="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/scolaris-content-display/js/ui.submit.failed.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1581717691000" type="text/javascript"></script> <script src="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/scolaris-content-display/js/ui.comment.form.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1581717691000" type="text/javascript"></script> <script src="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/scolaris-content-display/js/safety-alerts.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1581717691000" type="text/javascript"></script> <script src="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/scolaris-content-display/js/ui.translation-notes-modal.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1581717691000" type="text/javascript"></script> <script src="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/scolaris-content-display/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1581717691000" type="text/javascript"></script> <script src="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/notifications-portlet/notifications/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1581717708000" type="text/javascript"></script> <script src="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/scolaris-search/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1581717777000" type="text/javascript"></script> <script src="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/scolaris-topics/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1581717709000" type="text/javascript"></script> <script src="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/scolaris-language-portlet/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1581717714000" type="text/javascript"></script> <script type="text/javascript">Liferay.Util.addInputFocus();</script> <script type="text/javascript">Liferay.Portlet.register("scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_",portletId:"scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dreferences\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD006383\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD006383\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dreferences\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD006383\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD006383\x2epub2"});Liferay.Portlet.register("scolariscontentdisplay_WAR_scolariscontentdisplay");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_",portletId:"scolariscontentdisplay_WAR_scolariscontentdisplay",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentdisplay_WAR_scolariscontentdisplay\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dcolumn-1\x26p_p_col_pos\x3d0\x26p_p_col_count\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dreferences\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD006383\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD006383\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D"});Liferay.provide(Liferay.Util,"openKaleoDesignerPortlet",function(c){var b=AUI();var e=Liferay.PortletURL.createURL("https://www.cochranelibrary.com/en/content?p_p_id=2_WAR_kaleodesignerportlet&p_p_lifecycle=0");e.setParameter("mvcPath","/designer/edit_kaleo_draft_definition.jsp");e.setParameter("availableFields",c.availableFields);e.setParameter("availablePropertyModels",c.availablePropertyModels);e.setParameter("ddmStructureId",c.ddmStructureId);e.setParameter("draftVersion",c.draftVersion);e.setParameter("kaleoProcessId",c.kaleoProcessId);e.setParameter("name",c.name);e.setParameter("openerWindowName",c.openerWindowName);e.setParameter("portletResourceNamespace",c.portletResourceNamespace);e.setParameter("propertiesSaveCallback",c.propertiesSaveCallback);e.setParameter("refreshOpenerOnClose",c.refreshOpenerOnClose);e.setParameter("saveCallback",c.saveCallback);e.setParameter("version",c.version);e.setWindowState("pop_up");c.uri=e.toString();var d=c.dialog;if(!d){var f=b.one(Liferay.Util.getOpener()).get("region");d={destroyOnHide:true};c.dialog=d}if(!("align" in d)){d.align=Liferay.Util.Window.ALIGN_CENTER}var a=c.dialogIframe;if(!a){a={closeOnEscape:false};c.dialogIframe=a}Liferay.Util.openWindow(c)},["liferay-portlet-url"]);Liferay.Portlet.register("1_WAR_kaleodesignerportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_1_WAR_kaleodesignerportlet_",portletId:"1_WAR_kaleodesignerportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3d1_WAR_kaleodesignerportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dreferences\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD006383\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD006383\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dreferences\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD006383\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD006383\x2epub2"});Liferay.Portlet.register("scolarissearchportlet_WAR_scolarissearch");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarissearchportlet_WAR_scolarissearch_",portletId:"scolarissearchportlet_WAR_scolarissearch",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarissearchportlet_WAR_scolarissearch\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dreferences\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD006383\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD006383\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dreferences\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD006383\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD006383\x2epub2"});Liferay.Portlet.register("scolariscontentlanguagebanner_WAR_scolarislanguageportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_",portletId:"scolariscontentlanguagebanner_WAR_scolarislanguageportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentlanguagebanner_WAR_scolarislanguageportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dreferences\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD006383\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD006383\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dreferences\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD006383\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD006383\x2epub2"});AUI().use("aui-base","liferay-menu","liferay-notice","liferay-poller","liferay-session",function(a){(function(){Liferay.Util.addInputType();Liferay.Portlet.ready(function(b,c){Liferay.Util.addInputType(c)});if(a.UA.mobile){Liferay.Util.addInputCancel()}})();(function(){new Liferay.Menu();var b=Liferay.Data.notices;for(var c=1;c<b.length;c++){new Liferay.Notice(b[c])}})();(function(){Liferay.Session=new Liferay.SessionBase({autoExtend:true,sessionLength:1800,redirectOnExpire:false,redirectUrl:"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane",warningLength:0})})()});</script> <script src="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/cochrane-theme/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1581423095000" type="text/javascript"></script> <script type="text/javascript"></script> <div class="mobile-righthand-nav"> <a href="#" class="rh-nav-close-btn"> <span>Close</span> <span class="fa fa-chevron-down"></span> </a> <div class="wrapper"> </div> <a href="#" class="rh-nav-open-btn"> <span>Review tools & navigation</span> </a> </div> <iframe title="Print frame" id="printframe" name="printframe" style="position: absolute; left: -2000px; top: 0;" aria-hidden="true"></iframe> <div class="mobile-navigation"> <div class="close-container"> <a href="#" class="main-nav-back-btn" aria-label="Navigate back"><i class="fa fa-chevron-left"></i></a> <a href="#" class="main-nav-close-btn" title="Close menu">Close menu <i class="fa fa-times"></i></a> </div> <div class="mobile-search basic-search-container"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end " id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img id="ymag__null__null" src="/scolaris-search/icon.png" alt="" /> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class=" portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_auth=y8F68iId&p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=1&p_p_state=normal&p_p_mode=view&_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input type="hidden" name="searchType" value="basic" /> <input type="hidden" name="facetDisplayName" value="" /> <input type="hidden" name="facetQueryTerm" value="" /> <input type="hidden" name="facetQueryField" value="" /> <input type="hidden" name="facetCategory" value="" /> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select title="Search by options" aria-label="Search by options" name="searchBy" class="custom-select-enabled search-type"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" style="display: none;" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=topics-list&p_p_cacheability=cacheLevelPage"> <select class="search-select-topic-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input type="text" size="30" class="field browser-search search-text ui-autocomplete-input" value="" aria-label="Enter search term" id="searchText" name="searchText" placeholder="Search">
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button type="submit" class="searchByBtn" aria-label="Search">
<i class="fa fa-search" aria-hidden="true"></i>
</button>
</div>
</div>
</fieldset>
</form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=references&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD006383.pub2&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD006383.pub2';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input type="hidden" name="freelabel" id="freelabel" value='Free access'>
<input type="hidden" name="openlabel" id="openlabel" value='Open access'>
</div>
</section>
</div>
<a href="/en/browse-by-topic" class="btn secondary">Browse </a>
<a href="/en/advanced-search" class="btn secondary advanced-search-button">Advanced search</a>
</div>
<div class="menu-items parent">
<ul>
<li class="nav-root-item parent">
<a href="#" title="Select language" class="language-selection-title-link">
<span class="mobile-nav-language-title">Select your preferred language</span><span class="icon fa fa-caret-down"></span>
<ul class="mob-child">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_  portlet-static portlet-static-end  " id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img id="fdkn__null__null" src="/scolaris-language-portlet/icon.png" alt="" /> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class=" portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hr, ja, ko, ms, pl, pt, ru, ta, th, zh, za]"> <a title="Select your preferred language" class="language-select-mobile" href="#"> <i class="fa fa-file-text"></i> English </a> <a title="Select your preferred language" class="language-select-mobile" href="#"> <i class="fa fa-globe"></i> English </a> </div> <div class="form-content language-selector-modal child"> <div class="row-fluid"> <h3><i class="fa fa-file-text"></i> Cochrane Review language</h3> <p>Select your preferred language for Cochrane Reviews. You will see translated Review sections in your preferred language. Sections without translation will be in English.</p> <div id="active-content-language" class="dropdown-trigger"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=de" class="content-language-selector " data-languagecode="de">Deutsch</a> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=en" class="content-language-selector is-active" data-languagecode="en">English</a> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=es" class="content-language-selector " data-languagecode="es">Español</a> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fa" class="content-language-selector " data-languagecode="fa">فارسی</a> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fr" class="content-language-selector " data-languagecode="fr">Français</a> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hr" class="content-language-selector " data-languagecode="hr">Hrvatski</a> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ja" class="content-language-selector " data-languagecode="ja">日本語</a> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ko" class="content-language-selector " data-languagecode="ko">한국어</a> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ms" class="content-language-selector " data-languagecode="ms">Bahasa Malaysia</a> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pl" class="content-language-selector " data-languagecode="pl">Polski</a> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pt" class="content-language-selector " data-languagecode="pt">Português</a> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ru" class="content-language-selector " data-languagecode="ru">Русский</a> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ta" class="content-language-selector " data-languagecode="ta">தமிழ்</a> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=th" class="content-language-selector " data-languagecode="th">ภาษาไทย</a> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh" class="content-language-selector " data-languagecode="zh">简体中文</a> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=za" class="content-language-selector " data-languagecode="za">繁體中文</a> </div> </div> <div class="row-fluid"> <h3 class="portal-language-header"><i class="fa fa-globe"></i> Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> <div id="active-portal-language" class="dropdown-trigger"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a href="/en/cdsr/doi/10.1002/14651858.CD006383.pub2/references/en" class="portal-language-selector is-active" data-portallanguage="en">English</a> <a href="/es/cdsr/doi/10.1002/14651858.CD006383.pub2/references/es" class="portal-language-selector " data-portallanguage="es">Español</a> </div> </div> <a class="btn secondary ok-btn pull-right" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> <div style="display:none"> <input type="hidden" name="freelabel" id="freelabel" value='Free access'>
<input type="hidden" name="openlabel" id="openlabel" value='Open access'>
</div>
</section>
</div>
</ul>
</a>
</li>
<li class="parent">
<a class="mobile-link signin" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/c/portal/login?p_l_id=20757&redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD006383.pub2%2Freferences" data-redirect="false" rel="nofollow">
Sign In
</a>
</li>
</ul>
<div class="menu-items-footer">
<div class="utility-links">
<a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/P75YPLUDN7SXR6UBN3TT655TMH/" class="cochrane-link" target="_blank">Visit Cochrane.org</a>
</div>
</div>
</div>
<div class="menu-items child"></div>
</div>
<div class="basic-login-form-content" style="display: none;" data-modal-title="Sign in">
<div class="form-content">
<div class="row-fluid">
<div class="span12">
<div class="portlet-boundary portlet-boundary_58_  portlet-static portlet-static-end portlet-login " id="p_p_id_58_INSTANCE_MODAL_">
<span id="p_58_INSTANCE_MODAL"></span>
<section class="portlet" id="portlet_58_INSTANCE_MODAL">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img id="dbam__null__null" src="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/cochrane-theme/images/spacer.png" alt="" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;" /> <span class="taglib-text hide-accessible">Sign In</span> </span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_MODAL" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class=" portlet-content-container"> <div class="portlet-body"> <form action="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=58_INSTANCE_MODAL&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_MODAL_struts_action=%2Flogin%2Flogin" class="form sign-in-form " id="_58_INSTANCE_MODAL_fm" method="post" name="_58_INSTANCE_MODAL_fm" autocomplete="on"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_MODAL_formDate" type="hidden" value="1583237263762" /> <input class="field" id="_58_INSTANCE_MODAL_saveLastPath" name="_58_INSTANCE_MODAL_saveLastPath" type="hidden" value="false" /> <input class="field" id="_58_INSTANCE_MODAL_redirect" name="_58_INSTANCE_MODAL_redirect" type="hidden" value="&#x2f;cdsr&#x2f;doi&#x2f;10&#x2e;1002&#x2f;14651858&#x2e;CD006383&#x2e;pub2&#x2f;references" /> <input class="field" id="_58_INSTANCE_MODAL_doActionAfterLogin" name="_58_INSTANCE_MODAL_doActionAfterLogin" type="hidden" value="false" /> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_login"> Email Address </label> <input class="field clearable" id="_58_INSTANCE_MODAL_login" name="_58_INSTANCE_MODAL_login" type="text" value="" /> </div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_password"> Password </label> <input class="field" id="_58_INSTANCE_MODAL_password" name="_58_INSTANCE_MODAL_password" type="password" value="" /> </div> <span id="_58_INSTANCE_MODAL_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="clearfix"> <div class="checkbox-list pull-left"> <div class="checkbox-list-item"> <div class="control-group form-inline input-checkbox-wrapper"> <label for="_58_INSTANCE_MODAL_rememberMeCheckbox"> <input id="_58_INSTANCE_MODAL_rememberMe" name="_58_INSTANCE_MODAL_rememberMe" type="hidden" value="true" /> <input checked class="field" id="_58_INSTANCE_MODAL_rememberMeCheckbox" name="_58_INSTANCE_MODAL_rememberMeCheckbox" onClick="Liferay.Util.updateCheckboxValue(this); " type="checkbox" value="true" /> Remember Me </label> </div> </div> </div> <div class="pull-right"> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/N7YGZ4LPMWXGTZUTMF3HTLUYNFXGK8JPMNYXN/user/forgottenpassword" target="_blank">Forgotten password?</a> </div> </div> <div class="login-form-footer clearfix"> <div class="pull-left"> <button type="submit" class="btn primary">Sign in</button> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/N7YGZ4LPMWXGTZUTMF3HTLUYNFXGK8JPMNYXN/user-registration" target="_blank" class="btn secondary">Register</a> </div> <div class="pull-right"> <a class="institutional-login-form-button" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&p_p_lifecycle=0&p_p_state=normal&p_p_mode=view&_scolariscontentdisplay_WAR_scolariscontentdisplay_action=institution-access">Institutional login</a> </div> </div> </fieldset> </form> </div> </div> </div> <div style="display:none"> <input type="hidden" name="freelabel" id="freelabel" value='Free access'>
<input type="hidden" name="openlabel" id="openlabel" value='Open access'>
</div>
</section>
</div>
</div>
</div>
</div></div>
<div class="institution-login-form-content" style="display: none;" data-modal-title="Institutional login">
<div class="form-content">
<div class="row-fluid access-content-wrapper">
<div class="span12">
<div class="section">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_  portlet-static portlet-static-end scolaris-content-display-portlet " id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img id="obft__null__null" src="/scolaris-content-display/icon.png" alt="" /> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class=" portlet-content-container"> <div class="portlet-body"> <div class="access-content-section"> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form method="post" action="/shibboleth" id="institutionLoginForm"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" name="institutionName" id="institutionName" value="" type="text">
</div>
<button class="btn primary" type="submit" name="button">Go</button>
</div>
<div id="institutionLookupErrorDiv" class="message error" style="display:none">
'<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access.
</div>
</div>
<input type="hidden" id="entityId" name="entityId" value="">
</form>
<h4>Previously accessed institutions</h4>
<ul class="plain" id="previousInstitutions">
<li>(none)</li>
</ul>
</div>
<div class="section-content">
<div class="open-athens-login">
Login using <a href="/openathens">OpenAthens</a>
</div>
</div>
</div>
</div>
</div>
</div>
<div style="display:none">
<input type="hidden" name="freelabel" id="freelabel" value='Free access'>
<input type="hidden" name="openlabel" id="openlabel" value='Open access'>
</div>
</section>
</div>
<div class="portlet-boundary portlet-boundary_58_  portlet-static portlet-static-end portlet-login " id="p_p_id_58_INSTANCE_4_">
<span id="p_58_INSTANCE_4"></span>
<section class="portlet" id="portlet_58_INSTANCE_4">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img id="joiu__null__null" src="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/cochrane-theme/images/spacer.png" alt="" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;" /> <span class="taglib-text hide-accessible">Sign In</span> </span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_4" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class=" portlet-content-container"> <div class="portlet-body"> <p>If you have a <strong>Wiley Online Library</strong> institutional username and password, enter them here.</p> <form action="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=58_INSTANCE_4&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_4_struts_action=%2Flogin%2Flogin" class="form sign-in-form " id="_58_INSTANCE_4_fm" method="post" name="_58_INSTANCE_4_fm" autocomplete="on"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_4_formDate" type="hidden" value="1583237263765" /> <input class="field" id="_58_INSTANCE_4_saveLastPath" name="_58_INSTANCE_4_saveLastPath" type="hidden" value="false" /> <input class="field" id="_58_INSTANCE_4_redirect" name="_58_INSTANCE_4_redirect" type="hidden" value="&#x2f;cdsr&#x2f;doi&#x2f;10&#x2e;1002&#x2f;14651858&#x2e;CD006383&#x2e;pub2&#x2f;references" /> <input class="field" id="_58_INSTANCE_4_doActionAfterLogin" name="_58_INSTANCE_4_doActionAfterLogin" type="hidden" value="false" /> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_login"> Username </label> <input class="field clearable" id="_58_INSTANCE_4_login" name="_58_INSTANCE_4_login" type="text" value="" /> </div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_password"> Password </label> <input class="field" id="_58_INSTANCE_4_password" name="_58_INSTANCE_4_password" type="password" value="" /> </div> <input class="field" id="_58_INSTANCE_4_institutionalLogin" name="_58_INSTANCE_4_institutionalLogin" type="hidden" value="true" /> <span id="_58_INSTANCE_4_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="login-form-footer clearfix"> <div class="pull-left"> <button type="submit" class="btn primary">Sign in</button> </div> </div> </fieldset> </form> </div> </div> </div> <div style="display:none"> <input type="hidden" name="freelabel" id="freelabel" value='Free access'>
<input type="hidden" name="openlabel" id="openlabel" value='Open access'>
</div>
</section>
</div>
</div>
</div>
</div>
</div></div>
<div class="get-access-form-content" style="display: none;" data-modal-title="Unlock the potential of Cochrane evidence">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_  portlet-static portlet-static-end scolaris-content-display-portlet " id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img id="wpdq__null__null" src="/scolaris-content-display/icon.png" alt="" /> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class=" portlet-content-container"> <div class="portlet-body"> <div class="readcube-checkout-container-outer"> <div class="row-fluid access-content-wrapper"> <div class="span6 access-left-content"> <div class="section"> <div class="access-content-section"> <h3 class="title">Institutional users</h3> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form method="post" action="/shibboleth" id="institutionLoginForm"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" name="institutionName" id="institutionName" value="" type="text"> </div> <button class="btn primary" type="submit" name="button">Go</button> </div> <div id="institutionLookupErrorDiv" class="message error" style="display:none"> '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access. </div> </div> <input type="hidden" id="entityId" name="entityId" value=""> </form> <h4>Previously accessed institutions</h4> <ul class="plain" id="previousInstitutions"> <li>(none)</li> </ul> </div> <div class="section-content"> <div class="open-athens-login"> Login using <a href="/openathens">OpenAthens</a> </div> </div> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title"> Other access options </h3> <div class="section-content"> <ul class="plain"> <li> <a class="get-access-individual-login-button" href="/c/portal/login"> Individual access - via Wiley Online Library </a> </li> </ul> </div> </div> </div> </div> <div class="span6 access-right-content readcube-checkout-container"> <div class="section"> </div> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input type="hidden" name="freelabel" id="freelabel" value='Free access'> <input type="hidden" name="openlabel" id="openlabel" value='Open access'> </div> </section> </div> </div>  <script>window.urlTitle="/cdsr/doi/10.1002/14651858.CD006383.pub2";addthis_config={pubid:"ra-593597d01cdf9a55",ui_508_compliant:true};addthis_share={url:window.location.href,title:document.title};</script> <script src="//s7.addthis.com/js/300/addthis_widget.js#pubid=ra-593597d01cdf9a55"></script> <script type="text/javascript">if(window._satellite){_satellite.pageBottom()};</script> </div> </body> </html> 